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Abstract 
Development of mature oocytes from primordial follicles in vitro could lead to major 
advances in assisted reproductive technologies for humans and domestic species. The 
overall aim of this thesis was to determine how far oocytes from bovine and human 
primordial follicles could develop in vitro and evaluate factors affecting development at 
key transition stages 1) primordial to preantral and 2) preantral to antral. Specific 
experiments investigated the ability of hormones and growth factors to; I) activate in 
vitro primordial follicle growth and to support primary to secondary stage transition 
within cortical strips and 2) promote growth in isolated preantral cultured follicles. The 
effects of recombinant human activin A (rhAct A), recombinant follicle stimulating 
hormone (rFSH) and testosterone on somatic and germ cell development and follicular 
steroidogenesis were evaluated using a combination of histology, irnrrìunohistochemistry, 
enzyme irnrnunoassay and confocal analysis. 
Primordial follicle activation occurred in all cultured bovine cortical strips compared to 
freshly fixed controls but was unaffected by treatment. The growth of primary follicles to 
the secondary stage within strips of cultured bovine tissue was promoted by testosterone 
but unaffected by the additional presence of either rFSH or rhAct A, however in these 
secondary follicles testosterone was associated with misshapen oocytes and a loss of 
somatic cell contact, features that were ameliorated by the presence of rhAct A resulting 
in a significant improvement in oocyte morphological health. Testosterone had a 
similarly deleterious effect on the oocytes of isolated bovine preantral follicles cultured 
for 8 days and follicle growth, antral formation and oocyte health observed in these 
experiments was attributed to the additional presence of rhAct A. Extending the culture 
UI 
of isolated bovine preantral follicles beyond 8 days was deterimental to oocyte survival 
as was the addition of fetal calf serum to the culture medium, however suppplementation 
with rhAct A promoted follicle growth, granulosa cell proliferation, accelerated 
formation of antral cavities and oocyte health with preservation of germ and somatic cell 
contact; as confirmed by confocal imaging analysis. Activin binding was confirmed by 
the localisation of pSMAD 2/3 proteins in all the follicular components of bovine 
follicles cultured in the presence of rhAct A. 
To determine whether follicles grown in vitro within cortical strips could be isolated and 
develop further, strips of fresh human and bovine cortical tissue containing only 
primordial and primary follicles were cultured for 6 days after which time secondary 
follicles were mechanically isolated and cultured individually for 4-6 days. In the 
presence of rhAct A, human and bovine follicles grew, formed antra and underwent 
steroidogenesis moreover oocyte growth and follicle survival were enhanced by rhAct A. 
This study has identified rhAct A as a promoter of in vitro preantral growth and 
differentiation in human and bovine follicles, moreover, it has described a two-step 
system capable of supporting in vitro oocyte growth and health in activated primordial 
follicles, an encouraging step towards the possibility of complete in vitro development of 
oocytes in humans and ruminants. 
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I.I. Outline of Ovarian Follicle Development 
1.1.1. Origin and Morphology of Primordial Follicles 
Mammalian oocytes develop within highly specialised cellular units known as ovarian 
follicles and over a species-specific period of time undergo sequential growth, 
development and maturation prior to ovulation as fertilisable gametes. Oocytes originate 
from primordial germ cells (PGCs) which migrate from the developing embryonic 
hindgut, growing and dividing mitotically to become oogonia (Anderson et al. 2000. 
Motta and Makabe 1986). Oogonia populate the gonadal ridge where they localise in the 
cortex of the developing ovary in clusters referred to as germ cell cysts or oocyte nests 
(Molyneaux et al. 2001. Pepling and Spradling 2001, reviews: Peplirig 2006, Hirshfield 
1991). In humans, oogonia numbers peak in the second trimester (Martins da Silva et al. 
2004). On completion of mitosis oogonia enter meiosis and are referred to as primary 
oocytes. At this point the oocyte nests disassemble and degeneration results in less than 
10% of the oocytes surviving at birth (De Pol et al. 1997, reviews: Pepling 2006, van den 
Hurk and Zhao 2005). Surviving oocytes associate with flattened somatic cells forming 
primordial follicles which arrest in the diplotene stage of prophase I (Erickson 1966. 
Telfer 1998a). Morphologically primordial follicles are characterised by the flattened 
appearance of the somatic or pre-granulosa cells which are at the GO stage of the cell 
cycle (Byskov eral. 1977). Primordial follicles are frequently found in close proximity to 
each other, individually bound by a basement membrane, the basal lamina (Rajah et al. 
1992,   Merchant-Larios and Chimal-Monroy 1989,   review: Loftier and Koopman 2002). 
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1.1.2. Initiation of Primordial Follicle Growth 
Primordial follicles are considered a pool of germ cells that must last a female throughout 
her reproductive life. Recently it was proposed that the murine and possibly human 
oocyte pool is replenished during adulthood by germ-line stem cells derived from the 
ovarian epithelium (Johnson et al. 2004) and blood cell precursors in the bone marrow 
(Johnson et at. 2005). The findings of the Johnson studies have been challenged and 
alternative interpretations of the data offered (Liu et al. 2007, Telfer et al. 2005, Gosden 
2004) in addition to new experimental evidence using a parabiotic model (E—an et al. 
2006) all of which appear to strengthen the fixed oocyte pool hypothesis nevertheless, the 
debate continues. In domestic species and primates, primordial follicles gradually leave 
the quiescent stage whilst other primordial follicles are still being formed (reviews: 
Fortune 2003, Gougeon 1996). Initiation of growth appears to be independent of 
gonadotrophin or endocrine factors (Baker and Neal 1973, Peters etal. 1973) and results 
in the transformation of the primordial follicle into a primary follicle, i.e. an oocyte 
enclosed by a single layer of cuboidal granulosa cells (Figure 1. I). In large animals the 
duration of the primordial to primary transition is believed to be an extremely protracted 
process taking many weeks to complete (reviews: Picton 2001, Telfer etal. 1999, Salha 
et al. 1998, Hirshfield 1991) however exact timings of this process are unclear. 
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Figure 1.1 Primordial to primary development in human follicles. A) Primordial 
follicle, arrow indicates squamous granulosa cell. B) Primordial to primary transition, 
arrow indicates cuboidal granulosa cell. C) Follicle with mixed squamous and cuboidal 
granulosa cells. D) Primary follicle with second layer of cuboidal granulosa cells forming 
as indicated by arrow. All images 40x, adapted from Erickson 2003. 
Activation of follicle growth has been evaluated in knockout rodent models, where 
specific genes believed to be involved in the initiation of follicle growth have been 
disrupted or deleted. As follicular activation occurs in the absence of gonadotrophin 
stimulation, studies have examined loss of function of specific intraovarian candidate 
regulators of the process resulting in the identification of several contributory factors. 
Extensive primordial follicle activation and subsequent premature ovarian failure has 
been demonstrated in Foxo3a", Nobox "and AMI-T 7 rodent models, implicating the 
forkhead transcription factor subfamily FOXO member Foxo3a (FKHRL1), the oocyte-
specific homeobox gene Nobox and Anti-Mullerian hormone (AMH) respectively in the 
regulation of primordial follicle activation (Rajkovic et al. 2004, Castrillon et al. 2003, 
Durlinger ci' al. 1999). A recent study examining the pattern of receptor expression in 
early follicle growth was unable to demonstrate the presence of AMH receptor type II 
(AMHRII) messenger ribonucleic acid (mRNA) in primary follicles and has questioned 
the role of AMI-I in human primordial activation (Rice et al. 2007). nonetheless AMH 
expression has been demonstrated in human follicles from the primordial stage onwards 
(Stubbs ci' al. 2005). The culture of ovaries, pieces of ovarian cortex and individual 
follicles in the presence of certain factors and their corresponding neutralising antibodies, 
as well as receptor blocking studies have all led to the identification of several molecules 
involved in primordial follicle activation including insulin (Kezele et al. 2002), kit ligand 
(KL) and basic fibroblast growth factor (hFGF) (Nilsson and Skinner 2004, Nilsson ci' al. 
2001, Parrott and Skinner 1999), leukaemia inhibitory factor (LIF) (Nilsson etal. 2002), 
bone morphogenic proteins - 4 and -7 (BMP-4, BMP-7) (Nilsson and Skinner 2003, Lee 
ci' al. 2001), platelet—derived growth factor (PDGF) (Nilsson et al. 2006) and 
keratinocyte growth factor (KGF) (Kezele ci' al. 2005). As the factors above illustrate, a 
combination of oocyte and somatic cell factors are involved in primordial follicle 
activation, interacting in a coordinated manner to ensure progression from the primordial 
to the primary stage (Albertini and Barrett 2003). Follicle growth and development is 
regulated in part by molecular exchange occurring via gap junctions, and connexin 
proteins that comprise the most abundant gap-junctions have been immunolocalised from 
the secondary stage of development onwards (Wright et al. 2001). Models utilising 
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knock-outs of gap-junction protein genes have demonstrated that the connexin protein 
Cx43 plays a vital role in the formation of ovarian gap-junctions and consequently early 
follicle development (Granot and Dekel 2002). 
1.1.3. Somatic Cell Development 
In primary follicles, growth accelerates as the granulosa cells proliferate and the oocyte 
enlarges resulting in a steady increase in the size of the follicle. The growing primary 
follicle becomes a secondary or preantral follicle when it comprises of two or more layers 
of cuboidal granulosa cells and begins to sequester interstitial stromal cells lying beyond 
the basal lamina to form the steroidogenic theca cells. The theca cells differentiate into 
two layers, the theca externa and the theca interna, the latter being penetrated by 
arterioles thus exposing the previously avascular follicle to blood-borne factors (reviews: 
Picton 2001, Salha et al. 1998, Gougeon 1996, Hirshfield 1991). An acellular glyco-
protein extracellular layer, the zona pellucida (ZP) forms between the enlarging oocyte 
and its surrounding granulosa cells. The ZP comprises of 3 proteins Zpl, Zp2 and Zp3 
and is imniunoactive preventing polyspermy and fertilisation by sperm of a heterologous 
species in addition to being involved in preservation of oocyte granulosa cell 
communication (Rankin et cii. 2001, Wassarman et at 1996). Direct contact between the 
oocyte and the granulosa cells is maintained via transzonal projections, extensions of the 
granulosa cell membrane that penetrate the zona pellucida and terminate in gap junctions 
on the oolemma (Carabatsos etal. 2000, reviews Albertini et al. 2001. Grazul-Bilska et 
al. 1997,   Anderson and Albertini 1976). When the follicle diameter reaches a species-
specific size, a fluid-filled cavity or antruni emerges within the granulosa cell mass 
S 
(Gosden and Telfer 1987) and it is around this time that the follicle becomes dependent 
on gonadotrophins for subsequent development; from here on until just prior to ovulation 
the follicle is referred to as an antral follicle. As growth continues antral fluid 
accumulates within the follicle effectively separating the granulosa mass into two distinct 
populations, the cumulus granulosa cells immediately surrounding the oocyte and the 
mural granulosa cells found lining the basal lamina, these two populations being 
connected by a 'stalk' of cells (Figure 1.2) thus the mature follicle is a multicellular unit 
comprising of the oocyte and several differentiated somatic cell types (reviews: Gougeon 
















Figure 1.2 Section of a multilaminar antral follicle. Cumulus granulosa cells of the 
antral follicle are connected to the mural granulosa cells lining the basement of the 
follicle by a "stalk" of somatic cells. Drops of follicular fluid coalesce to form an antral 
cavity. Adapted from Hardy et al. 2000. 
1.1.4. Growth and Maturation of the Oocyte. 
Immature oocytes are referred to as incompetent i.e. incapable of nuclear maturation, 
fertilisation or subsequent blastocyst formation. To achieve competency, the oocyte must 
grow and undergo nuclear maturation and cytoplasmic differentiation, processes which 
occur chiefly in concert with granulosa cell proliferation prior to the formation of an 
antrurn i.e. during preantral follicle growth (reviews: Rodrigues et al. 2008, Telfer and 
McLaughlin 2007, Fortune 2003, Telfer 1998a, E-Iirshfield 1991). It has been 
demonstrated in cows that the ability of an oocyte to complete meiosis is acquired after 
its ability to resume the process: moreover, oocyte size is a determinant in reaching 
metaphase II (Hardy et al. 2000, Hyttel et al. 1997, Fair et al. 1995). Growing oocytes 
accumulate cytoplasmic organelles and these are dispersed to the periphery of the cell in 
readiness for fertilisation and pre-implantation embryo development (Rodrigues et at. 
2008, Eppig 1994, Schultz and Wassarman 1977) additionally the ZP becomes notably 
porous as maturity approaches (Familiari et al. 2006). The preovulatory surge of 
luteinising hormone (LI-I) precedes the breakdown of the germinal vesicle thereafter the 
oocyte, released from nuclear arrest, proceeds to metaphase II and extrudes the first polar 
body in readiness for ovulation however only oocytes that have completed both 
cytoplasmic and nuclear maturation are capable of fertilisation and embryo development 
to term (Crozet et al. 1995, review: Rodrigues et at. 2008, Hardy et at. 2000, Moor et al. 
1998). Oocyte-specific growth differentiation factor-9 (GDF-9) and bone morphogenetic 
protein-15 (BMP-15) are essential for normal oocyte development and follicle 
progression beyond the primary stage (Elvin et al. l999b, Dong et al. 1996) as is 
connexin protein Cx37 (Liu ci at. 2006), the oocyte component of oocyte/granulosa cell 
gap-junctions underscoring the necessity of germ/somatic cell communication for normal 
oocyte development. Bidirectional communication between the oocyte and somatic cells 
is maintained throughout follicle development with the oocyte dependent on the 
granulosa cells for growth and meiotic-arrest maintaining factors (Eppig 2001, Pincus 
and Enzmann 1935), while the granulosa rely on oocyte-secreted factors for regulation of 
proliferation, differentiation and steroidogenesis (Diaz et al. 2007, Solovyeva et al. 2000, 
Elvin etal. 1999b, Hayashi etal. 1999, review: Eppig etal. 1997). 
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1.1.5. Ovulation, Luteinisation and Atresia 
1.1.5.1. Ovulation 
In monovular animals ovulation is episodic and is preceded by selection of a dominant 
follicle from a cohort of growing antral follicles. Although the exact mechanism of 
follicle selection is unknown, it is thought that inhibin may have an indirect effect by 
promoting an increase in circulating follicle stimulating hormone (FSH) (Groorne et al. 
1994, Meunier et al. 1988. Woodruff et al. 1988). Several events are prerequisites for 
ovulation and appear to be associated with the LI-I surge, the production of progesterone 
and of prostaglandins (review: Richards et al. 1998). These events include cumulus cell 
expansion, resumption of meiosis and formation of the macula pellucida through which, 
and due to underlying tissue degradation by matrix metal loproteinases (MMPs), the 
mature gamete will be expelled (Chappell etal. 1997, Lim etal. 1997, Lydon etal. 1995, 
review: Parr 1975). 
1.1.5.2. Luteinisation 
The ovulated follicle quickly becomes vascularised and is transformed into an endocrine 
gland known as the corpus luteiim. The granulosa cells are no longer mitotic and become 
hypertrophied, actively secreting progesterone a transformation known as luteinisation 
which is initiated and maintained by LH although prolactin, oestrogen and FSH are 
thought to be involved in a species-specific manner (Risk and Gibori 2001, McLean and 
Miller 1986, Richardson 1986). If pregnancy does not occur the corpus luteum gradually 
regresses concomitant with a decrease in progesterone secretion. 
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1.1.5.3. Follicular Atresia 
Atresia is the fate of the vast majority of follicles; in humans 85% are lost by birth and by 
puberty only 1 % of the original pool remains (Forabosco et al. 1991, Baker 1963). This 
loss is believed to be due to apoptosis or programmed cell death whereby an immature 
follicle will autonomously undergo degeneration, its constituent cells being degraded and 
reabsorbed (reviews: Hsueh et al. 1996, Tilly 1996). Follicular apoptosis results in the 
breakdown of the cytoskeleton and shrinkage, chromatin condensation, nuclear 
membrane disintegration and blebing of the cell membrane (reviews: Amsterdam et al. 
1998, Wyllie et al. 1980). Pro and anti-apoptotic factors exert control over this process 
with Bcl-2 expression being associated with a reduction in apoptosis and Bax and 
expression of the caspase cascade promoting cell death (Kim and Tilly 2004, Jiang et al. 
2003, reviews: Tilly et al. 1997, Billig et al. 1996). FSH and oestradiol are also thought 
to contribute to cell survival by promoting the expression of the proteins XIAP and FLIP 
in the granulosa cells, indeed FSH withdrawal results in the expression of the FAS 
receptor and its ligand, events occurring prior to initiation of the caspase death signalling 
pathway (Jiang et al. 2003). During cell death endogenous endonucleases cleave 
deoxyribonucleic acid (DNA) into short oligonucleosomes enabling them to be detected 
by chromophore labeled deoxynucleotides using the enzyme terminal deoxynucleotidyl 
tranferase (TdT) (Yuan and Giudice 1997, Gavrieli et al. 1992). Follicles undergoing 
apoptosis can also be distinguished from healthy follicles by detection of caspase 3, an 
effector caspase responsible for apoptotic proteolytic cleavage. By labelling anti-caspase 
3 antibodies with the fluorophore fluorescein isothiocyanate (FITC), caspase 3 can be 
detected using fluorescent microscopy (Berardinelli et al. 2004). These techniques are 
frequently used to assess the proportion of healthy cells in fixed ovarian follicles. 
1.1.6. Follicular Steroidogenesis 
Mammalian ovarian steroidogenesis is a highly regulated process necessary for the 
maintenance and local regulation normal ovarian follicle development, ovulation and 
fertilisation. It involves steroid production in two follicle cell types. 
1.1.6.1. Androgen Synthesis 
The vascular theca cells are stimulated by binding LH to synthesise the androgens 
dehydroepiandrosterone (DHEA) and androstenedione from cholesterol and acetate via 
an 3', 5'- cyclic adenosine nionophosphate (cAMP) and protein kinase A (PKA) 
regulated pathway, a reaction catalysed by the enzyme l7a-hydroxylase (P450 17 ) 
(Sasano et al. 1989, review: Hillier and Tetsuka 1997). DHEA and androstenedione can 
be further converted into testosterone and dihydrotestosterone (DHT) (Burger 2002) or 
converted into oestrogens. 
The follicular actions of androgens primarily involve their conversion to oestrogens in 
FSH sensitive granulosa cells by the action of the enzyme aromatase (review: Jamnongjit 
and Hammes 2006) however it has also been demonstrated that androgens can exert a 
receptor mediated effect, distinct from aromatisation, on follicle development (Yang and 
Fortune 2006, Otala el al. 2004, Wang et al. 2001, Murray ci' al. 1998, Vendola et al. 
1998, Billig et al. 1993, Farookhi 1985). Recent research suggests that in addition to 
regulating extracellular free steroid levels, the protein sex hormone-binding globulin 
(SI-IBG) may exert an effect on androgen action by a novel membrane bound-mechanism 
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(Forges et al. 2005, Kahn et al. 2002) moreover SHBG has been immunolocalised in 
human ovarian cells (Forges et al. 2005). Although androgen synthesis is thought to 
occur principally in the theca cells, LH receptors have been localised in the mural 
granulosa cells where changes in their expression have been observed coincident with 
fluctuations in FSH levels (Piquette et al. 1991). 
1.1.6.2. Oestrogen Synthesis 
Follicular oestrogen synthesis can occur by two routes, either via the aromatisation of 
testosterone or by conversion of androstenedione, both reactions occurring via the 
catalytic action of aromatase (P450 arom). Oestrogen is produced in the FSH exposed-
granulosa cells of antral follicles and is involved in follicular mitosis, follicle selection, 
ovulation and the maintenance of gap junctions (Wiesen and Midgley 1993). The 
production of oestrogen induces its own positive feed back loop by promoting the 
expression of oestrogen receptors, mainly oestrogen beta receptors (ERJ3) as well as the 
expression of more FSH receptors in the granulosa cells, this in turn promotes increased 
LH receptor expression in the theca consequently the potentiation of androgen conversion 
is maximised causing oestrogen output from maturing follicles to rise dramatically. 
Escalating oestrogen levels inhibit FSH secretion from the anterior pituitary resulting in 
the continued development of one dominant follicle and atresia of the remaining cohort 













0 	 increased 
Oocyte E 2 
0 	secretion A 
J
FSH binding • E 




Figure 1.3. Regulation of FSH secretion by oestrogen. (1) FSH binds to granulosa cell 
transmembrane receptors stimulating (2) increased LH receptor (LHR) expression on the 
theca thereby initiating androgen production. Androgens can be aromatised to oestrogen 
in the FSI-I stimulated granulosa cells. (3) Increasing oestrogen (E 2 ) secretion stimulates 
the expression of more (4) FSH receptors (FSHR) resulting in the production of more 
oestrogen. (5) Rising oestrogen levels ultimately inhibit FSI-E secretion from the anterior 
pituitary. 
1.2. Control and Regulation of Follicular Development 
Many of the factors involved in the later stages of follicle development have been 
identified and their actions elucidated yet much remains to be determined, in particular 
the factors involved, and the mechanisms controlling, the activation of follicle growth 
and early development. 
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1.23. Systemic and Ovarian Hormones 
The systemic regulation of follicle development is controlled by the pituitary-produced 
hormones FSH and LH. FSH binding triggers an intracellular signalling cascade 
activating adenylate cyclase to catalyse the synthesis of cAMP from adenosine 
triphosphate (ATP). By binding to protein kinase-A (PKA), cAMP instigates the 
phosphorylation of proteins that in turn bind to regulatory DNA elements thereby 
potentially altering transcription of genes involved in follicle development including the 
LH receptor gene and CYPI9, the gene encoding aromatase (Erickson 1994). Follicle 
growth does not become critically dependent on gonadotrophins until the late 
preantral/emerging antral stage is reached (Oktay el (i!. 1998, Dufour et al. 1979) 
however the presence of FSH receptors/FSH receptor mRNA has been demonstrated in 
the granulosa cells of bovine (Wandji et al. 1992), human (Oktay et al. 1997b), ovine 
(Eckery et al. 1997) and rodent (Monniaux and de Reviers 1989, O'Saughnessy et al. 
1996, Roy et al. 1987) primary and secondary follicles suggesting that FSH is an 
important determinant of early follicle development indeed it has been demonstrated that 
in the absence of FSH, follicles in human xenografted ovarian tissue could not progress 
beyond the two-layer granulosa cell stage (Oktay ci al. 1998). FSE-l's role as a promoter 
of in vitro growth and development and a suppressor of apoptosis is well reported in 
human (Abir et al. 1997, Roy and Greenwald 1996, Roy and Treacy 1993), bovine (Itoh 
et al. 2002, Mizunuma et al. 1999, Wandji et al. 1996b, Hulshof et al. 1995), rodent 
(Spears et al. 1998, Cortvrindt. etal. 1996, Nayudu and Osborn 1992), caprine (Matos ci 
al. 2007), porcine (Mao ci al. 2002) and ovine (Cecconi ci al. 1999) follicles. It has also 
been demonstrated that FSH receptors occur in the oocytcs of human and porcine 
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follicles from the primary stage onwards therefore it is conceivable that FSH may play a 
direct role in controlling oocyte development (Méduri et al. 2002). 
Androgens are produced primarily de nova in the theca cells under the influence of LH 
and the enzyme P4501 7 . From the theca layer the androgens diffuse into the FSH 
stimulated granulosa cells where P450ar011)  catalyses their conversion to oestrogens. This 
is the basis of the two-cell two gonadotrophin model of steroid biosynthesis (Hillier et 
al. 1994, Kobayashi et al. 1990, Fevold 1941). A surge of LII acts on the granulosa cells 
of the preovulatory follicle promoting the expression of genes involved in ovulation and 
luteinisation (review: Richards 2001) however the precise role of LH in follicle growth is 
unclear and appears to have a species dependent significance. It has been demonstrated 
that LH is not required for in vivo follicle growth in humans (Shoham et al. 1993a, 
Schoot el al. 1992) albeit that LII and FSH synergism appears to be required for adequate 
steroidogenesis (Shoham et al. 1993b, Schoot et al. 1992). Knockout mice lacking the 
hormone specific LH beta subunit (LH-null) are infertile. Although healthy primary and 
secondary follicles with differentiated theca layers were observed in LHf3-null ovaries, 
severe antral follicle degeneration as well as an absence of preovulatory follicles, corpora 
lutea and cyclooxygenase 2 (Cox2) are observed (Ma et al. 2004). The importance of LU 
in a culture system would appear to largely be determined by the model under 
investigation and the stage of development, with oestradiol being necessary for rabbit and 
rat granulosa cell proliferation but not primate (review: Chappel and Howles 1991). 
Whether LH is a prerequisite for optimum ruminant or human follicle development in 
vitro is yet to be ascertained. 
Oestradiol acts as an endocrine indicator of follicular development to extra-ovarian 
tissues in addition to being an autocrine mitogen which, under the influence of FSH, 
promotes follicle growth. The ovarian role of oestradiol has been examined using mice 
homozygous for both alpha (aERKO) and beta (3ERKO) oestrogen receptors knockouts 
and in mice lacking the capacity to produce oestradiol i.e. aromatase knockout (ArKO) 
mice. Despite apparently normal early growth aERKO mice are completely infertile a 
feature attributed to the elevated serum gonadotrophin levels resulting from the absence 
of the oestradiol negative feedback. Similarly, ArKO mice demonstrate raised serum 
gonadotrophin levels with a reduction in ovulation and arrested antra] follicle 
development. f3ERKO mice have reduced fertility with small cumulus oocyte complexes 
(COC's) and a reduced ovulation rate (review: Jamnongjit and Hammes 2006). There 
appears to be a difference in the in vivo and in vitro mitogenic capability of oestradiol 
with granulosa cell proliferation and a reduction in apoptosis being observed in vivo, 
actions augmented by the addition of FSH with the development of antral follicles 
(review: Richards 1980) whereas oestradiol does not appear to affect in vitro preantral 
follicle growth (Hulshof et al. 1995). 
1.2.2. Intraovarian Factors 
Intraovarian factors can regulate follicle development either directly or by modulating the 
actions of the gonadotrophins. 2 major classifications of intraovarian factors involved in 
follicle growth and survival are the insulin-like growth factor (IGF) system and the 
transforming growth factor beta (TGF) superfamily. The activity of the IGF system is 
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regulated by the IGF peptides IGF-1 and IGF-2, the IGF binding proteins (IGFBPs). the 
IGF receptors and the proteases responsible for enzymatic breakdown of the IGF/IGFBP 
complexes. The absolute requirement for IGF in follicle culture systems appears to be 
determined by species and is highly sensitive to growth stage (Walters et al. 2006) 
nevertheless the IGF family are important regulators of granulosa cell proliferation, 
differentiation and steroidogenesis (Thomas et al. 2007, review: Giudice 1992). 
The TGFf3 superfamily comprises of many signalling molecules including 3 TGFI3s, 20 
BMPs, 2 inhibin isoforms, 3 activin isoforrns, AMH and 9 GDFs with each of these 
subfamilies being involved to varying extents in specific stages of mammalian follicle 
development. TGFf3-] and TGF3-2 have been more widely investigated than TGF-3 and 
appear to have varying effects on ovarian cells in vitro (review: Juengel and McNatty 
2005). The effects of TGF3-1 and TGF3-2 on cultured granulosa cells differ quite 
markedly between species with granulosa cell proliferation and inhibition being observed 
in rodent and bovine cultures respectively (Saragueta etal. 2002, Roy 1993, Dorrington 
et al. 1988, Skinner et al. 1987). Similarly the effect of the TGF3 subfamily on 
steroidogenesis also appears to be species dependent (review: Juengel and McNatty 
2005). 
The BMPs appear to play an important role throughout follicle development from the 
earliest stages through to ovulation indeed studies using BMP1 5 knockout mice have 
demonstrated that homozygous female mutants are sLlbfertile with reduced ovulation and 
fertility rates (Yan et al. 2001). Mutations in the BMP pathway are also associated with 
variable ovulation rates in sheep for example Inverdale ewes heterozygous for an X-
linked mutation of the gene encoding BMPI5 have an increased rate of ovulation and 
twin and triplet births whilst homozygote mutant Inverdale ewes are sterile (Galloway et 
at. 2000). Similarly the increased ovulation rate and litter size observed in Booroola 
Merino sheep has been identified as a naturally occurring mutation in the gene encoding 
the BMP receptor type lB (BMPRIB) protein resulting in ovulation of small diameter 
follicles (Mulsant etal. 2001). A range of BMPs are expressed in the theca cells (BMP2, 
BMP3b, BMP4. BMP7), granulosa cells (BMP2, BMP6, BMPIS) and the oocyte (BMP6, 
BMP15) and are implicated in activation of follicle growth, inhibin and activin 
production, cumulus cell expansion (review: Knight and Glister 2006) and regulation of 
gonadotrophin secretion (Faure et at. 2005). 
Inhibin is secreted by the granulosa cells where its production is influenced by the 
gonadotrophins and intraovarian growth factors e.g. IGF-1 (review: Findlay 1993). In 
rodent and human follicles inhibin exerts a powerful stimiilatory effect on the LH 
induced production of androgens. It is suggested therefore that inhibin may indirectly 
affect follicle selection by increasing the amount of androgen available for aromatisation 
thereby increasing the intrafollicular ocstradiol whilst concomitantly reducing the FSH 
thus creating a restrictive environment for the non-dominant antral follicles (Groome et 
at. 1994, Findlay 1993). 
The intrafollicular actions of activin are regulated by its physiological antagonist inhibin 
and by the neutralising binding protein follistatin (review: Woodruff 1998). Previous 
studies have demonstrated that activin influences mammalian follicle growth in several 
species with both promotion and inhibition being observed in vitro (Silva et al. 2006, 
Thomas et al. 2003a, Mizunuma et al. 1999, Hulshof ci al. 1997, Yokata et al. 1997), and 
these will be discussed in depth later in this chapter. 
AMH is produced in the granulosa cells from gestation throughout reproductive life. In 
addition to regulating primordial follicle recruitment, studies suggest that AMH is 
involved in sensitising growing follicles to FSI-I with inhibition (Durlinger et al. 2001) 
and stimulation (McGee et al. 2001) of FSH-induced growth being observed in cultured 
preantral rodent follicles. This apparent paradox may be due to species differences and 
the addition of growth factors to the culture environment in the form of serum 
supplementation (review: Durlinger etal. 2002). 
The prominent GDF involved in follicle development is GDF-9, an oocyte-derived factor 
expressed from the primary stage through to ovulation in rodent, bovine, ovine and 
human follicles (review: Senbon et al. 2003). Studies using GDF-9 knock-out mice have 
demonstrated that the factor is critical to fertility. Although initial oocyte growth is 
stimulated and zona pelliicida formation occurs in GDF-9 null follicles, there is complete 
failure of secondary follicle development and of thecal layer formation (Carabatsos et al. 
1998. Don-0  ci al. 1996, McGrath ci al. 1995, review: Senbon ci al. 2003). 
1.2.2.1. Morphological Markers of Follicle Development 
The classic morphological hallmark of primordial follicle activation is the cuboidal 
transformation of flattened pre-granulosa cells. Thereafter the distinguishing 
morphological features of follicle development are granulosa cell proliferation as the 
follicle progresses from the primary to the secondary stage, appearance of the zona 
pellucida followed by formation of the antral cavity. The effect of in vivo and in vitro 
treatments on primordial follicle activation are evaluated by comparison of the proportion 
of oocytes surrounded by flattened cells to the proportion of oocytes surrounded by at 
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least one cuboidal cell, the presence of which is indicative of the follicle's release from 
primordial arrest. This shape change or 'rounding-up' is attributed to the readiness of the 
granulosa cells to divide (and therefore no longer considered to be quiescent) and is a 
characteristic of impending eukaryotic mitosis (Boucrot and Kirchhausen 2007, Meyers 
et al. 2006). The uniformity of this principle has been challenged by detailed studies 
made of bovine ovaries which suggest that contrary to other mammalian species 
examined, bovine primordial follicles are prolate rather than spherical due to the 
accumulation of granulosa cells at the long axis poles of the follicles. Furthermore the 
same study found that 82.5% of primordial bovine follicles comprised of a least one 
cuboidal granulosa cell (van Wezel and Rodgers 1996). Classification of these prolate 
shaped, cuboidal granulosa-containing follicles as primordial was argued by the high 
number of such follicles observed, which had they been activated follicles, would have 
implied grossly premature sterility. These follicles were also devoid of a zona pellucida 
and ultrastructural studies of the oocyte cytoplasm concurred with ultrastructural 
observations made of the oocyte cytoplasm of human and rodent primordial follicles 
(Makabe et al. 1991, Adams and Hertig 1964, Odor 1960). The presence of a combined 
single layer of flattened and cuboidal cells in human follicles has been observed by other 
investigators and these follicles referred to as intermediary (Gougeon 1996) with growth 
considered to have been initiated whereas in bovine follicles with similar morphology the 
release from quiescence is less clear therefore careful consideration of this should be 
made when analysis of activated primordial growth is assessed on bovine granulosa cell 
shape change alone. 
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The formation of an antral cavity is an apparent morphological marker of a follicle's 
progression through the secondary growth stage towards maturation and additionally an 
indicator that oocyte growth is nearing completion however debate still surrounds the 
physiological role the cavity plays in the developmental process. It is suggested that the 
antrum's follicular fluid provides a vehicle through which the oocyte and its cumulus 
cells can be propelled at ovulation. It is also proposed that as the follicle grows the 
presence of the antrum limits the number of granulosa cell layers that are established 
thereby limiting the distance between the cells and their blood supply (Rodgers et al. 
2001). Antral follicles can be categorised as dominant or non-dominant cohort follicles 
distinguished by the rate of antral cavity enlargement, the dominant follicle undergoing 
accelerated expansion. Differentiation of the granulosa cells accompanies antral 
formation. Columnar, rounded and flattened granulosa cells have been identified in early 
bovine antral follicles whereas only rounded cells were observed in larger follicles 
suggesting that the granulosa cell shape may confer a physiological advantage in bovine 
follicles (Irving-Rodgers and Rodgers 2000, van Wezel et al. 1999). 
1.2.2.2. Germ and Somatic Cell Communication 
Bi-directional communication is a prerequisite for competent oocyte development 
(Carabatsos et al. 2000, Elvin et al. 1999b, review: Matzuk et al. 2002, Eppig 2001). 
Paracrine signalling between the oocyte and adjacent somatic cells is the means by which 
many regulatory and growth molecules exert their influence on follicle development. For 
example oocyte synthesised GDF-9 stimulates cumulus cell expansion by binding to 
GDF-9 receptors on the granulosa cells (Elvin et al. 1999a), while the binding of 
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granulosa cell produced KL to its oocyte membrane receptor c-kit is necessary for oocyte 
growth (Huang et al. 1993). Somatic and germ cell communication is also mediated by 
gaps junctions, membrane channels occurring in closely apposing cells. Follicular gap 
junctions are composed of two connexons, one from each cell, each composed of six 
connexin proteins permitting the direct exchange of small molecules between adjacent 
cells (review: Kidder and Mhawi 2002). The permeability of gap junction is believed to 
depend principally on particulate mass with the passage of molecules of 1000 daltons or 
less permitted e.g. inorganic ions and second messengers (review: Harris 2001), however 
a recent study in arthropods suggests that molecular configuration may also be a decisive 
factor in allowing passage of factors between gap junctions in invertebrates (Cieniewicz 
and Woodruff 2008). Homologous and heterologous gap junctions occur in ovarian 
follicles. Homologous junctions are composed of two identical connexons, one in each 
opposing cell, each comprising of the same six identical connexin proteins, whereas as 
heterologous junction is comprised of two dissimilar connexons, each being composed 
of six proteins identical to eachother but different to the protein compliment of the 
opposing connexon (review: Kidder and Mhawi 2002). Homologous junctions are found 
between apposing granulosa cells where the most prevalent connexin protein is Cx43; 
heterologous junctions are found uniting the oocyte with its surrounding somatic cells. In 
heterologous junctions the prevalent oocyte connexin protein is believed to be Cx37 
(Nuttinck et at. 2000, Grazul-Bilska etal. 1997. Simon etal. 1997, Valdimarsson etal. 
1993, Anderson and Albertini 1976). The importance of gap junction communication to 
normal follicle development from the early stages has been demonstrated by the inability 
of neonatal Cx43 knockout mice ovaries to develop rnultilaminar follicles (Ackert et al. 
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2001, Juneja et al. 1999). Although it has long been recognised that the oocyte relies on 
the somatic cells to provide metabolic support (Zamboni 1974), to promote oocyte 
growth (Cecconi et al. 1996) and to prevent meiotic resumption (Bornslaeger and Schultz 
1985), it is now accepted that the oocyte secretes factors involved in the regulation of 
granulosa cell proliferation and differentiation (Elvin et al. 1999a, Joyce et al. 1999, 
Eppig et al. 1997. Buccione et al. 1990, Vanderhyden et al. 1992, Vanderhyden et al. 
1990). Considering the importance of this intercellular molecular 'talk' it must be of 
prime consideration when designing culture systems to provide an environment which 
promotes this communication in order to 1) understand the nature of these junctions and 
elucidate the factors involved in their formation from the earliest stages and 2) 
understand the plasticity of these structures throughout the follicle growth period. 
Complete in vitro growth (IVG) of oocytes has already been accomplished using murine 
primordial follicles (O'Brien et al. 2003, Eppig and O'Brien 1996) however similar 
success has yet to be achieved in primates or domestic species. Culture of domestic 
species (Thomas et al. 2007, Walters et al. 2006, Thomas et al. 2003a, Shuttleworth et al. 
2002, Gutierrez et al. 2000, Huanmin and Yong 2000, Cecconi et al. 1999) and human 
(Telfer etal. 2008, Carlsson et al. 2006, Abir et al. 1997, Roy and Treacy 1993) follicles 
at various stages of development has demonstrated the requirement for different factors at 
different periods of follicle growth however the routine acquisition of competent oocytes 
from early cultured large animal follicles remains a challenge. Currently major stumbling 
blocks appear to be the provision of I) a system capable of supporting growing follicles 
beyond the secondary follicle stage and 2) a system capable of promoting antral 
formation in growing follicles. Moreover, in these species preantral follicle growth and 
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antral cavity formation are thought to occur over several months in vivo, therefore in vitro 
systems would require to promote these events over a considerably shorter period of time. 
Mimicking the dynamic in vivo environment will require not only recognition of the 
specific factors needed for the acquisition of the developmental milestones but also 
identification of the factors necessary to maintain the complex intercellular systems 
within the follicle throughout the culture period in order to ensure the necessary factors 
reach their target cells. Given the dynamic in vivo milieu a sequential multi-step culture 
system is a potential in vitro alternative. 
1.3. Mammalian Follicle Development In Vitro. 
1.3.1. In Vitro Studies: Primordial Follicle Activation 
Initiation of follicle growth in vitro has been studied in rodents by culturing whole 
ovaries (O'Brien et of. 2003. Eppig and O'Brien 1996) with the rate of primordial follicle 
activation being comparable to that in vivo (Eppig and O'Brien 1996). Human and large 
animal primordial follicle activation has been achieved by culturing pieces of ovarian 
cortex (Telfer et al. 2008, Hovatta et al. 1999. Wright et al. 1999, Fortune et al. 1998, 
Hovatta et al. 1997, Wandji et al. 1997, Wandji et al. 1996a) with extensive significant 
activation reported after only 2 days of culture in bovine tissue (Wandji et al. 1996a) and 
after 5 days in human (Wright et al. 1999). Primordial follicles undergo activation when 
cultured in gonadotrophin-free media (Gigli et al. 2005, Braw-Tai and Yossefi 1997, 
Wandji et al. 1997. Wandji et al. 1996a) suggesting locally produced factors, such as 
those discussed earlier, are involved in the reL- 
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-ulation of in vitro activation. Initiation of 
primordial follicle growth has also been achieved using fresh and cryopreserved auto, 
allo and xenotranspl anted tissue (Dolmans et al. 2008, Liu et al. 2001. Oktay etal. 1998, 
Gosden et al. 1994a, Gosden et al. 1994b). In addition to allowing the evaluation of 
culture media factors on follicle development, the technique of culturing ovarian pieces 
can be used to provide a source of in vitro grown follicles for dissection and further 
individual culture (Telfer etal. 2008, Hovatta etal. 1999). 
1.3.2. In Vitro Studies: Follicle Culture 
Immature follicles represent a more homogeneous population than more developed 
follicles, indeed it has been demonstrated that 90% of isolated bovine antral follicles 
exhibit signs of apoptosis, with seemingly healthy antral follicles developing apoptotic 
sequelae with 72 hours of culture, whereas less than 10% of isolated preantral follicles 
display any signs of apoptosis or develop significant apoptosis in vitro (Telfer et al. 
1998b). These observations suggest that the earliest follicles represent the least 
compromised stages of development and hence are the most appropriate candidates for in 
vitro culture studies. Preantral follicle isolation from cortical tissue is usually achieved by 
either mechanical dissection or enzymatic isolation. Mechanical isolation using fine 
needles has the advantage of preserving follicular integrity by maintaining the basal 
lamina and thecal layers (Telfer ci' al. 2008, Walters ci' al. 2006, Thomas et al. 2003a, 
Thomas ci' al. 2001) however the yield of follicles is low and the procedure protracted 
and laborious due to the dense fibrous cortical tissue in the ovaries of large mammals. 
Enzymatic isolation employs proteinases, commonly collagenase and DNase to liberate 
primordial and preantral follicles from stromal tissue. This method yields many more 
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follicles than mechanical dissection (Park et al. 2005) moreover enzymatic isolation of 
mw-inc preantral follicles has been associated with enhanced steroidogenesis (Demeestere 
et al. 2002). Collagenase however can exert a species-specific effect which has been 
associated with follicle damage and poor survival in large mammals (Telfer et al. 2000, 
Wandji et al. 1996b) but this may be overcome by the introduction of modified 
techniques and new purified enzyme preparations including liberase (Dolmans et al. 
2008, Rice et al. 2008, Dolmans et al. 2006). 
1.3.3. Rodent Follicle Culture Systems 
Early rodent follicles can be grown in vitro with the production of competent oocytes 
(Cortvrindt etal. 1996, Eppig and O'Brien 1996, Spears et al. 1994, Eppig and Schroeder 
1989). Follicles can he cultured individually in systems supporting the 3-dimensional 
structure of the follicle, thereby mimicking the in vivo environment, by suspending 
follicles within droplets of protein-rich gels (Oktem and Oktay 2007, Loret de Mola etal. 
2004, Torrance ci al. 1989), encapsulating follicles in calcium alginate droplets (West et 
al. 2007, XU et al. 2006, Heise et al. 2005, Pangas es al. 2003,) or supporting them on 
microporous membranes (Loret de Mola ci al. 2004, Eppig and O'Brien 1996, Nayudu 
and Osborn 1992, Eppig and Schroeder 1989). In vitro growth has also been reported 
using a flat substratum where despite loss of the 3-dimensional structure, follicles 
isolated from pubertal mice attached and grew developing antral-like cavities, moreover 
the fertilisation rate of oocytes from these follicles was comparable to in vivo matured 
controls, suggesting that the importance of preserving the follicular structure in rodent 
follicle culture systems varies, and may he dependent on various factors including 
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maturity of the ovary, methods of isolation and consequently the presence or absence of 
the basal lamina (Cortvrindt etal. 1996). 
1.3.4. Bovine Follicle Culture Systems 
The success of rodent follicle culture systems has led to sustained interest in the 
development of culture systems to support the growth of preantral follicles in domestic 
species (Thomas et al. 2007. Thomas et al. 2003a, Mao et at. 2002, Shuttleworth et al. 
2002, Thomas et cit. 2001, Gutierrez et al. 2000, Saha et al. 2000, Teller et al. 2000, 
Cecconi et (it. 1999, Katska and Ryñska 1998, Flowers and Turner 1996, Wandji et al. 
1996a, Hirao et al. 1994). Bovine ovary sizes negates the possibility of whole organ 
culture and complete enzymatic isolation of follicles is unsuitable due to disruption of the 
basal lamina and consequently follicle damage (Teller ci al. 2000, Wandji ci al. 1996b) 
moreover the follicles are embedded in bulky, fibrous, cortical stroma where their 
distribution appears sparse compared to the densely follicle-rich, much smaller rodent 
ovary, making the process of mechanical isolation more technically demanding and 
ultimately yielding fewer follicles. Due to the considerable length of the preantral growth 
period in large animals (Lussier et al. 1987, Cahill and Mauleon 1980) in vitro systems 
would either have to support the follicle over a protracted period of time or substantially 
accelerate the time taken for a growing follicle to reach the antral stage. Bovine preantral 
follicles can be cultured successfully in gel drops (Itoh ci al. 2002, Wandji ci al. 1996b) 
and supported by v - bottomed culture plates (Thomas et al. 2007. Thomas et al. 2001, 
Gutierrez et al. 2000, Hulshof et al. 1995). Systems supporting preantral follicle growth 
over short (a few days) and long (over a week) in vitro periods have been established 
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with certain factors identified as promoting development (Itoh et al. 2002, Thomas et al. 
2001, Gutierrez et al. 2000, Saha et al. 2000, Wandji etal. 1996b); these systems can be 
broadly divided into those incorporating or omitting serum. Serum is rich in growth 
factors and can enhance bovine preantral follicle development in vitro (Saha et al. 2000, 
Hulshof et al. 1995) however the relatively poor characterisation and high variability 
between batches can result in difficulties in reproducibility and standardisation of the 
culture conditions. 
1.3.5. Human Follicle Culture Systems 
In contrast to rodents or domestic species human tissue availability is severely limited 
and as a result less is known about the optimisation of culture conditions. Although it is 
difficult to ascertain precisely the size of the ovarian follicular pool it is generally 
accepted that the ovarian reserve in women of reproductive age is in sharp decline, with 
the remaining follicles being relatively inaccessibly embedded in the fibrous cortex, 
therefore as with the bovine cortex, the mechanical difficulties of isolation are 
considerable. Enzymatic (Dolmans et al. 2008, Dolmans et al. 2006), partial enzymatic 
(Rice et al. 2008, Abir et al. 1999, Hovatta ci' al. 1999, Roy and Treacy 1993) and 
mechanical (Scott ci' al. 2004, Wright ci' al. 1999, Abir ci' al. 1997) isolation methods 
have been used to dissociate follicles from the cortical stroma with the resulting follicles 
being either xenografted for up to 5 months or cultured for up to 4 weeks. Xenografted 
follicles are able to survive and undergo granulosa cell proliferation with antral cavity 
formation observed in the presence of FSH (Dolmans ci' al. 2008) however isolated 
human follicle culture systems to date have been less successful. .Although follicle 
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growth and differentiation is possible in small human follicles in vitro, currently isolated 
follicle culture systems have not been capable of long-term follicle support with high 
levels of follicular atresia encountered in some cases (Scott et al. 2004, Abir et al. 1999, 
Hovatta et at. 1999, Abir et al. 1997). Thus the optimisation of conditions for the culture 
of growing human follicles is ongoing indeed the results of the studies discussed above 
suggest that a multi-step process may be necessary with activation and early growth 
being maintained within the cortical strips followed by a period of individual follicle 
Culture. 
1.4. The Role of Activin in Preantral Follicle Development 
Activin is a member of the TGFI3 superfamily expressed by the granulosa cells and 
oocytes of mammalian follicles and known to be involved in the activation of follicles 
(Findlay 1993) and preantral follicle development (Knight and Ouster 2001, Ethier and 
Findlay 2001, Findlay ci' al. 2002). Activin comprises of two beta subunits (A or B) 
identical to the beta subunits that comprise its structural homologue inhibin and exists as 
a honio or heterodimer therefore three forms of activin can be formed; A, AB, and B, 
activin A being the predominant activin isoform. Systemically activin promotes the 
release of FSH from the anterior pituitary (Katayama et al. 1990) whilst in the ovary 
activin promotes follicle growth by increasing granulosa cell proliferation and enhancing 
antral formation (Zhao etal. 2001). 
Activin has been localised in the oocytes and granulosa cells of rodent (Zhao etal. 2001) 
porcine (Van Den Hurk and Van de Pavert 2001), caprine (Silva et al. 2006) and bovine 
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follicles (Hulshof et al. 1997), in the granulosa cells of human (Roberts et al. 1993; 
Rabinovici ci' al. 1992) follicles and in thecal cell layers of porcine (Van Den Hurk and 
Van de Pavert 2001) and human (Roberts etal. 1993) follicles. Activin stimulated follicle 
growth has been demonstrated in preantral ovine (Thomas et al. 2003a) and caprine 
follicles (Silva et al. 2006) and in ovine oocytes (Thomas ci' al. 2003a). Activin also 
stimulates expression of granulosa cell FSH receptors and consequently potentiates 
somatic cell responsiveness to this gonadotrophin (Knight and Ouster 2003). In rodent 
species however the effect of activin on in vitro cultured follicles is less clear with studies 
demonstrating both promotion (Li ci' al. 1995, Zhao ci' al. 2001) and inhibition 
(Mizunuma ci' al. 1999) of preantral follicle growth. Activin exerts its intrafollicular 
effect by a series of binding and phosphorylation events modulated by membrane 
serine/threonine kinase receptors and intracellular receptor-regulated SMAD proteins 
(Figure 1.4). Firstly activin binds to a type H receptor dinier causing recruitment of a type 
I receptor dimer, ALK4, forming a hetero-tetrameric---li-and complex. The conformation 
of the complex is such that the type II receptor phosphorylates serine residues on the 
ALK4 receptor thereby activating the protein (Wrana ci' al. 1992). The activin 
intracellular signaling pathway is mediated by the receptor activated SMAD proteins 
SMAD-2 and SMAD-3, one of which binds to the activated ALK4 receptor under the 
regulation of SARA, a SMAD anchoring protein which induces phosphorylation of the 
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Figure 1.4. Activation of the SMAD signaling pathway by activin. (1) Activin binds to 
a type II membrane receptor (RTYPE II) causing the (2) binding of a cytoplasmic type I 
receptor (ALK4). ALK4 becomes phosphorylated (P) and in turn (3) phosphorylates and 
thereby activates the SMAD2/3. (4) Activated SMAD2/3 now dissociates from SARA the 
membrane anchoring protein and (5) binds with high affinity to a mediator co-SMAD 
SMAD4 (6) forming a complex. (7) The complex is internalised in the nucleus where it 
can alter the transcription of activin dependent genes. 
The activated SMAD protein binds with high affinity to the cytoplasmic coSMAD 
protein SMAD4 and this complex enters the nucleus where it can alter activin-dependent 
transcription. The action of activin is directly neutralised by the glycoprotein follistatin 
which binds activin and other TGF3 family members and by inhibin its physiological 
antagonist (Woodruff 1998). Activin can also be regulated by a BMP and activin 
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membrane bound inhibitor (BAMBI). BAMBI is a pseudoreceptor similar to the activin 
ALK4 receptor but lacking the serine residues necessary for activation of the complex 
(Massague and Chen 2000). 
1.5. The Role of Testosterone in Preantral Follicle Development 
Testosterone is derived from cholesterol and is synthesized in LI-I-stimulated thecal cells. 
Previous studies have suggested that androgens promote ovarian follicle growth (Yang 
and Fortune 2006, Wang et al. 2001, Murray et al. 1998, Vendola et al. 1998) with 
increased steroidogenesis and anti-apototic effects being attributed to the presence of 
androgens and their modulation of FSH stimulation (Otala et al. 2004, Murray et cii. 
1998, Weil ci al. 1998). The mechanism of androgenic action on growing follicles 
appears to be complex (Figure 1 .5). In addition to acting as a substrate for the synthesis 
of oestrogen, immunolocalisation of androgen receptors predominantly in the granulosa 
cells of primordial and growing follicles (Hampton et al. 2004, Otala ci al. 2004, Hillier 
etal. 1997, Tetsuka etal. 1995, Hillier and de Zwart 1981) indicates their ability to act 
independently of arornatisation to oestradiol, indeed this appears to be a dynamic 
processs with the distribution and abundance of androgen receptors being 
developmentally regulated (Yang and Fortune 2006, Hampton et al. 2004, Tetsuka ci al. 
1995). Androgens however are also associated with follicular atresia (Bagnell ci al. 1982) 
specifically demonstrated by increased DNA fragmentation in follicles of 
hypophysectomised rats (Billig etal. 1993) and an increased androgen to oestrogen ratio 
existing in the follicular fluid of atrectic follicles (Maxson ci al. 1985). Additionally 
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androgens can antagonise the FSH stimulated induction of thecal cell LH receptors in 
vivo (Farookhi 1980, Farookhi and Desjardins 1986) and in vitro (Jia et al. 1985). In the 
Sertoli cells of the testes, the male counterparts of the granulosa cells, FSH regulates 
androgen receptor expression, and indeed it has been demonstrated that FSH is involved 
in the regulation of androgen receptor mRNA in the rodent granulosa cells (Tetsuka and 
Hillier 1996). 
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Figure 1.5. Putative multiple binding of follicular androgens. 
Androgens produced by LI-I stimulated theca cells can exert their follicular actions by (1) 
P450aro rn mediated aromatisation to oestrogen (E2) in the FSH stimulated granulosa cells 
(2) binding to androgen receptors (AR) in the theca or granulosa cells or (3) binding to 
the steroid hormone binding globulin receptor complex (SHBG CO ) on the granulosa cell 
membrane. (4) Extracellular steroid levels can be regulated by binding to the steroid 
hormone binding globulin protein (SHBG) thus limiting free androgen availability. 
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Androgens can be bound by sex-hormone binding globulin (SHBG), a serum 
glycoprotein which regulates the intracellular bioavailability of the sex-steroids. Evidence 
suggests that S1-IBG also interacts with putative membrane binding sites forming a SHGB 
complex (Kahn etal. 2002) inducing an increase in intracellular cAMP (Rosner 1990), an 
effect which is enhanced by the binding of steroid to the complex (Hryb et al. 1990) 
(Figure 1.6). A recent study demonstrated SHBG expression in the ovary in the absence 
of exogenous ovarian stimulation strengthening the proposal of a role for SHBG as a 
local regulator of ovarian function (Forges et al. 2005). Immunolocalisation of SHBG has 
been demonstrated in the somatic cells and ooplasm of primordial, primary and early 
secondary human follicles and in the somatic cells of antral and preovulatory follicles 
(Forges et al. 2005). Although it is tempting to speculate a relationship may exist 
between the switching-off" of a potential means of maintaining intracellular cAMP via 
SHBG binding when the oocyte nears maturation, whether the absence of oocyte SHBG 
expression at the stage when follicle becomes FSH dependent is coincidental or linked 
remains to be ascertained. In summary it appears androgens are capable of exerting an 
effect on follicle development via 3 distinct mechanisms; by aromatization to oestradiol, 
by binding to androgen receptors and interacting with SHBG, moreover the regulation 
and coordination of these mechanisms may be crucial to the acquisition of competent 
oocytes in developing follicles. 














Figure 1.6. The SHBG signaling system. SHBG can bind to its receptor RSHBG on the 
cell membrane forming a Sl-IBG-RSEJndI complex. SHBG, already bound by a steroid, 
inhibits the binding of SHBG to R5 111 . The SHBG-RSEIBG complex can bind free steroids 
forming a SterOid-SHBG-RSHRG complex, activating adenylate cyclase and the production 
of the second messenger, cAMP. Adapted from Kahn et al. 2002. 
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1.6. Aims of Research 
The overall aim of the work described in this thesis is to define conditions that support in 
vitro development of ovarian follicles focusing on 2 key developmental junctures; 
The primordial to preantral transition and, 
Preantral progression to the antral stage. 
To determine optimal in vitro conditions for follicle activation and development, the 
effects of a TGF3 family growth factor, a gonadotrophin and an androgen were evaluated 
using ovarian tissue from 2 species; bovine and human. The effects of activin, FSH and 
testosterone on somatic and germ cell development and follicular steroidogenesis were 
analysed using a combination of histology, immunohistochemistry, enzyme immunoassay 
and confocal analysis. Single and combined effects of these factors were determined by 
their effect on some or all of the following parameters, either during, or on completion of, 
the culture period; 
I) Follicle growth 
2) Antal cavity formation 
Granulosa cell proliferation 
Granulosa cell pyknosis 
Oocyte growth and morphological health 
Oocyte-somatic cell association 
Development of intercellular cytoskeletal filaments 
Intracellular signalling pathways 
Follicular steroidogenesis 
-37- 
By assessing these parameters a detailed evaluation of the effect of culture media 
supplementation could be made at an individual cell as well as whole follicle level. The 
defining marker of normal folliculogenesis is production of a fertilisable oocyte capable 
of supporting embryogenesis and to emulate this process in vitro is the ultimate goal of 
ovarian follicle culture. Complete human and ruminant follicle development in vitro from 
the primordial stage to oocyte maturity would enable identification of the developmental 
factors and regulatory mechanisms involved moreover the resulting oocytes could be 
used for ART studies, stem cell derivation and fertility preservation research. By 
examining the ability of cultured follicles to grow, undergo steroidogenesis, somatic cell 
proliferation and differentiation, the development of the follicle as a syncytium can be 
evaluated in response to activin, FSH and testosterone. The effect of these factors on 
germ cell development can he evaluated by analysing oocyte growth and morphology, 
where morphology is an indicator of oocyte survival, moreover con-focal imaging of the 
actin present in cultured follicles allows visualisation of the distribution and density of 
cytoskeletal filaments occurring between the oocyte and its surrounding somatic cells and 
between adjacent somatic cells, in response to culture conditions. The localisation of 
receptors and molecules associated with inter and intra-cellular signaling mechanisms 
allows the observed effects to be attributed to factors being investigated. 
INE 
CHAPTER TWO 
GENERAL MATERIALS AND METHODS 
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2.1 Cortical Strip Dissection 
2.1.1. Collection of Ovarian Cortical Strips 
Bovine ovaries from random stages of the oestrous cycle were collected from local 
abattoirs and transported at 30-35 °C in M199 (HEPES buffered) medium supplemented 
with sodium pyruvate (2mM), glutamine (2mM). BSA (3mg/mI), penicillin G (75.ig/ml), 
streptomycin (50jigIml) and amphotericin B (2.5.ig/ml) (all chemicals from Sigma 
Chemicals, Poole, Dorset UK, unless stated otherwise). Under laminar flow conditions 
ovaries were rinsed in 70% alcohol and fine cortical strips removed using a scalpel-
These fine strips were placed in dissection medium (see paragraph 2.1.2.) and under light 
microscopy trimmed of excess stromal tissue using no. 15 scalpel blades and/or 25 gauge 
needles and then placed in fresh dissection medium (Figure 2. I a). 
2.1.2. Dissection Medium 
Dissection medium was used as a holding medium for pieces of cortical tissue as well as 
individually dissected follicles prior to allocation to a treatment group and culture. 
Dissection medium comprised of Leibovitz medium (GEBCO BRL. Life Technologies 
Ltd. Paisley, Renfrewshire, UK) supplemented with sodium pyruvate (2mM). glutarnine 
(2mM), BSA (Fraction V. 3mgIml), penicillin G (75ig/ml) and streptomycin (50ig/ml). 
Dissection medium was preheated to 37 °C prior to use. 
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2.1.3. Micro-Dissection 
Cortical strips or cortical fragments were placed in a petri dish in dissection medium and 
preantral follicles dissected out using 25 gauge needles (Terumo Europe, Belgium) 
attached to I ml syringe barrels (BD Plastipak, Becton Dickinson and Company. Madrid, 
Spain) under a dissecting microscope (Olympus, UK) fitted with a calibrated eyepiece 
graticule (Graticules Ltd, Tonbridge, Kent, UK). Preantral follicles with an intact basal 
lamina and evenly spaced granulosa cells were selected either for immediate fixation (0 
1-Irs) or culture (Figure 2. I b). Follicle diameters were measured on perpendicular planes 
and recorded as the mean of these two measurements; mean diameter measurements were 
recorded on the day of isolation (Day 0) and the frequency of measurement thereafter 
varied with experiments. 
2.2. Tissue Culture 
2.2.1. Culture Medium 
Basic culture medium for cortical strips and isolated follicles was prepared from McCoys 
5a medium with bicarbonate and HEPES (20mM) (GIBCO BRL, Life Technologies Ltd. 
Paisley, Renfrewshire, UK) supplemented with BSA (1mg/mi), glutamine (3mM), 
penicillin G (0.1mg/mi), streptomycin (0.1mg/mi), transferrin (2.5pglml), selenium 
(4ngIml), insulin (lOng/mi) and ascorbic acid (50.ig/ml). Following preparation, and 
prior to use, the medium was filter sterilised (Corning Costar Europe, Badhoevedorp, The 
Netherlands) and equilibrated in a humidified incubator at 37 °C and an air atmosphere 
with 5% CO,. 
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2.2.2. Culture of Ovarian tissue 
2.2.2.1 Culture of Cortical Strips and Fragments 
Trimmed pieces of bovine cortex were placed in flat-bottomed 24-well culture plates 
(Corning Costar Europe, Badhoevedorp, The Netherlands), one piece per well, with 
300.il of culture medium (Figure 2.1a). The plates were cultured for 6 days in an 
incubator at 37°C in a humidified air atmosphere with 5% CO2 . Half the volume of 
medium per well was removed and replaced every second day of the culture period. Each 
set of experiments was established under constant conditions. 2 size ranges of cortical 
tissue pieces were cultured. To analyse the effect of testosterone on all stages of bovine 
follicle development (Chapter 6) cortical strips of between 1mm 2 and 3m m2 were 
cultured as described above. To investigate primordial follicle activation within bovine 
and human cortical tissue (Chapters 7 and 8) small fragments of tissue of between 
0.5mm2 and 1mm2 in size were cultured as described above. 
2.2.2.2 Culture of Isolated Follicles 
Preantral bovine follicles were cultured in 96-well V-bottomed culture plates (Corning 
Costar Europe, Badhoevedorp, The Netherlands), one follicle per well, with I 501.11 of 
culture medium (Figure 2. lb). The plates were cultured for 4-20 days within an incubator 
in a humidified air atmosphere with 5% CO2 at 37°C. Half the volume of medium per 
well was removed and replaced every 2-4 days during the culture period. On 
establishment of the culture and on every 2-4 days thereafter, concomitant with 
refreshing the culture media, the diameters of the follicles were measured in 2 
perpendicular planes using a calibrated eyepiece graticuic, and these measurements were 
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averaged to determine a mean follicle diameter at these specific time points during the 
culture period. Media removed from the culture plates was stored at -70 °C until required 
for analysis. Each set of experiments was established under constant conditions. 
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Strips of ovarian cortex containing 
quiescent and growing follicles 
Cortical pieces trimmed of excess 
stroma and growing follicles, then 
cultured individually 
Figure 2.1a. Dissection of ovarian cortex and culture of ovarian pieces 
Micro-dissection 













by hormone assay 
Figure 2.1b. Dissection and culture of secondary follicles 
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2.3. Histology 
2.3.1. Fixing and Processing of Ovarian Tissue 
On completion of the culture period strips of ovarian cortex or individual follicles were 
fixed overnight in Bouiri's solution (70% picric acid, 25% formaldehyde, 5% glacial 
acetic acid) or in 4% paraformaldehyde (4% paraformaldehyde in distilled H 20, 0. IM 
NaOH, 0.1M Na phosphate, pH 7. use and store at 4 °C). Fixative was removed and 
replaced by 70% ethanol for a minimum of one hour. When fixing individual follicles 
70% ethanol was replaced with 70% ethanol coloured with eosin to allow visualisation of 
the follicles during subsequent processing. 70% ethanol was replaced with increasing 
concentrations of ethanol up to and including absolute ethanol. Absolute ethanol was 
replaced with cedar wood oil (Fisher Scientific, Loughborough, Leicestershire, UK) for a 
minimum of 24 hours after which the oil was cleared using toluene (in a fume hood) for 
30 minutes. Thereafter the samples were embedded in paraffin wax (McCormack 
Scientific. St Louis, Mo) at 60 °C for 4 hours, the wax being renewed every hour to ensure 
complete clearance of all the toluene. 
2.3.1.1. Sectioning and Mounting 
61.lrn thick samples were sectioned using a microtome (Leica UK Ltd, Milton Keynes, 
UK), floated on a water bath at 42 °C. Depending on the subsequent analysis required 
sections were affixed onto gelatin coated (gelatin-coating solution comprised of 1% 
gelatine and 0.1% chromic potassium sulphate in dH2O) or charged slides (VWR 
International Ltd, Lutterworth, Leicestershire, UK) and left to dry overnight at 37 °C prior 
to staining. 
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2.3.1.2. Staining 
Sections were de-waxed in xylene for 30 minutes (2 x 15 minute immersions) and re-
hydrated by subsequent immersions in decreasing concentrations of alcohol with lithium 
carbonate being added to the final alcohol bath to ensure removal of all Bouin's fixative. 
Following rinsing in tap water, the sections were placed in Harris' Haematoxylin (BDH 
Laboratory Supplies, Poole, UK) for 4 minutes then rinsed in tap water, immersed in 
Scotts tap water substitute and rinsed again in tap water. The sections were then placed in 
eosin (Sigma Chemicals, Poole, Dorset UK) solution (I:!) for 2 minutes and finally 
placed in potassium aluminium solution for 3 minutes prior to a tap water rinse and 
dehydration through increasing concentrations of ethanol. Following immersion in xylene 
for a minimum of 15 minutes the sections were mounted using DPX mounting medium 
(BDH Laboratory Supplies, Poole, UK) and glass cover-slips (BDH Laboratory Supplies, 
Poole, UK). 
2.3.2. Processing of Ovarian Tissue for Immunohistochemistry 
2.3.2.1. Processing of Samples 
Ovarian strips and follicles were processed and embedded as described in 2.3.1. 
2.3.2.2. Sectioning and Mounting 
6jim thick samples were sectioned using a microtome, floated on a water bath at 42 °C 
then affixed onto charged slides as described in 2.3.1.1.(VWR International Ltd, 




Immunohistocheniistry was performed to localise I) Ki-67 antigens. 2) activated 
SMAD2/3 antigens and 3) androgen receptor antigens in sections of freshly fixed and 
cultured ovarian follicles and cortical strips. Details of the primary and secondary 
antibodies employed, incubation timings and concentrations, method of antigenic 
retrieval, blocking and endogenous peroxidase neutralising procedures and visualisation 
techniques for each specific procedure are shown in the Methods and Materials sections 
of Chapters 4, 5 and 6. The following paragraph outlines the general process of 
immunohistochemical analysis of paraffin embedded ovarian tissue sections. 
Following de-waxing in xylene and rehydration in graded ethanol, samples washed twice 
in phosphate buffered saline 0.01M (PBS) or Tris buffered saline 0.05M (TBS) and then 
rinsed in tap water. Antigen retrieval was performed either by microwave (4 mins full 
power, 4 inins half power) or by pressure cooking (5 mins at l5lbs/in 2 ) in sodium citrate 
0.01M. Sections were washed in PBS/TBS (2 x 5 minute immersions), placed in 1.5%-
3% hydrogen peroxide and methanol to block endogenous peroxidase activity for 10 
minutes and washed again in PBS/TBS (2 x 5 minute immersions). Sections were placed 
in blocking serum followed by incubation with the primary antibody (one to 24 hours at 
40C). Negative controls were performed by conducting the procedure in the absence of 
primary antibody and inclusion of the appropriate non-immune lgG. Following 
incubation with the primary antibody slides were washed in PBSITBS (2 x 5 minute 
immersions) and incubated with biotinylated secondary antibody for 30 minutes at room 
temperature and washed in PBS/TBS (2 x 5 minute immersions). Slides were then 
incubated with Streptavidin Horseradish Peroxidase (Streptavidin HRP) for 30 minutes at 
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room temperature and washed in PBS/TB S. Localisation of the antigen was performed by 
incubation with 3, 3'-diaminobenzidine (DAB) for 2-3 minutes. Slides were washed in 
tap water, counterstained with haematoxylin and/or eosin, dehydrated and mounted. 
2.3.3. Collection and Analysis of Histological Results 
Histological observations and measurements were made on isolated follicles and follicles 
enclosed within cortical pieces using a light microscope with a crossed micrometer. 
2.3.3.1. Analysis of Follicles within Cortical Pieces 
To avoid counting and categorising the same follicle within a cortical piece twice every 
seventh section from each piece of mounted tissue was analysed; follicles contained 
within these sections were included in analysis if the germinal vesicle was present. 
Follicular developmental stage was categorised using the same criteria as Wandji et a! 
(1996a) as follows: 
( I ) Primordial— oocyte surrounded by a single layer of flattened somatic cells. 
Primary - oocyte surrounded by a complete single layer of cuboidal granulosa cells. 
Secondary - oocyte surrounded by two or more complete layers of granulosa cells. 
As discussed in 1.2.2.1. some uncertainty exists as to the developmental activity of 
bovine transitory follicles i.e. follicles surrounded by a single mixed layer of flattened 
and cuboidal cells with evidence suggesting that in the bovine ovary at least these 
follicles remain in an arrested state (van Wezel and Rodgers 1996) consequently 
primordial and transitory follicles were grouped together and designated as quiescent. 
Therefore follicles were designated to one of three developmental stages; quiescent, 
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primary or secondary. The morphological health of oocytes within cortex enclosed 
follicles was evaluated as described below in 2.3.3.2. 
2.3.3.2. Analysis of Isolated Follicles: Freshly Fixed and Cultured (including oocytes 
within cortical pieces) 
When present the section containing the nucleolus was analysed, or if absent, the section 
containing the largest cross-section of the oocyte was used, incomplete or torn follicles 
damaged by processing were excluded from analysis. Follicle and oocyte diameters were 
measured directly, morphological oocyte health was determined by the presence of the 
following parameters; I) general circularity of the oocyte. 2) integrity of the oolemma 
and 3) presence of a germinal vesicle and nucleolus, therefore grossly spherical oocytes 
with an unbroken outer membrane and a visible germinal vesicle and nucleolus were 
considered healthy. Oocytes not meeting all of these criteria were deemed unhealthy. 
Granulosa cell proliferation was estimated qualitatively by counting the number of 
granulosa cell layers present in the section of the follicle containing the nucleolus. 
Follicles from each treatment group were selected for this analysis on the basis of I) 
having undergone in viiro growth. 2) being of a similar diameter on completion of the 
culture period. These criteria were applied to ensure only growing follicles were 
compared. Under light microscopy sections being analysed were positioned to allow 
division into four equal quadrants by the micrometer axes. By counting the number of 
cells between the basal lamina and the zona pellucida lying on or touching the axes, a 
mean number of cell layers per section was determined from the maximum and minimum 
values (Figure 2.2). Quantitative granulosa cell proliferation was determined by 
calculating the proportion of positively stained granulosa cells per section following 
immunohistochemistry to detect the Ki-67 antigen in growing cells. 
Mic 
Basal Lamina 
Figure 2.2. Qualitative Analysis of Granulosa Cell Proliferation. Granulosa cell 
proliferation was estimated in growing follicles by counting the number of granulosa 
cells lying on, or in contact with, the axes as shown above. The mean number of cells per 
section was calculated from the maximum and minimum values obtained. 
Antral cavity formation was determined as the presence of one or more discreet fluid 
filled cavities within the granulosa cell population and was determined by inspecting 
serial sections of fixed follicles. To distinguish antral cavity formation from incipient 
cavity formation i.e. the accumulation of follicular fluid between cells observed prior to 
emergence of a cavity, areas within the granulosa devoid of cells were measured. The 
diameter of a cavity was calculated by measuring the space at its widest and narrowest 
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point and calculating a mean diameter value areas with a diameter of ? 50tm were 
considered to be established antral cavities (Figure 2.3a). Spaces occurring between the 
basal lamina and the outermost layers of granulosa cells were occasionally observed 
within sections however these were considered to be histological artefacts and not 
regarded as antral cavities (Figure 2.3b). For statistical comparison, follicles forming 
antral cavities were expressed as a proportion of the total number of follicles per 
treatment group. The presence of signalling molecules and receptors as detected by 
immunohistochemistry was determined by the presence of positively stained cells as per 
the respective protocols 
Area of Detachment 
(b) (a) 	
Areas of Cavitation 
Figure 2.3. Determination of Antral Cavity Formation. (a) Spaces within the 
granulosa cells were considered to be antral cavities if the mean diameter measured 
?50im (circled in red). (b) Detachment of granulosa cells from the basal lamina 
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Previous work in this laboratory has concentrated on developing in vitro systems to grow 
follicles from domestic species to identify factors involved in oocyte development and 
follicle survival (Thomas et al. 2007, Walters et al. 2007, Walters et al. 2006, Thomas et 
al. 2003a, Thomas et a!, 2001, McCaffery et at. 2000). These studies all used serum-free 
systems and examined the effect of different culture media supplements including IGF-1 
and ascorbic acid on growing follicles, demonstrating significant follicle growth and 
survival in ovine, bovine and porcine follicles over 6-12 day in vitro periods. A recurring 
feature of these cultured follicles however was loss of oocyte-somatic cell contact usually 
around the 6' day of culture, and this was associated with reduced oocyte development 
thereafter. As discussed in Chapter one, normal oocyte development relies on the 
paracrine and gap junction mediated communication with the granulosa (Eppig 2001, 
Anderson and Albertini 1976) suggesting that rupture of the connections between the 
oocyte and its surrounding somatic cells would be deleterious to oocyte survival. The 
objective of the follicle culture system utilised in this chapter was to promote coordinated 
germ and somatic cell growth in preantral bovine follicles whilst maintaining oocyte and 
somatic cell contact throughout. The overall aim of the experiments described in this 
chapter was to evaluate the effect of serum in the presence and absence of FSH on 
preantral bovine follicles over a prolonged in vitro period. The hypothesis was that 
supplementation of the culture media with serum would maintain existing follicular gap 
junctions and promote the formation of nascent gap junctions as follicles developed in 
vitro thereby supporting oocyte growth. Serum is known to contain a rich variety of 
proteins which may promote follicle viability especially over extended periods in culture, 
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however the complexity of these proteins can vary greatly with cultured cells being 
especially susceptible to disruptions in the culture medium therefore continuity of the 
serum source and supply must be ensured to maintain stability thereby avoiding 
unnecessary perturbation of the in vitro milieu which might compromise reproducibility 
and standardisation of the culture conditions. Supplementation of culture media with a 
combination of serum and gonadotrophins has been evaluated in several species with the 
promotion of follicle growth and viability being reported in very early bovine preantral 
follicles (Saha et al. 2000), porcine preantral follicles (Mao et al. 2002) and murine 
preantral follicles (Cortvrindt et al. 1997, Nayudu and Osborn 1992). Although not an 
absolute requirement for preantral growth, the presence of FSH receptors in preantral 
somatic cells suggests a possible role for the gonadotrophin during this developmental 
stage (Dufour et al. 1979) indeed this has been reinforced by the observation of FSH 
receptor expression in the primary stage of human follicle development (Rice et at. 2007, 
Oktay et al. 1998). FSH alone, and in combination with growth factors, has been 
associated with follicle growth, antral formation, oocyte growth and steroid in 
bovine, porcine, murine and human preantral follicles (Wu and Tian 2007, Adriaens et al. 
2004, Itoh et cii. 2002, Gutierrez et al. 2000, Wright et al. 1999, Ralph et al. 1995, 
Wandji et al. 1996b, Roy and Treacy 1993, Roy and Greenwald 1989). Follicle growth 
was assessed every fourth day during the in vitro period. Follicles were removed from 
culture at 4-day intervals throughout the 20-day culture period. The same number of 
follicles was removed from each treatment group; follicles were randomly selected for 
removal from culture. Antral cavity formation, oocyte diameter and oocyte 
morphological health were evaluated by histological assessment. 
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3.2. MATERIALS AND METHODS 
3.2.1. Isolated Preantral Follicle Culture 
Preantral follicles (132 - 199prn) were isolated from freshly collected bovine cortical 
strips and cultured individually for up to 20 days as previously detailed in Chapter 2, with 
media being removed and replaced every fourth day. Follicles were assessed at 4 day 
intervals during the culture period. A total of 20 experiments were set up, the first set of 
experiments (n = 7) looked at the effect of fetal calf serum (FCS) and the second set (n = 
13) considered the effect of FCS in combination with FSH. 
3.2.2. Treatments 
3.2.2.1. Treatment with FCS and FSH 
Basic culture medium (control) was prepared as previously described in 2.2. I. Basic 
culture medium was supplemented with 5% FCS (BioSera Ltd. East Sussex, UK) alone 
or 5% FCS and recombinant FSH (rFSH) (Serono, Geneva, Switzerland). The total 
number of follicles per treatment group is shown in Table 3.1. The number of follicles 
removed and remaining in culture is shown in Figure 3. ]a. 
Table 3.1. Total number of follicles in each treatment group per experiment 
Control 
iirgiusiriutI 
n = 106 ii = 109 
5% FCS n = 109 
5% FCS-i-lOng/ml rFSH ii =106 
5% FCS+20ng/ml rFSH n = 104 
5% FCS+50i'tg/ml rFSH ii = 103 
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Expt 1. • Control Follicles 
Removed • 5%FCS 
Total 	24 21 	 24 	 19 18 
No. Follicles 	22 24 22 21 20 
106 
109 
Day 0 	Day 4 	Day 8 Day 12 	Day 16 	Day 20 
Follicles 	82 	 61 37 	 18 
Remaining 87 63 41 20 • Control 
Expt 2. 
D FCS+10FSH • FCS+20FSH 
Total 	Follicles • FCS+50FSH 
No. Follicles 	Removed 





2224 	2220 	2220 
)2119 2422 	121 22 
)2020 
1922 
Day 0 	Day 4 	Day 8 	Day 12 	Day 16 	Day 20 
8684 6460 4240 2020 Follicles 8585 	6466 	4044 	1922 Remaining 
Figure 3.1a. Removal and maintenance of preantral bovine follicles in vitro. The 
number of follicles in culture declined over time in both experiments with follicles 
randomly removed at the time points shown. In Expt I and Expt 2 colour-coded numerals 
above the timeline at Day 0 indicate the total number of follicles per treatment group per 
experiment. From Day 4 onwards, coloLir-coded numerals above both timelines indicate 
the number of follicles removed from each treatment group: colour-coded numerals 
below both timelines indicate the total number of follicles per treatment group 
progressing to the next time point. 
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3.2.3. Statistical Analyses 
Distribution of data for parametric analysis was checked using GraphPad Software Instat 
Guide to choosing and interpreting statistical tests version 3.05, 1998, GraphPad 
Software Inc., San Diego, California, USA. In Experiment I, mean follicle diameters 
were compared between both treatment groups at Day 0 and every fourth day of the 
culture period using Minitabl4 Statistical Software Students t-test. In Experiment 2 mean 
follicle diameters were compared between treatment groups at Day 0 and every fourth 
day of the culture period using Minitabl4 Statistical Software one-way unstacked 
ANOVA with subsequent t-tests to allow for individual inter and intra-group comparison. 
Oocyte diameters were compared between treatment groups by histological measurement 
using Minitabl4 Statistical Software Students t-test (Experiment I) and a Min1tab14 
Statistical Software one-way unstacked ANOVA with subsequent t-tests to allow for 
individual inter-group comparison (Experiment 2). The proportions of antral cavity 
formation and oocyte morphological health were assessed using Minitab14 Statistical 
Software Contingency Tables: Chi Square Test. 
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3.3. RESULTS 
3.3.1. Experimental Outline 
2 experiments were conducted and a total of 20 cultures established with a variable 
number of follicles in each culture (range 28 - 43 follicles). 
Experiment 1: 7 replicate 20-day cultures of preantral follicles in the presence and 
absence of 5% FCS. Follicle diameters measured on days 0, 4, 8, 12, 16 and 20 of the 
culture period. An equal number of follicles randomly removed at Day 4 and every 4 1 
day thereafter from each treatment group for histological evaluation of follicular 
parameters at these time points therefore the number of follicles declined over time in this 
experiment. The same number of follicles was removed from each treatment group where 
possible, when this was not possible the number of follicles removed or remaining in 
culture differed between treatment groups by no more than I. 
Experiment 2: 13 replicate cultures were set up to investigate the effect of 3 
concentrations (10, 20 and 50 no/ml) of FSH in combination with 5% FCS on preantral 
follicle development. In vitro diameter measurements were made and follicles removed 
from culture as described above for Experiment I. For each experiment histological 
observations were made on a number of uncultured controls i.e. freshly fixed follicles (0 
1-Irs), (Experiment I, n = 21; Experiment 2, n = 19). 
3.3.2. Follicle Growth and Differentiation: Control versus FCS and FSH 
3.3.2.1. Effect of FCS and FSH on the Growth of Preantral Bovine Follicles cultured 
for 20 days 
In Experiment I, follicles were cultured for a maximum of 20 days in control medium or 
in medium containing 5% FCS. In Experiment 2, follicles were cultured for a maximum 
of 20 days in control medium or in medium containing 5% FCS and 10, 20 or 50ng/ml 
rFSH. In Experiment I significant growth was observed in follicles supplemented with 
5% FCS compared to control follicles (p < 0.05) at Day 20 of the culture period (Figure 
3.lb). 
In Experiment 2, significant growth was observed in follicles supplemented with 5% FCS 
and lOng/mI rFSH compared to control follicles (p  <0.05) at Day 20 of the culture period 
(Figure 3.1c). 
Table 3.2. Number of follicles removed for analysis at 5 time points during culture 
period 
Experiment 1 
Control 	 it = 24 	it = 21 	it = 24 	n = 19 	it = 18 
5% FCS 	 it = 22 	it = 24 	it = 22 	it = 21 	it = 20 
Experiment 2 
Control n = 23 it = 22 ii = 22 it = 22 n = 20 
5% FCS+lOng/mI rFSH n = 22 it = 24 it = 20 it = 20 n = 20 
5% FCS+20ng/nil rFSH ii = 19 n =21 n = 24 n = 21 n =19 
5% FCS+SOng/mL rFSH n =18 n = 19 it = 22 it = 22 it = 22 
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Figure 3db. Effect of FCS on follicular growth. 
Preantral follicle growth in the presence (pink) and absence (black) of 5% FCS. Values 
are mean follicle diameters ± SEM. (*) denotes a significant difference between 
treatment groups at Day 20 only. At Day 20 significant growth was observed in follicles 
cultured in 5% FCS compared to control (p < 0.01). 
Figure 3.1c. Effect of FCS and FSH on follicular growth. 
Preantral follicle growth in the presence of 5% FCS and I Ong/ml (white), 20ngImI (blue), 
SOng/mI (pink) rFSH or control medium (black). Values are mean follicle diameters ± 
SEM. (a) and (b) denote significant differences between treatment groups at Day 20 only. 
Significant growth was observed in follicles cultured in 5% FCS and lOng/mi rFSH 
compared to control (p <0.05) at Day 20 of the culture period. 
Fig 3.lb 
In Vitro Preantral Bovine Follicle Growth: 
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Fig 31c 	
In Vitro Preantral Bovine Follicle Growth: 
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3.3.2.2. Effect of FCS and FSH on Antral Cavity Formation in Preantral Bovine 
Follicles cultured for 20 days 
Antral cavity formation was determined on histological evaluation as a fluid filled cavity 
within the basal lamina dividing the granulosa into mural cells adjacent to the basement 
membrane and cumulus close to the oocyte (Figure. 3.2). Analysis of antral cavity 
formation is described in detail in Chapter 2 section 2.3.3.2. and illustrated in Figure 2.3. 
Antral cavity formation is expressed as a proportion of the total number of follicles per 
treatment group. In Experiment I antral cavity formation was significantly higher in 
follicles cultured in 5% FCS from Day 12 onwards compared to control follicles (p < 
0.05) (Figure 3.3a). In Experiment 2 antral cavity formation occurred in a significantly 
higher proportion of follicles cultured in the presence of FCS and any concentration of 








Figure. 3.2. Antral cavity formation in a cultured preantral bovine follicle. 
Formation of an antral cavity in a bovine follicle cultured in the presence of 5% FCS and 
I Ong/rnl rFSH for 20 days. Granulosa cell population distinguished as mural granulosa 
cells (MG A) adhering to the basal lamina and cumulus granulosa cells (CG A) close to 
the oocyte. 
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Figure 3.3a. Effect of FCS on antral cavity formation in cultured preantral bovine 
follicles. 
Antral cavity formation in follicles cultured in 5% FCS (pink) compared to control 
(black) follicles. Values are antral follicles expressed as proportion of the total follicle 
population per treatment group. (*) denotes a significant difference between treatment 
groups at specific time points only. No significant difference in antral formation observed 
between control and 5% FCS cultured follicles on Day 4 and Day 8 of the culture period. 
On Day 12, Day 16 and Day 20, follicles cultured in the presence of 5% FCS had a 
significantly greater proportion of antral follicles (p  <0.05) than those cultured in control 
medium. 
Figure 3.3b. Effect of FCS and FSH on antral cavity formation in cultured preantral 
bovine follicles. 
Antral cavity formation in follicles cultured in 5% FCS and lOng/mi (white), 20ng/ml 
(blue), 50ng/ml (pink) rFSH or control medium (black). Antral cavity formation is 
expressed as a proportion of the total number of follicles per treatment group. (*) denotes 
a significant difference between treatment groups at specific time points only. No 
significant difference in the proportion of follicles forming antra between control and 5% 
FCS and any of the concentrations of FSH on Day 4. A significant larger proportion of 
follicles formed antral cavities in the presence of FCS and all concentrations of FSH 
compared to control cultured follicles on Day 8 (p  <0.05), Day 12 (p  <0.01), Day 16 (p 
<0.01) and Day 20 (p  <0.05). 
Fig 33a 
Antral Cavity Formation in Cultured Preantral Bovine Follicles: 
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Fig 3.3b 
Antral Cavity Formation in Cultured Preantral Bovine Follicles: 
Control versus FS and FSH 
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3.3.3. Oocyte Growth and Morphological Health: Control versus FCS 
3.3.3.1 Effect of FCS and FSHon the Growth of Oocytes in Preantral Bovine Follicles 
cultured for 20 days 
In Experiment 1 significant oocyte growth was observed on Day 4 and Day 8 in follicles 
cultured in the presence of 5% FCS compared to the oocytes of follicles cultured in 
control medium on the same days (p < 0.05). The oocytes of follicles cultured in 5% FCS 
on Day 4 and Day 8 were also significantly larger than oocytes of follicles cultured in 5% 
FCS on days 12, 16 and 20 (p < 0.01) and the oocytes of freshly fixed follicles (0 Hrs) (n 
= 21) (p < 0.05) (Figure 3.4a). Of the follicles cultured 5% FCS, significant oocyte 
growth was observed at Day 8 compared to Day 4 (p  <0.05). 
In Experiment 2, significant oocyte growth was observed in follicles supplemented with 
5% FCS and [Ong/nil, 20ngIml and 50ng/rnl rFSH on Day 4 (p < 0.05) and Day 8 (p < 
0.05) of the culture period compared to the oocytes of freshly fixed follicles (0 Hrs) (n = 
19) and follicles cultured in control medium. No significant difference observed in oocyte 
growth between treatment groups at days 12. 16 and 20 (Figure 3.4b). Oocytes in all 
treatment groups were significantly smaller on days 12, 16 and 20 than the oocytes of 
freshly fixed follicles (p  <0.05). 
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Figure 3.4a. Effect of FCS on oocyte growth. 
Oocyte growth in the presence (pink) and absence (black) of 5% FCS compared to oocyte 
diameters in freshly fixed follicles (OHrs) (hatch). Values are mean ± SEM. (*) and  (**) 
denote a significant difference between treatment groups at specific time points only. 
Significant oocyte growth was observed in follicles cultured in the presence of 5% FCS 
on Days 4 and 8 (p < 0.05) compared to control and freshly fixed follicles (Day 0). 
Oocytes grown in the presence of 5% FCS were significantly larger at Day 8 compared to 
Day 4 (p  <0.05). 
Figure 3.4b. Effect of FCS and FSH on oocyte growth. 
Oocyte growth in the presence of control (black), 5% FCS and I Ong/mi (white), 20ng/ml 
(blue) or 5Ong/ml (pink) rFSH compared to oocytes diameters in freshly fixed follicles (0 
Hrs) (hatch). Values are mean ± SEM. (*) denotes a significant differences in oocyte 
growth between treatment groups at specific time points only. Significant oocyte growth 
occurred in the oocytes of follicles cultured in the presence of 5% FCS and 10. 20 and 
SOng/mI rFSH on Day 4 (p  <0.01) and Day 8 (p  <0.01) compared to oocytes of follicles 
fixed at 0 Hrs oocytes cultured in control medium on Days 4 and 8. No significant 
difference in oocyte diameter between treatment groups on Day 12, Day 16 or Day 20 of 
the culture period. 
Fig 3.4a 
Oocyte Growth in Cultured Preantral Bovine Follicles: 
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Fig 3.4b 	
Oocyte Growth in Cultured Preantral Bovine Follicles: 
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3.3.3.2. Effect of FCS and FSFI on Oocyte Morphological Health in Preantral Bovine 
Follicles cultured for 20 days 
Morphological health was determined by the shape of the oocyte, integrity of the 
oolemrna and the presence of a germinal vesicle and nucleolus in each section being 
evaluated. Grossly spherical oocytes with an unbroken outer membrane and a visible 
germinal vesicle and nucleolus were considered healthy (Figure 3.5a) whereas oocytes 
not meeting all of these criteria were deemed unhealthy (Figure 3.5b). Oocyte health 
deteriorated over time in both experiments and was associated with a loss of uniformity 
of somatic cell shape and arrangement in the inner most layer around the oocyte (Figure 
3.5b). In Experiment 1 morphological oocyte health was significantly higher in the 
oocytes of freshly fixed follicles (Day 0) (p <0.01) and those cultured in control medium 
for 4 days (p <0.01) or 5% FCS for either 4 (p  <0.01) or 8 (p  <0.05) days compared to 
the oocytes of follicles in either treatment cultured for longer periods (Figure 3.6a). 
In Experiment 2, oocyte health was significantly higher in the oocytes of freshly fixed 
follicles (Day 0) (p < 0.01) and follicles supplemented with 5% FCS and lOng/mi rFSI-I 
(p <0.01), 5% FCS and 20ng/ml rFSH (p  <0.01), 5% FCS and SOng/mI rFSH (p  <0.01) 
on Days 4 and 8 and in follicles supplemented with control medium on Day 4 (p  <0.01) 
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Figure. 3.5. Oocytes from cultured bovine follicles. (a) Healthy spherical oocyte in a 
bovine follicle cultured for 4 days in 5% FCS and SOng/mI rFSH. Germinal vesicle, 
nucleolus and intact oolemma all clearly visible, good contact with sulTounding granulosa 
cells of uniform shape and arrangement. (b) Shrunken misshapen oocyte from follicle 
cultured in 5% FCS and 50ng/rnl rFSH for 20 days; no distinguishable germinal vesicle, 
oolemnia ruptured and granulosa cell contact lost; disordered somatic cells visible of 
variable shape. 
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Figure 3.6a. Effect of FCS on morphological oocyte health. 
Morphological oocyte health in follicles cultured in control (black) and in 5% FCS (pink) 
compared to the oocytes of freshly fixed follicles (0 Hrs) (hatch). Values expressed as a 
proportion of the total number of oocytes analysed in each treatment group. (*) denotes a 
significant difference in oocyte morphological health between treatment groups. No 
significant difference between the proportion of morphologically healthy oocytes 
observed in freshly fixed follicles and those Cultured in 5% FCS on Day 4 or Day 8, or 
control medium on Day 4. A significantly greater proportion of morphologically healthy 
oocytes were observed in follicles cultured in 5% FCS on Day 8 compared to control 
medium (p < 0.05). No significant difference in oocyte morphology between treatments 
on Day 12, Day 16 or Day 20. 
Figure. 3.6b. Effect of FCS and FSH on morphological oocyte health. 
Oocytc health in follicles cultured in control (black) and follicles cultured in 5% FCS and 
10 (white), 20 (blue) and SOng/mI rFSH (pink) compared to oocyte health in freshly fixed 
follicles (0 Hrs) (hatch). Values expressed as a proportion of the total number of oocytes 
analysed in each treatment. (*) denotes a significant difference in oocyte morphological 
health between treatment groups. No significant difference between the proportion of 
morphologically healthy oocytes observed in freshly fixed follicles and those cultured in 
any of the treatments on Day 4 or those cultured in the presence of FCS and any 
concentration of FSH on Day 8. A significantly greater proportion of morphologically 
healthy oocytes were observed in follilces cultured in 5% FCS and 10, 20 or SOng/ml 
rFSH compared to those cultured in control medium on Day 8 (p  <0.05). No significant 
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Figure 3.7. Preantral bovine follicles cultured for 8 days (a) and 20 days (b) in 5% 
FCS. (a) Morphologically healthy oocyte with visible germinal vesicle and nucleolus and 
good oocyte somatic cell contact, follicle diameter 275.im; no antral cavity formation, (b) 
Morphologically unhealthy oocyte with shrunken misshapen oocyte with no visible 
germinal vesicle and poor somatic cell oocyte contact, follicle diameter 250p.m; no antral 
cavity formation. 
3.4. DISCUSSION 
The experiments described in this chapter examined the effect of FCS alone and in 
combination with FSH on the development of isolated preantral bovine follicles. Serum is 
a commonly used tissue culture additive and considered an excellent source of essential 
proteins, nutrients and attachment proteins (Klebe 1974), however, serum may also 
include potentially inhibitory factors as characterisation of all the constituent molecules 
in such a complex mixture is not possible, therefore the effects observed can be a 
combination of stirnulatory and inhibitory actions. As a rule, in culture systems, the 
derivation of the serum matches the species being investigated with supplementation of 
cultures with dissimilar serum causing inhibition of follicle growth (NayLidLi and Osborn 
1992) however there are exceptions with post-menopausal human serum being suitable 
for murine follicle culture (Qvist et al. 1990) demonstrating the variability between 
serum types and potential impact of these differences on cell culture. 
In other studies utilising early growing follicles, serum comprises 5 - 10% of the culture 
medium (Mitchell et al. 2002, Saha et al. 2000, Abir et al. 1999. Hovatta ci' al. 1999, 
Figueiredo ci al. 1994). In this study significant follicle growth was observed in the 
presence of 5% FCS and 5% FCS with lOng/mI rFSH at Day 20 of the culture period 
compared to control follicles, with the largest follicle diameters reaching around 3501im. 
This study is in agreement with Saha and colleagues (2000) who demonstrated follicle 
growth in a serum-based FSH supplemented medium in very early preantral bovine 
follicles however in the present study follicle growth appeared to be reduced in the 
presence of increasing concentrations of FSH therefore it would seem appropriate to 
attribute the observed growth to the actions of FCS. By Day 12, follicles cultured in 5% 
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FCS alone and in combination with rFSH formed significantly more antral cavities than 
follicles cultured in control medium with 70-100% of the serum and serum with 
gonadotrophin supplemented follicles forming antral cavities between Days 12 and 20 
concurring with previous studies associating FSH with antral formation in cultured 
bovine (Itoh et cii. 2002, Gutierrez et al. 2000, Wandji ci al. 1996b) and human follicles 
(Roy and Treacy 1993). Interestingly in this study although significant antral cavity 
formation occurred in the presence of FCS and FCS in combination with rFSH from Day 
12 onwards, in the absence of these supplements antral cavity formation did not occur 
significantly until Day 20 despite increasing follicle diameters. In vivo, antral formation 
is associated with increased follicle growth with cavities usually established in bovine 
follicles with diameters of 200irn (Webb ci al. 1999). In this study all cultured follicles 
approached or had achieved diameters of 200j.m by Day 4 at which time antral cavity 
formation was not observed in follicles cultured in control medium and seen in only a 
small proportion of serum and FSH cultured follicles indicating that whereas in vivo 
antral cavity formation is associated with maintenance of increased nutrient and gaseous 
requirements in the expanding follicle, bovine follicles can be maintained in vitro and 
continue to grow without forming antra, in agreement with observations of cultured 
pi-eantral opossum follicles made by Butcher and Ullmann (1996). Oocyte growth and 
morphology did not appear to be significantly adversely affected by follicles with 
diameters beyond 200tm remaining without antral cavities as oocyte growth (Fig 3.4a, 
Fig 3.4h) and health (Fig 3.6a, Fig 3.6b) were significantly higher in all serum and 
gonadotrophin supplemented groups on Day 4 of the culture period than at later stages 
(Figure 3.7a). It is recognised that follicles cultured within cortical strips very seldom 
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progress to the antral stage (Hovatta et al. 1999, Wright et al. 1999, Hovatta et at. 1997) 
and isolation and individual culture are required for further development (Telfer et al. 
2008), implying that stromal factors are not responsible for stimulating antral cavity 
formation and may inhibit differentiation however it is possible that in vivo, factors are 
delivered to follicles from the systemic circulation via stromal tissue, and that serum and 
gonadotrophin supplementation compensates for the loss of systemic support promoting 
the formation of antral cavities. Conversely the presence of FCS and FCS in combination 
with FSH may expedite release from intrafollicular inhibition of antral formation. 
Oocyte development was assessed by diameter measurement and morphology evaluation. 
In this study the greatest proportion of healthy oocytes and the largest oocyte diameters 
were observed in follicles cultured in the presence of serum, with or without FSH, at Day 
4 and Day 8 respectively, with oocyte size and health decreasing significantly thereafter 
in all treatment groups. In vitro oocyte growth has been demonstrated in murine oocytes 
from primordial (Eppig and O'Brien 1996), secondary (Xu et al. 2006) and preantral 
follicles (Demeestere ci al. 2002, Spears etal. 1994), in ovine preantral follicles (Thomas 
et al. 2003a), ovine oocyte-granulosa cell complexes (Newton et al. 1999) and in bovine 
oocyte-cumulus complexes (Hirao ci al. 2004) during culture periods ranging from 6-21 
days. In the present study oocyte growth was supported for 8 days in culture with oocyte 
diameters increasing from 5 1 tm on isolation to a maximum of 75im on Day 8 in oocytes 
grown in 5% FCS. The significant decline in oocyte diameter after Day 8 was 
concomitant with a similar decline in health of oocytes from all experimental groups 
however follicle growth continued to the end of the culture period suggesting that the 
culture system conditions had induced asynchronous development within the follicle unit, 
-72- 
supportive of somatic cell development but deleterious to germ cell survival (Figure 
3.7b), an effect previously observed in ovine preantral follicle culture (Thomas et cii. 
2003a). Normal oocyte development is known to rely on the formation of gap junctions 
occurring between the oocyte membrane and its surrounding granulosa cells (Albertini et 
al. 2001, Eppig 2001, Vozzi et al. 2001, Carabatsos et al. 2000, Carabatsos et al. 1998, 
Simon et al. 1997, Brower and Schultz 1982) with these junctions appearing at the 
secondary stage of development in bovine follicles (Fair et al. 1997). In this study the 
morphology of degenerate oocytes was similar irrespective of experimental group, with 
surrounding granulosa cell contact severely reduced or completely absent whilst healthy 
oocytes retained somatic cell contact thus implying that the disruption of gaps junctions 
is deleterious to oocyte survival (Fig. 3.5b). Both experiments demonstrated that whilst 
serum and serum in combination with FSI-I are sufficient to support follicle growth and 
antral formation over a 20-day culture period, these conditions are deleterious to germ 
cell survival with oocyte growth and health declining beyond 8 days relative to the 
observed loss of oocyte-somatic cell contact; furthermore, it was concluded that the 
addition of serum increased the likelihood of asynchronous growth due to complexity its 
composition and that in subsequent experiments it would he omitted from the culture 
media. In the remaining experiments, preantral follicle culture was not prolonged beyond 
8 days whilst culture conditions were modified to included growth factors and 
gonadotrophins in an attempt to maximise oocyte growth whilst preserving health. 
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CHAPTER FOUR 
Effect of Activin and FSH on Isolated 
Preantral Bovine Follicle Development 
-74- 
4.1. INTRODUCTION 
It has been demonstrated that exposure of preantral human follicles from normal ovaries 
to extended periods of culture can result in high levels of atresia (Webber et al. 2007, 
Abir et cii. 1997) and as demonstrated in Chapter 3, extending the culture period to 20 
days under the conditions described, adversely affected oocyte development in preantral 
bovine follicles. Previous studies have used a shorter period of time to demonstrate the 
effect on development of a variety of factors including ascorbic acid, LGFs and MMPs 
(Thomas et al. 2007, Walters et al. 2006, Thomas et al. 2003a, Thomas et al. 2001, 
McCaffery et at, 2000) and activin has emerged as an important factor in maintaining the 
coordination between oocyte and somatic cell development in ovine follicles in vitro. 
(Thomas et al. 2003a). 
Activin is a TGFI3 superfamily member comprising of two beta subunits (A or B) which 
are identical to the beta subunits of inhibin the structural homologue of activin. Activin 
exists as a homo or heterodimer with three possible isoforms occurring, A, AB, and B, 
with the most abundant being activin A. Activin exerts its actions by binding to it type II 
serine-threonine kinase receptor thereby phosphorylating a type I (ALK-4) receptor 
resulting in alteration of activin-dependent gene expression (Figure 1.4). The intraovarian 
actions of activin include bovine (Huishof et al. 1997) and rodent (Nishimori and Matzuk 
1996, Li et at. 1995) granulosa cell proliferation, FSH receptor up-regulation in the rat 
(Xiao et cii. 1992, Hasegawa et al. 1988), stage-dependent regulation of steroidogenesis 
in primates, domestic species and rodents (Erämaa etal. 1995, Cataldo et al. 1994, Hillier 
and Miro 1993, Hutchinson et al. 1989), regulation of androgen synthesis in bovine 
thecal cells (Wrathall and Knight 1995) and oocyte maturation in primates (Alak et al. 
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1998, Alak etal. 1996) and rodents (Sadatsuki etal. 1993); whilst, systemically, activin 
promotes the release of FSH from the anterior pituitary in rats (Katayama et al. 1990). 
The experiments in this chapter were designed to address the following questions; I) can 
activin enhance the growth and development of isolated bovine preantral follicles over an 
8-day in vitro period 2) what is the optimal concentration of activin required to enhance 
development and 3) how does its interaction with FSH affect in vitro development? 
In the initial experiments follicle and oocyte diameter, morphological oocyte health and 
the proportions of antral cavity formation and granulosa cell pyknosis were evaluated in 
cultured preantral bovine follicles in the presence of 50 or bOng/mI of recombinant 
human activin A (rhAct A). To evaluate the effect of FSH in the presence of activin, 50 
or lo0nglml rFSH was added to the culture media and follicle growth and, granulosa cell 
differentiation and proliferation were measured. The effect of activin and FSH on oocyte 
growth, oocyte health and oocyte-somatic cell communication will he discussed in the 
following chapter. 
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4.2. MATERIALS AND METHODS 
4.2.1. Isolated Preantral Follicle Culture 
Preantral follicles (132 - 199im) were isolated from freshly collected bovine cortical 
strips and cultured individually for up to 8 days as detailed previously in chapter 2, with 
media being removed and replaced every fourth day. Follicles were assessed at 4 day 
intervals during the culture period. Experiments were divided into two sets with a total of 
20 cultures set up. The first set of experiments looked at the effect of 2 concentrations of 
rhAct A on preantral bovine follicle development (9 replicate cultures) and the second set 
of experiments (11 replicate cultures) considered the effect of FSH in combination with 
rhAct A on preantral follicle development. Irnmunohistochemistry was performed to 
confirm cell proliferation using Ki67 antigen labelling on at least 6 selected follicle 
sections from each treatment group and freshly fixed follicles. 
4.2.2. Treatments 
4.2.2.1. Treatment with r/zAct A and rFSH 
Basic culture medium (control) was prepared as previously described in 2.2. 1. Basic 
culture medium was supplemented with rhAct A (R & D Systems, Abingdon, UK) and/or 
recombinant FSH (rFSH) (Serono, Geneva, Switzerland). The specific treatment groups 
were as shown in table 4. I. 
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Table 4.1. Treatment groups and number of follicles in each group per experiment 
Control 





n = 31 
SOng/rn! rhAct A ii = 94 
I OOng!ml rhAct A n = 97 ii = 29 
1 OOng/ml rhAct A+SOng/ml rFSI-1 n = 33 
lOOng/mi rhAct A+lOOng!nil rFSU n = 32 
50ngIrnl rFSH n = 32 
lOOngIml rFSH it = 35 
4.2.3. Detection of Ki67 Antigen by Inimunohistochemistry 
For evaluation of granulosa cell proliferation, sections were selected from freshly fixed 
follicles and from each treatment group in Experiment 2. Cultured follicles were chosen 
on the basis of having undergone in vitro growth and having a similar diameter on 
completion of culture. Freshly fixed follicles (ii = 6) and follicles cultured in the presence 
of control medium (n = 7), rhAct A (n = 7), rhAct A and 50 (ii = 6) or bOng/mI (n = 6) 
rFSH or 50 (n = 7) or bOng/nil (n = 7) rFSH were fixed in 4% parafornialdehyde 
(preparation described in 2.3. 1.) for 24 hours then processed and affixed to charged slides 
as described in 2.3.1 .1. Details of the antibodies and serum used are shown in Table 4.2. 
Sections of freshly fixed and selected cultured follicles were deparaffinised in xylene for 
5 minutes and rehydrated in reducing concentrations of alcohol (100%, 90% and 70%) 
for 2 minutes in each concentration. Slides were then rinsed in distilled H70 for 5 
minutes followed by 2 x 5 minutes washes in PBS on a rocking tray at 25°C. 
-78- 
Table 4.2 Immunolocalisation of Ki67 Antigen: Antibodies and Serum 
Horse Serum 










Newcastle Upon Tyne, UK 
Reconstituted with distilled H70, 
Diluted with PBS 
Working concentration 1: 100 
ABC-Elite Mouse IgG 







150[d horse serum+ 
lOrnI PBS 
To unmask antigen sites, the slides were placed in a glass vessel to which enough 
recently boiled Sodium Citrate 0.0IM (pH 6.0) was added to cover the slides. Slides were 
covered with film to prevent drying out and heated in a microwave oven for a total of 8 
minutes, 4 minutes at 800W followed by 4 minutes at 400W, thereafter the slides cooled 
in the citrate for 20 minutes before being washed for 2 x 5 minutes in PBS on a rocking 
tray at 25 °C. Slides were incubated in 1.5% hydrogen peroxide in methanol for 10 
minutes at 25°C to quench endogenous peroxidases then washed for 2 x 5 minutes in PBS 
on a rocking tray at 25 °C. Excess moisture was carefully removed from the slides then 
blocking serum applied (see Table 4.2). Slides were incubated in blocking serum for 30 
minutes in a humidified chamber at 25°C. Excess serum was shaken off the slides and 
primary antibody applied (see Table 4.2) 80 - I OOpJ per slide depending on the number 
of sections. A negative control was established by omitting the primary antibody and 
leaving blocking serum on one slide. Slides were incubated in primary antibody (or 
serum for negative control) for 60 minutes in a humidified chamber at 25 °C then washed 
for 2 x 5 minutes in PBS on a rocking tray at 25°C; negative control washed separately. 
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Secondary antibody was prepared and applied (see Table 4.2) 100 - 120111 per slide 
depending on the number of sections and incubated in a humidified chamber for 30 
minutes. Avidin biotinylated complex (ABC) (Vectastain Elite ABC Kit, PK-6100, 
Vector Laboratories, CA) prepared by combining 5 ml PBS, 2 drops of Avidin DH 
solution and 2 drops of Biotinylated Peroxidase together and standing for 30 minutes. 
Following secondary antibody incubation, slides were washed in PBS for 2 x 5 minutes 
and ABC was applied to sections (100 - 120111 per slide). Slides were incubated in a 
humidified chamber at 25°C for 30 minutes then washed in PBS for 2 x 5 minutes. 3, 3 
Diaminobenzdine (DAB) (DAB Substrate Kit, SK- 4100, Vector Laboratories, CA) 
solution was prepared by combining 5m1 distilled H20, 2 drops of buffer, 4 drops of 
DAB solution and 2 drops of hydrogen peroxide. DAB solution was applied to the slides 
for a maximum of 10 minutes thereafter the slides were rinsed in tap water for 5 minutes, 
counterstained in haematoxylin for 15 seconds, rinsed again in tap water (2 x 5 minutes) 
and dehydrated, firstly using increasing concentrations of alcohol (70%, 90% and 100%), 
2 minutes in each concentration and then xylene for 5 minutes. Slides were then mounted 
using DPX and left to dry overnight. 
4.2.4. Statistical Analyses 
Distribution of data for parametric analysis was checked using GraphPad Software Instat 
Guide to choosing and interpreting statistical tests version 3.05, 1998, GraphPad 
Software Inc., San Diego, California, USA. In Experiments 1 and 2, mean follicle 
diameters were compared between treatment groups at Day 0 and every fourth day of the 
culture period using Minitab14 Statistical Software one-way unstacked ANOVA with 
subsequent t-tests to allow for individual inter and intra-group comparison. Oocyte 
diameters observed in Experiment 1 were compared between treatment groups by 
histological measurement using Mi nitab 14 Statistical Software one-way unstacked 
ANOVA with subsequent Students [-test: unpaired. The proportions of antral cavity 
formation, granulosa cell pyknosis. quantitative and qualitative granulosa cell 
proliferation and oocyte morphological health (Experiment I) were assessed using 
Minitab 14 Statistical Software Contingency Tables: Chi Square Analysis. 
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4.3. RESULTS 
4.3.1. Experimental Outline 
2 experiments conducted, Experiment 1: 9 replicate 8-day cultures of preantral follicles in 
the presence and absence of 2 concentrations activin. Follicle diameters measured on 
days 0, 4 and 8 of the culture period. An equal number of follicles were randomly 
removed at Day 4 from each treatment group for histological evaluation of follicular 
parameters at this time point therefore the number of follicles declined over time in this 
experiment. Remaining follicles fixed and processed for evaluation after 8-days in vitro. 
Experiment 2: II replicate 8-day cultures of preantral follicles in the presence and 
absence of activin and 2 concentrations of FSH. Follicles processed for 
immunohistochemical localisation of androgen receptors and histological analysis of 
follicle and oocyte morphological status on Day 8; no follicles removed for analysis prior 
to Day 8 of the culture period. No less than 6 growing follicles from all treatment groups 
and 6 freshly fixed follicles processed for immunohistochemical localisation of Ki67 
nuclear anti gen. 
4.3.2. Follicle Growth and Differentiation: Control versus rhAct A 
4.3.2.1. Effect ofrhAct A on the Growth of Cultured Preantral Bovine Follicles 
In Experiment I follicles were cultured for a maximum of 8 days in control medium (n = 
86) or in medium containing 50 (n = 94) or 100 ng/ml (ii = 97) rhAct A. Significant 
follicle growth occurred in all groups over time (p < 0.05). Significant follicle growth 
was observed in follicles supplemented with bOng/mI rhAct A compared to control 
follicles (p <0.0]) and follicles cultured in 50nglnil rhAct A (p < 0.05) at Day 4 and Day 
8 of the culture period. Significant follicle growth was observed in follicles supplemented 
with 50ng/ml rhAct A compared to control follicles (p < 0.05) at Day 8 of the culture 
period. By dividing the in vitro period in two, the rate of growth in each treatment group 
can be estimated by calculating the gradient of the straight lines (in = Ay/Ax) between 
Day 0 and Day 4, and Day 4 and Day 8 (Figure 4. 1). The greatest acceleration of growth 
appears to occur during the first 4 days of culture, i.e. from Day 0 to Day 4, in follicles 
cultured in the presence of lOOng/mI rhAct A (m = 34.47) compared to follicles cultured 
in the presence of 50ng/ml rhAct A (rn = 20.05) and control follicles (in = 15.13) over 
the same time period. 
In Vitro Preantral Bovine Follicle Growth: 
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Figure. 4.1. The effect of activin on follicle growth in cultured preantral bovine 
follicles. Preantral follicle growth in the presence of 50 (yellow) or I OOng/rnl rhAct A 
(red) or control medium (black). Values are mean follicle diameters ±SEM. (a) (b) and 
(c) denote significant differences between treatment groups at specific time points. 
Significant growth was observed in follicles cultured in lOOng/mI rhAct A compared to 
those cultured in 50ng/rnl rhAct A (p  <0.01) and control medium (p  <0.01) at Day 4. By 
Day 8, follicles cultured in bOng/mt rhAct A were significantly larger than those 
cultured in 5Ong/ml rhAct A (p < 0.05) and control (p < 0.01) while those cultured in 
SOng/mI rhAct A were significantly larger than those cultured in control (p  <0.05). The 
rate of growth appeared most accelerated in follicles cultured in lOOng/mI rhAct A 
between days 0 and 4 (in = 34.47) compared to the rate of growth of follicles in the other 
2 groups over the same time period. 
4.3.2.2. Effect of rhAct A on Antral Cavity Formation in Cultured Preantral Bovine 
Follicles 
In Experiment I the presence of an antrum was determined on histological evaluation of 
follicles fixed at 2 time points during the in vitro period Day 4 and Day 8. Antral cavity 
formation is expressed as a proportion of the total number of follicles per treatment group 
per day of culture (see table 4.3 for n values per treatment group). Antral formation 
increased significantly over time in follicles cultured in the presence of activin (Figure. 
4.3). Antral cavity formation was observed to be significantly higher in follicles cultured 
in I OOng/ml rhAct A (n = 45) compared to follicles cultured in either SOng/mi rhAct A (n 
= 46) or control medium (n = 40) on Day 8 of the culture period (p < 0.05). 
Table 4.3. Number of follicles in each group per experiment 
Experiment 1 
Control 	 n=39 	n=40 
50ngJml rhAct A 	 ii = 41 	 ii = 46 
lOOng/mI rhAct A 	 n=45 
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Antral Cavity Formation in Cultured Preantral Bovine 
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Figure. 4.2. Effect of rhAct A on antral cavity formation in cultured preantral 
bovine follicles. (*) denotes a significant difference in antral formation between 
treatment groups. On Day 4 no significant difference was observed between treatment 
groups. By Day 8 a significantly larger proportion of follicles formed antral cavities when 
cultured in bOng/mi rhAct A (red) (p  <0.05) compared to follicles cultured in 50 ng/ml 
rhAct A (yellow) and control medium (black). 
4.3.2.3. Effect of rizflct A on Granulosa Cell Health in Cultured Preantral Bovine 
Follicles 
Unhealthy granulosa cells were distinguished from healthy granulosa cells by the 
presence of hyperchromatic pyknotic nuclei with condensed chromatin and blebbing of 
the plasma membrane. Pyknotic granulosa cells were expressed as a proportion of the 
total number of granulosa cells per treatment group on Day 4 and Day 8 of the culture 
period. In the presence of lOOng/mi rhAct A, a significant increase was observed in the 
proportion pyknotic granulosa cells within follicles on both Day 4 (p  <0.05) and Day 8 (p 
<0.05) of the culture period compared to freshly fixed follicles (0 Hrs). No significant 
difference was observed in the proportion of pyknotic granulosa cells in observed in 
follicles cultured in 50ng/ml rhAct A or control medium 011 either Day 4 or Day 8 of the 
in vitro period compared to 0 Hrs follicles (Table 4.4). 
Table 4.4. Pyknotic granulosa cells within cultured preantral bovine follicles: the 
effect of rhAct A. 
Treatment Day of Culture (n) Proportion of 
Pyknotic Cells 
OHrs Day  n24 0.0417 
Control Day 4 n = 39 0.139 
Control Day 8 n = 40 
(* **) 
0.161 
SOng/mI rhAct A Day 4 n = 41 
(* *) 
0.121 
SOng/mI rhAct A Day 8 n = 46 0.147 
I OOng/ml rhAct A Day 4 ii = 42 0.27 
1 OOng/nil i'hAct A Day 8 n = 45 0.27 
(*) and (**) denote significant differences between treatment groups (p < 0.05) 
4.3.3. Oocyte Growth and Morphological Health: Control versus rhAct A 
4.3.3.1. Effect of rhAct A on the Growth and Morphology of Oocytes in Cultured 
Preantral Bovine Follicles 
Oocyte growth occurred over time and was observed to be significant in all cultured 
follicles compared to the freshly fixed follicles (0 Hrs) (p < 0.05). Significant oocyte 
growth occurred in follicles cultured in lOOng/mi rhAct A compared to follicles cultured 
in 50ng/ml rhAct A (p  <0.05) and follicles cultured in control medium (p  <0.05) at Day 
4. By Day 8 follicles cultured in rhAct A were significantly larger than those cultured in 
control medium (p < 0.05) (Figure 4.3). Morphological oocyte health was significantly 
IRJE 
Figure 4.3. Effect of activin on oocyte growth in cultured preantral bovine follicles. 
Oocyte diameters of freshly fixed follicles (0 Hrs) (hatch) compared to the oocyte 
diameters of follicles cultured in control medium (black), 50ngIml rhAct A (yellow) or 
lOOng/mi rhAct A (red) on Day 4 and Day 8 of the culture period. Values are mean 
oocyte diameters ± SEM. (a) and (b) denote significant differences between treatment 
groups. Oocytes of follicles cultured in loong/ml rhAct A were significantly larger 
compared to freshly fixed follicles (0 Hrs) and those cultured in control medium at Day 4 
(p <0.05) and Day 8 (p  <0.05) of the culture period. 
Figure 4.4. Effect of activin on morphological oocyte health in cultured preantral 
bovine follicles. 
Qocyte health in follicles cultured in control (black) and follicles cultured in 50ng/ml 
rhAct A (yellow) and lOOng/ml rhAct A (red) compared to oocyte health in freshly fixed 
follicles (0 Hrs) (hatch). Values expressed as a proportion of the total number of oocytes 
analysed in each treatment group per day of culture. (*) denotes a significant difference 
in oocyte health between treatment groups. The proportion of follicles with healthy 
oocytes was significantly greater in freshly fixed follicles (p < 0.05) and in follicles 
cultured in either 50 or l0Ong/ml rhAct A on Day 4 (p < 0.05) and Day 8 (p < 0.05) 
compared to oocytes cultured in the presence of control medium on the same days. 
reduced in follicles cultured in control medium compared to the health of oocytes of 
freshly fixed follicles (Day 0) and those cultured in the presence of 50 or 1 OOng/ml rhAct 
A on Day 4 and Day 8 of the culture period (Figure 4.4). 
Fig 4.3 
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4.3.4. Follicle Growth and Differentiation: Control versus rhAct A and rFSH 
4.3.4.!. Effect of r/zAct A and rFSH on the Growth of Cultured Preantral Bovine 
Follicles 
In Experiment 2 follicles were cultured for 8 days in control medium (n = 31) or in 
medium containing lOOng/ml rhAct A (n = 29). bOng/mI rhAct A and 50ng/ml rFSH (n 
= 33), lOOng/mI rhAct A and lOOng/mI rFSH (n = 32), 50ng/ml rFSH (n =32) or 
I 00nglml rFSH (a = 35). Significant follicle growth occurred in all treatment groups over 
time (p < 0.01). Follicles cultured in control medium were significantly smaller than 
follicles cultured in the presence of rhAct A with or without rFSH and follicles cultured 
in the presence of rFSH only, at Day 4 (p < 0.05) and Day 8 (p < 0.05) of the culture 
period. No significant difference was observed in diameter between rliAct A and rFSH 
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Figure. 4.5. The effect of activin and FSH on follicle growth in cultured preantral 
bovine follicles. Comparison of growth of bovine preantral follicles in control medium 
(black), lOOng/nil rhAct A (red), lOOng/mi rhAct A and 50ng/ml rFSH (blue circles), 
bOng/mi rhAct A and lOOng/mI rFSH (grey circles), 50ngIml rFSH (blue dots) or 
bOng/mI rFSH (grey dots). Values are mean follicle diameters ± SEM. Growth is 
significant in all groups over time (p  <0.05). (*) denotes a significant difference between 
control and all other treatment groups. The mean diameter of follicles cultured in control 
medium was significantly smaller on Day 4 (p < 0.05) and Day 8 (p < 0.05) than the 
mean diameter of any of the other treatment groups at the same time points. 
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4.3.4.2. Effect ofrhActA and FSHon Antral Cavity Formation in Cultured Preantral 
Bovine Follicles 
In Experiment 2 the presence of an antrum was determined on histological evaluation of 
follicles fixed at Day 8 of the in vitro period. Antral cavity formation is expressed as a 
proportion of the total number of follicles per treatment group. Antral cavity formation 
was found to be significantly higher in follicles cultured in the presence of lOOng/mi 
rhAct A (n = 29), lOOng/mI rhAct A and 50ng/rnl rFSH (n = 33) and lOOng/mi rhAct A 
and lOOngIml rFSH (n = 32) compared to follicles cultured in SOng/mi rFSH (n = 32) 1  
I OOng/ml rFSH (11 = 35) or control medium (n = 31) (Figure 4.6). 
Antral Cavity Formation in 
Cultured Preantral Bovine Follicles: 
Control versus Activin and FSH 
Treatment Group 
Figure 4.6. Effect of activin and FSH on antral cavity formation in preantrat bovine 
follicles cultured for 8 days. (*) denotes a significant difference in antral cavity 
formation between treatment groups. A significantly larger proportion of follicles formed 
antra when cultured in lOOngIml rhAct A (red), lOOng rhAct A and 50ng/ml rFSH (blue 
hatch) or lOOng/ml rhAct A and lOOng/rnl rFSH (grey hatch) compared to follicles 
cultured in control medium (black) (p < 0.05), rFSH 50 ng/ml (blue) (p < 0.01) or 
I OOng/ml rFSH (grey) (p <0.05). 
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4.3.4.3. Effect of rhAct A and rFSH on Granulosa Cell Proliferation in Cultured 
Preaiitral Bovine Follicles 
Qualitative granulosa cell proliferation was determined by counting of the number of 
layers of granulosa cells observed in freshly isolated preantral follicles (n = 19) and in 
selected growing cultured follicles from each experimental group (n = 15) on completion 
of the in vitro period as described in Chapter 2, section 2.3.3.2. and illustrated in Figure 
2.2. The number of granulosa cell layers was significantly higher in all cultured follicles 
compared to freshly fixed follicles (p < 0.05). Follicles cultured in the presence of either 
rhAct A or rFSI-E were observed to have significantly more granulosa cell layers than 
control follicles (p < 0.05) (Figure 4.7a and 4.7b). Granulosa cell proliferation was 
confirmed by detection of the nuclear antigen Ki67 and quantitatively analysed by 
calculating the proportion of Ki67 positive granulosa cells per total number of granulosa 
cellsper follicle (Figure 4.8a). The proportion of granulosa cells positively staining for 
Ki67 was significantly higher in follicles cultured in lOOng/ml rhAct A (n = 7) and rhAct 
A supplemented with either SOng/mI rFSI-1 (n = 6) or lOOng/ml rFSH (n = 6) compared to 
those follicles cultured in control media (n = 7) or rFSH alone (SOng/mI n = 7; lOOng/mi 
ii = 7) while follicles cultured in both concentrations of rFSH had a significantly greater 
number of Ki67 positive granulosa cells than those cultured in control medium (p < 
0.05). All follicles cultured in the presence of rhAct A, FSH or a combination of both had 
a significantly greater proportion of Ki67 positive granulosa cells than freshly isolated 
follicles (p  <0.05) (Figure 4.8b). 
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Figure 4.7a. Effect of rhAct A and FSH on granulosa cell proliferation in cultured 
preantral bovine follicles. 
and (***) denote a significant difference in the mean number of granulosa cell 
layers between treatment groups. Values are mean number of cell layers ±SEM. The 
number of layers of granulosa cells increased in all cultured follicles (p < 0.05) compared 
to freshly fixed follicles (hatch). A significantly greater mean number of granulosa cell 
layers were observed in follicles cultured in the presence of rhAct A (p < 0.05) or rFSH 
(p < 0.05) compared to freshly fixed follicles and those cultured in control medium. 
Figure 4.7b. Granulosa cell proliferation in the presence of rhAct A and FSH in 
cultured preantral bovine follicles. 
(i) Multiple layers of granulosa cells surrounding the oocyte in a follicle cultured in rhAct 
A and 50ng/ml rFSH for 8 days. (ii) 4-5 layers of granulosa cells present in a follicle 
cultured in control medium for 8 days. (iii) 2 to 3 layers of granulosa cells in an isolated 
freshly fixed follicle. 
Fig 4.7a 
Granulosa Cell Proliferation in Cultured Bovine Preantral 








& 	4 	 /C 
Treatment Group 
Fig 4.7b 

















(iii) 	 2Opm 
- 93 - 
Figure. 4.8a. Effect of rhAct A and FSH on the proportion of Ki67-positive 
granulosa cells in cultured preantral bovine follicles. Values are K167 positive 
granulosa cells expressed as a proportion of the total of granulosa cells population per 
treatment group. (a), (b) and (c) denote significant differences in the proportion of K167 
positive cells between treatment groups. Significantly fewer Ki67 positive granulosa cells 
were observed in freshly fixed follicles (black dots) (p < 0.01) and those cultured in 
control medium (black) (p < 0.01) compared to all other treatment groups. Follicles 
cultured in lOOng/mi rhAct A (red), lOOng/ml rhAct A and 50ng/ml rFSH (blue batch), 
lOOng/ml Act A and lOOng/mi rFSH (grey hatch) had a significantly greater proportion 
of Ki67 positive granulosa cells (p < 0.05) than follicles cultured in the presence of 50 
(blue) or lOOng/mI (grey) rFSH. 
Figure. 4.8b. Ki67-positive granulosa cells in preantral bovine follicles cultured in 
rhAct A. Immunohistochernistry against K167 nuclear antibody expressed in all 
proliferating cells. Proliferating cells stained dark brown, non proliferating cells stained 
purple with haematoxylin. (i) A significantly higher proportion of Ki67 positive 
granulosa cells (p < 0.05) were observed throughout the cytoplasm of follicles cultured in 
the presence of I OOng/ml rhAct A for 8 days. (ii) A few isolated Ki67 positive granulosa 
cells (indicated by A) in follicles cultured for 8 days in control medium (iii) Negative 
control (no primary antibody); follicle cultured follicle for 8 days in 100ng/rnl rhAct A 
and SOng/mi rFSH for 8 days. 
Fig 4.8a Proportion of Ki67 Positive Granulosa Cells 
in Cultured Bovine Follicles:Control versus 
Activin and FSH 
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4.4 DISCUSSION 
The aim of the initial experiment described in this chapter was to determine whether 
activin affected bovine preantral follicle development over an 8-day in vitro period. To 
compare two concentrations of activin, preantral follicles were cultured in either 50 or 
lOOngIml rhAct A and compared to follicles cultured in control medium. The expression, 
secretion and physiological actions of activin outwith the reproductive axis are now well 
understood (Luisi et al. 2001) however its precise role in early mammalian follicle 
development is less well defined and appears to be both species and stage dependent with 
follicle growth being observed in immature but not mature murine preantral follicles in 
the presence of activin (Mizunuma et al. 1999). Previous studies have demonstrated 
activin is associated with in vitro follicle growth in human (Telfer et al. 2008) bovine 
(Hulshof et al. 1997), ovine (Thomas et al. 2003a) and caprine (Silva et (i!. 2006) 
preantral follicles at a range of concentrations from 1-500ng/rnl. In Experiment I of this 
study. significant follicle growth was observed in follicles cultured in l00ng/ml rhAct A 
on Day 4 and Day S of the culture period compared to those in control medium whilst 
significant antral formation at Day 8 was observed in follicles cultured in bOng/mI rhAct 
A compared to those cultured in a lower concentration of rhAct A and those cultured in 
control. The observed follicle growth agrees with the previous studies mentioned above, 
although, whilst activin associated antral formation has been reported in human and 
rodent preantral follicles (Telfer ci' al. 2008. Zhao et (i!. 200 1) and rodent oocyte-cumulus 
complexes (Li ci' al. 1 995) it has not previously been demonstrated in bovine preantral 
follicles. While the molecular mechanism of antral formation is unclear it is understood 
that granulosa cell properties are not uniform between or within follicles and can differ 
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during follicular events for example during antral expansion (Rodgers et al. 2001). The 
significant antral formation observed in this experiment is attributed to supplementation 
of the media with bOng/mi rhAct A, moreover activin receptor mRNA and protein have 
been isolated in bovine cumulus oocyte complexes aspirated from large follicles during in 
vitro growth (Izadyar et al. 1998) and activin has been observed to stimulate granulosa 
cell reorganisation and cavity-like formation in rat cumulus oocyte complexes (Li et al. 
1 995) suggesting that granulosa cell differentiation may he mediated directly through 
activin binding. A significant proportion of follicles cultured in bOng/mi rhAct A i.e. the 
follicles with the largest diameters and most antral cavities, contained significantly more 
pyknotic granulosa cells on Days 4 and 8 of the culture period compared to the granulosa 
cells of freshly isolated follicles, however this did not correlate with oocyte degeneration 
or morphological deterioration in these follicles therefore it is suggested that the observed 
somatic cell pyknosis is associated with antral formation and may be a mechanism by 
which the follicle regulates the increase in follicle diameter whilst accommodating the 
expanding antral cavity. 
Significant oocyte growth was observed in the presence of rhAct A on Day 4 and Day 8 
in Experiment I in comparison with control follicles, with histological analysis showing 
that oocyte health was significantly reduced in the oocytes of follicles cultured in control 
medium compared to the oocytes of freshly isolated follicles and oocytes in either activin 
supplemented group, suggesting that activin is involved in the maintenance of oocyte 
morphological health in vitro, this will be discussed in detail in the following chapter. 
Taken together the results detailed above indicated that lOOng/mI rhAct A was the 
optimal concentration of activin to supplement bovine preantral follicle culture medium. 
MM 
The aim of the Experiment 2 was to evaluate the effect of a combination of rhAct A and 
rFSH on the somatic and germ cells of preantral bovine follicles in vitro. Follicle growth, 
granulosa cell proliferation and formation of antra will be discussed in this chapter whilst 
the effect of rhAct A and rFSH on oocyte growth, oocyte health and oocyte-somatic cell 
association will be discussed in Chapter 5. 
In Experiment 2 rhAct A alone, in combination with rFSft and rFSH alone significantly 
increased follicle growth compared to control although there was no significant 
difference between the rhAct A and/or rFSH supplemented groups. Follicles in activin 
and gonaclotrophin supplemented groups underwent significantly more granulosa cell 
proliferation than follicles in control medium, this being determined histologically by 
calculating the mean number of layers of granulosa cells present on completion of the 
culture period. Granulosa cell proliferation was verified by detection of significantly 
more Ki67 positive cells in the presence of activin, with and without FSH 
supplementation, than in the other treatments tested, these results concur with previous 
studies identifying activin as a promoter of rodent granulosa cell proliferation (Zhao et cii. 
2001, Smitz et al. 1998, Liu etal. 1999, Li etal. 1995). This action may be a direct effect 
as receptors for rhAct A have been isolated in bovine graiiulosa cells (Izadyar et al. 1998,   
Hulshof et al. 1997), alternatively proliferation may be an indirect consequence of rhAct 
A/rFSH for example promoting augmentation of GDF-9 and BMP-15 action which is 
known to be necessary for murine and ovine granulosa cell proliferation (Chang et cii. 
2002). 
In Experiment 2 the instance of antral formation was only significant in the presence of 
activin despite final mean diameters of 275iim and 285Lm observed in follicles cultured 
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in 5Ong/ml and lOOng/mi of rESH respectively. This concurs with findings in the 
previous chapter where bovine preantral follicles grown the presence of FCS and FCS 
with FSH continued to grow in vitro but failed to form antral cavities at the expected 
diameter, and again contrasts with the expected morphology of similar sized bovine 
follicles in vivo where antral formation is usually established in follicles of 20Otm 
diameter (Webb et al. 1999) raising interesting questions about the mechanism of 
granulosa cell differentiation within follicles grown in vitro. In the presence of FSH, 
activin has also been shown to positively influence the reorganisation of monolayers into 
multi-layer structures. Li et a! (1995) demonstrated that cumulus cell oocyte complexes 
(COC's) aspirated from immature rat follicles can form follicle-like structures, develop 
antra and yield morphologically mature oocytes with established gap junctions in the 
presence of activin and FSI-I. Whether bovine COC's can be aspirated from in vitro 
cultured follicles of diameters around 300Mm as were obtained during the present study 
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5.1. INTRODUCTION 
Several studies have established that activin is associated with growth and 
steroidogenesis in cultured preantral mammalian follicles however the effects of rhAct A 
supplementation on oocyte development in vitro are less well reported. (Telfer et al. 
2008, Silva et al. 2006, Thomas et al. 2003a, Zhao et al. 2001, Liu et al. 1998, Hulshof et 
al. 1997, Yokata et al. 1997, Li et al. 1995). Zhao et al. (200 1 ) demonstrated the presence 
of oolemma microvilli and cortical granule migration consistent with oocyte maturation 
(Hyttel et al. 1988) in activin supplemented preantral rat follicle cultures suggesting that 
activin promotes in vitro oocyte development with similar findings reported by Li et al. 
(1995) and in agreement with previous studies that demonstrated a role for activin in 
primate oocyte maturation (Alak ci' al. 1996). In contrast, a recent study examining the 
effect of growth factors and gonadotrophins on oocyte nuclear maturity in vitro showed 
that activin had no effect on the chromatin configuration of the oocytes in cultured 
preantral mouse follicles with most remaining developmentally incompetent, indicated by 
a non- surrounded nucleolus (NSN) (Ola et al. 2008). 
In this chapter the effect of rhAct A and rFSH on the morphology of oocytes in preantral 
bovine follicles cultured for 8 days will be discussed. The preantral phase of follicle 
development is primarily a period where oocyte growth and oocyte mRNA synthesis 
predominate. To attempt to emulate this process in vitro it is necessary to provide an 
environment wherein oocyte genome activation is supported and somatic cell 
proliferation and differentiation are simultaneously maintained. A major obstacle to 
progress in the development of long-term culture systems is oocyte degeneration 
associated with the disruption of the connections between the oocyte and its surrounding 
•iiiii 
somatic cells, therefore a better understanding of these connections and the factors 
influencing their maintenance is essential to achieving oocyte competency in cultured 
preantral follicles. Oocyte-granulosa cell communication is in part preserved by gap 
junctions forming intercellular channels through which the bidirectional exchange of 
specific-sized molecules can occur (Anderson and Albertini 1976). These channels are 
composed of connexons each comprising six trans-membrane proteins subunits or 
connexins, with heterologous junctions occurring between the germ and somatic cells 
(Valdimarsson et al. 1993, Anderson and Albertini 1976). Li ci al. (1995) demonstrated 
the formation of oocyte-sornatic cell gap junctions in immature rat COC's complexes 
cultured in the presence of activin and FSH. In that study the characteristic appearance of 
mature oocytes in viva (Phillips and Dekel 1991) was observed in the cultured COC's 
With cumulus microvilli penetrating the zona pellucida and terminating either on the 
oocyte surface or becoming intertwined with oocyte microvilli (Li et al. 1995). 
Furthermore Zhao etal. (200 1) demonstrated the formation of heterologous gap junctions 
occurring between the microvilli of the oocyte and similar outgrowths from the granulosa 
cells in preantral rat follicles during a 6-day culture period in the presence of activin, with 
cortical granules visible at the oocyte surface. The occurrence of these granulosa cell 
membrane outgrowths or transzonal projections (TZPs) fluctuates during follicle 
development with the greatest density being observed during the preantral period of 
oocyte growth (Albertini etal. 2001, Motta etal. 1994). Activin and activin receptors are 
present in mammalian follicles from the initial stages of development (McNatty ci al. 
2000) suggesting a role for the protein from the early preantral stages of growth when 
oocyte-granulosa cell communication is at its height (Albertini et al. 2001, Motta et al. 
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1994). The aims of the following experiments were to address the questions; can rhAct A, 
in the presence and absence of rFSH, enhance bovine oocyte growth in vitro, does a 
relationship exist between morphological oocyte health and oocyte—somatic cell contact 
and, if a relationship exists, is it affected by rhAct A in the presence or absence of rFSH? 
Oocyte growth and oocyte investment by granulosa cells was measured on histological 
examination and morphological oocyte health scored. The arrangement of granulosa cells 
around each oocyte was assessed by con-focal microscopy imaging of actin networks to 
determine the relationship between oocyte-somatic intercellular junctions and oocyte 
health. Immunolocalisation of the proteins SMAD 2/3 was performed to confirm the 
presence of the intracellular pathway via which activin exerts its effects. 
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5.2. MATERIALS AND METHODS 
5.2.1. Isolated Preantral Follicle Culture 
Preantral follicles (132 - 199pm) were isolated from cortical strips removed from freshly 
collected bovine ovaries and cultured individually as previously detailed in Chapter 2 
sections 2.1.3. and 2.2.2.2., with media being removed and replaced every fourth day. In 
vitro follicle growth was assessed at 4 day intervals during the culture period, histological 
evaluation and immunohistochemistry was performed on follicles cultured for 8 days. 11 
replicate cultures were set up to assess the effect of rhAct A in combination with rFSH on 
oocyte growth and morphological health and oocyte somatic cell association. To confirm 
activation of the rhAct A intracellular signalling pathway, immunohistochemical 
localisation pSMAD2/3 proteins was performed on sections of follicles cultured for 8 
days in control or rhAct A that had undergone in vitro growth. To assess the effect of 
rhAct A and rFSH on intercellular actin filament density between the oocyte and 
granulosa cells. 2-day preantral bovine follicle cultures (n = 3) were established using 
freshly isolated follicles (115 - 150pm) dissected from bovine cortical strips as detailed 
previously. During this set of experiments 5 freshly isolated follicles and at least 6 
growing follicles were selected from each treatment group (see table 5. 1 for details of 
treatment groups) and fixed for con-focal analysis. 
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5.2.2. Treatments 
5.2.2.1. Treatment with rhAct A and rFSH 
Basic culture medium (control) was prepared as previously described in 2.2. I. Basic 
culture medium was supplemented with rhAct A and rFSI-1 as described in 4.2.2. The 
specific treatment groups and follicle numbers are shown in table 5. 1. 
Table 5.1. Treatment groups and number of follicles in each group per experiment 
Control 
Act & FSH 
n = 28 
Con Focal 
n = 6 
lOOng/mI rhAct A n = 26 n = 6 
lOOng/mi rhAct A+5Ong/ml rFSH n = 28 n = 6 
lOOng/rnl rhAct A+lOOng/ml rFSH n = 27 
5Onjnil rFSH ii = 27 ii = 5 
lOOng/ml rFSH n = 26 
5.2.3. Confocal Analysis of Cultured Follicles 
5.2.3.1. Effect of rhAct A and rFSH on the Spacing of Granulosa Cells and Actin 
Filaments in Cultured Preantral Bovine Follicles. 
A number of freshly isolated (n = 5) and at least 5 growing follicles from the treatment 
groups shown in table 5. 1 were selected on Day 2 of culture and processed for analysis of 
oocyte morphology, follicle structure and total actin. On completion of culture, follicles 
were fixed in 2% paraformaldehyde supplemented with I mg/nil polyvinyl alcohol, 401.iM 
phenylarsine oxide and lOOtM sodium ortho vanadate at room temperature for 5 minutes. 
Following initial fixation follicles were immersed in microtubule stabilising buffer 
IF MI 
(100mM PIPES, 5mM MgCl2, 2.5mM EGTA, 2% formaldehyde, 0.1% Triton-X-100, 
1mM taxol, IOU/ml aprotinin and 50% deuterium oxide) for 30 minutes at 35°C and 
stored in wash solution (0.2% sodium azide, 2% normal goat serum, 1% BSA. 0.1% 
glycine and 0.1% triton X-100 in PBS) until ready for processing. For con-focal analysis 
samples were incubated for two hours in the presence of Phalloidin-Alex 568 (1:100, 
Molecular Probes) for the detection of total actin, in combination with I p,g/ml of Hoechst 
33258 (Molecular Probes) at 37°C with gentle agitation. Samples were washed three 
times in wash solution for a total of 45 minutes at 37°C. Samples were mounted in 
medium containing 50% glycerol! PBS containing 25mg/mi sodium azide and I j.tg/ml of 
Hoechst 33258 using wax cushions to avoid compression of samples, Samples were 
analysed on a Zeiss LSM 5 Pascal confocal microscope using a 40x C-Apochromat 
objective (na I .2), KrArg 405 and HeNe 543 lasers to allow the collection of a complete 
z-series of red and blue channels progressing through the entire oocyte of each follicle. 
5.2.4. Detection of Phosphorylated SMAD 2/3 by Immunohistochemistry 
To localise the phosphorylaled form of the SMAD2/3 protein, sections of growing 
follicles were selected from the control and rhAct A treatment groups on completion of 
the culture period. Follicles cultured in the presence of control medium (n = 5) or 
bOng/mi rhAct A (n = 5) were fixed in 4% parafornialdehyde (preparation described in 
2.3.1.) for 24 hours then processed and affixed to charged slides as described in 2.3.1.1. 
Details of the antibodies and serum used are shown in Table 5.2. 
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Table 5.2 Immunolocalisation of Phosphorylated SMAD 2/3: Antibodies and Serum 
Blocking Serum Primary Antibody Secondary Antibody 
Goat Serum (NGS) Rabbit Polyclonal Biotinylated Goat Anti- 
S2000, Phosphodetect 	' Rabbit secondary 
B ioSera Ltd. Anti-SMAD2/3 [pSer4651467 j Antibody 
East Sussex, UK Merck Chemicals, Ref E0432, 
1 part goat serum, Nottingham, UK Lot 00034259, 
4parts TBS,5%BSA Reconstituted with distilled H20, DakoCytomation Ltd, Ely, UK 
diluted with NGSITBS/5%BSA Dilute with 
as per blocking serum NGS/TBS/5%BSA 
Working concentration 1:200 as per blocking serum 
Working concentration 1:500 
Slides were deparaffinised in xytene for 2 x 5 minutes, rehydrated in reducing 
concentrations of alcohol (100%. 95% and 70%) 20 seconds in each concentration, then 
rinsed in tap water for 5 minutes. To unmask antigen sites, the slides were heated in 
Sodium Citrate 0.0IM (pH 6.0) by pressure cooking for 5 mins at 15lbs/in 2 . after which 
the pressure was released and the slides cooled in the citrate for 20 minutes before being 
rinsed in tap water. Slides were incubated in 3% hydrogen peroxide in methanol for 30 
minutes on a rocking tray at 25 °C to quench endogenous peroxidases, then rinsed in tap 
water for 5 minutes and washed for 2 x 5 minutes in TBS on a rocking tray at 25 °C. 
Slides were then incubated with Avidin (DakoCytomation Ltd. Ely, UK) 80tl - 100tl per 
slide (depending of section number and size), for 15 minutes in a humidified chamber at 
25°C. Following 2 x 5 minute washes in TBS on a rocking tray at 25 °C, slides were 
incubated in Biotin (DakoCytomation Ltd, Ely, UK) 80il - 100l.Ll per slide (depending of 
section number and size) for 15 minutes in a humidified chamber at 25 °C. Slides were 
washed again 2 x 5 minute in TBS on a rocking tray at 25 °C after which blocking serum 
(see table 5.2) was applied and the slides were incubated in a humidified chamber for 30 
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minutes at 25°C. Excess serum was shaken off the slides and primary antibody applied 
(see Table 5.2) 80 - lOOj.Ll per slide depending on the number and size of sections. A 
negative control was established by replacing the primary antibody with non-immune 
rabbit lgG. Slides were incubated in primary antibody (or rabbit IgG for negative control) 
overnight (minimum 12 hours) at 4°C then washed for 2 x 5 minutes in TBS on a rocking 
tray at 25°C. Negative control washed separately. Secondary antibody was prepared and 
applied (see Table 5.2) 100 - 120jl per slide depending on the number of sections and 
incubated in a humidified chamber at 25 °C for 30 minutes. Following secondary antibody 
incubation, slides were washed in TBS for 2 x 5 minutes and Streptavidin HRP (Ref 
p0397, Lot 00032671, DakoCytomation Lid, Ely, UK) was diluted 1:1000 with No Salt 
Tris (6.055g Tris /lOOrnl H70) and applied to sections (100 - 1201il per slide). Slides 
were incubated in a humidified chamber at 25 °C for 30 minutes then washed in TBS for 2 
x 5 minutes. 3, 3 Diaminobenzdine (DAB) (DAB Substrate Kit, SK- 4100, Vector 
Laboratories, CA) solution was prepared by combining 5rnl distilled H20. 2 drops of 
buffer, 4 drops of DAB solution and 2 drops of hydrogen peroxide. DAB solution was 
applied to the slides for a maximum of 8 minutes thereafter the slides were rinsed in tap 
water for 5 minutes, counterstained in eosin for 10 seconds, dipped in acid alcohol, rinsed 
again in tap water (2 x 5 minutes) and dehydrated, firstly using increasing concentrations 
of alcohol (70%, 80%, 95%, 100%), 20 seconds in each concentration and then xylene for 
5 minutes. Slides were then mounted using DPX and left to dry overnight. 
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5.2.5. Statistical Analyses 
Distribution of data for parametric analysis was checked using GraphPad Software Instat 
Guide to choosing and interpreting statistical tests version 3.05, 1998, GraphPad 
Software Inc., San Diego, California, USA. Mean oocyte diameters were compared 
between treatment groups on completion of the culture period at Day 8 using Minitabl4 
Statistical Software one-way unstacked ANOVA with subsequent t-tests to allow for 
inter-group comparison. The proportions of oocyte morphological health were assessed 
using Minitab14 Statistical Software Contingency Tables: Chi Square Test. 
5.3. RESULTS 
5.3.1. Experimental Outline 
II replicate 8-day cultures of preantral follicles in the presence and absence of activin 
and 2 concentrations of FSH. In vitro follicle diameters measured on days 0, 4 and 8 of 
the culture period histological analysis of oocyte morphological status on Day 8 no 
follicles removed for analysis prior to Day 8 of the culture period. 
Growing follicles cultured in control (n = 5) and rhAct A (n = 5) processed for 
immunohistochemical localisation of activated (phosphorylated) SMAD2/3 protein 
receptors following 8 days in vitro. Con-focal analysis of actin filament density and 
distribution performed on follicles cultured for 2 days representing each treatment group 
5.3.2. Oocyte Growth and Health: Control versus activin and rFSH 
5.3.2.2. Effect of rhAct A and rFSH on Oocyte Growth and Morphology, and the 
Association between Oocytes and Somatic Cells in cultured Preaiztrai Bovine Follicles 
Histological observations were made on freshly isolated follicles (0 I-Irs) (n = 19) and 
follicles cultured in control (n = 28), lOOng/mi rhAct A (n = 26), lOOng/mI rhAct A and 
50n/m1 rFSH (ii = 28), lOOng/mi rhAct A and lOOng/mI rFSH (n = 27), 50ng/ml rFSH 
(n = 27) or lOOng/mI rFSH (n = 26) for 8 days. A significant increase in oocyte diameter 
was observed in all treatment groups (p< 0.01) compared to freshly isolated follicles. 
Oocytes cultured in the presence of rhAct A were significantly larger than all other 
cultured oocytes (p< 0.05) (Figure 5.1 a). Oocyte health was assessed by determining the 
general morphology of the oocyte as described in Chapter2 section 2.3.3.2. Follicles 
cultured in rFSH lOOng/mI (p<0.05) or control medium (p<0.05) had a significantly 
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lower proportion of morphologically healthy oocytes compared to the oocytes of all other 
treatment groups and to the oocytes of freshly isolated follicles (Figure. 5.1 b). The effect 
of culture conditions on the association between granulosa cells oocytes was evaluated by 
counting the number of granulosa cells, observed on histology, to be in direct contact 
with the oocyte on the section containing the nucleolus or if absent, the section 
containing the largest cross-section of the oocyte. The investment of the oocyte by 
granulosa cells was significantly higher in the oocytes of freshly isolated follicles (p < 
0.05), those cultured in 50ng/nil rFSH (p < 0.05) and the oocytes of follicles cultured in 
the presence of rhAct A with (p < 0.05) or without (p < 0.05) rFSH compared to the 
oocytes of follicles cultured in lO0ng/rnl rFSH and control medium (Figure Sic and 
Figure 5.1d). 
Figure. 5.1a. The effect of rhAct A and rFSFI on oocyte growth in vitro. 
Oocyte diameters in follicles cultured for 8 days in control medium (black), lOOng/mi 
rhAci. A (red), bOng/mi rhAct A and SOng/mi rFSH (blue hatch), lOOng/mI rhAct A and 
lOOng/nil rFSH (grey hatch), SO (blue) or bOng/mI (grey) rFSIl compared to oocyte 
diameters of freshly isolated follicles (black dots). Values are mean oocyte diameters ± 
SEM. (*), (**) and (**) denote significant differences between treatment groups. 
Significant oocyte growth was observed over time in all cultured follicles (p < 0.05) 
compared to freshly fixed follicles (Day 0). Significant oocyte growth was observed in 
follicles cultured in bOng/mI rhAct A alone (p < 0.05) compared to the oocytes in all 
other cultured follicles. 
Figure 5.1b. The effect of rhAct A and rFSH on oocyte morphological health in 
vitro. 
Morphological oocyte health in follicles cultured for 8 days in control medium (black), 
l00ng/ml rhAct A (red), lOOng/mi rhAct A and SOng/mi rFSH (blue hatch), bOng/mi 
rhAct A and bOng/mI rFSH (grey hatch), 50 (blue) or bOng/mi (grey) rFSH compared 
to oocyte diameters of freshly fixed follicles (black dots). Values are healthy oocytes as 
expressed as proportion of the total number of oocytes analysed per treatment group. (*) 
denotes a significant difference between treatment groups. Oocyte health was 
significantly reduced in follicles cultured in control medium (black) (p < 0.05) or 
lOOng/mi rFSH (grey) (p < 0.05) compared to the health of oocytes in freshly fixed 
follicles (Day 0) and oocytes in all other treatment groups. 
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Figure. 5.1c. The effect of rhAct A and rFSH on oocyte-somatic cell association in 
cultured preantral bovine follicles. Values are mean number of granulosa cells in 
contact with the oocyte ±SEM. (*) denotes a significant difference between treatment 
groups. Mean number of granulosa cell directly associated with the oocyte was 
significantly less in follicles cultured in control medium (black) (p < 0.05) or bOng/mi 
rFSH ( grey) (p < 0.05) compared to oocytes in follicles cultured in lOOng/mI rhAct A 
(red), lOOng/ml rhAct A and SOng/ml rFSH (blue hatch), bOng/mi Act A and bOng/nil 
rFSH (grey hatch), 50ng/ml rFSH (blue) and Day 0 follicles (black dots). 
Figure. 5.1d. Histological assessment of oocyte-somatic cell association in cultured 
preantral bovine follicles. (i) Follicle cultured in 50ng/ml rFSH for 8 days, 
morphologically healthy oocyte completely surrounded by innermost layer of uniformly 
spaced somatic cells. (ii) Follicle cultured in bOng/mi rhAct A and 50ng/ml rFSH for 8 
days, morphologically healthy oocyte with incomplete innermost layer of uniformly 
spaced somatic cells, small spaces indicated by (A). (iii) Follicle cultured in control for 8 
days, oolemma incomplete and shrinkage of oocyte visible coincident with loss of 
somatic cell association, indicated by (A), irregular spacing of the innermost somatic cell 
layer. (iv) Follicle cultured in bOng/mI rFSH for 8 days, oocyte shrunken and 
misshapen, almost complete loss of somatic cell association, irregular spacing of the 
innermost somatic cell layer. 
Fig 5.lc 
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5.3.3. Effect of rhAct A and rFSH on the Distribution of Granulosa Cells and Actin 
Filament Networks in Cultured Preantral Bovine Follicles. 
Scanning confocal analysis was made on the arrangement of total actin filament networks 
in intact follicles cultured in the presence (n = 6) and absence (n = 6) of rhAct A, the 
presence of 50ng!ml rFSH (n = 5) or a combination of rhAct A and SOng/mi rFSH (n = 6) 
for 2 days. In these images actin filament distribution was observed to be distinct and 
extensive throughout the gmn ulosa cell population indicating pronounced somatic 
intercellular junctions with particularly dense areas of actin filaments being located at the 
cumulus cell-zona pellucida interface especially in the presence of rFSH (Figure. 5.2B) 
and actin filament projections observed extending from the zona pellucida interface in the 
presence of rhAct A and rFSH (Figure 5.2C). Follicles cultured in control medium for 2 
days appeared to have a considerably less widespread actin distribution and poorly 
defined cumulus-zona pell ucida networks (Figure.5 .2A). 
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Fig 5.2 
Figure. 5.2. Scanning confocal analysis of actin filament distribution in follicles 
cultured in the presence and absence of rhAct A and rFSH for 2 days. (A) Follicle 
cultured in control medium, poor definition of the cumulus-zona pellucida interface 
(CZP), very modest actin arrangement visible within the granulosa cell population. (B) 
Follicle cultured in 50ng/ml rFSH. Clearly defined dense network (DN) of actin filaments 
around the oocyte (Oo), extensive network of actin filaments throughout the granulosa 
cells extending to the basal lamina. (C) Follicle cultured in bOng/mI rhAct A and 
50ng/ml rFSH. Pronounced network of actin filaments visible throughout the granubosa 
cells, with distinct projections extending from the cumulus cells. Prominent dense 
network (DN) at the cumulus-zona pellucida interface. (D) Follicle cultured in lOOng/mI 
rhAct A. Network of actin filaments clearly visible within the granulosa cells extending 
to the basal lamina. Dense network of actin (DN) visible around the oocyte. Scale bar = 
50 microns. 
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5.3.4. Cell signaling in Cultured Preantral Bovine Follicles 
5.3.4.1. Detection of pSMAD 213 protein in cultured preantral bovine follicles 
Immunohistochemistry was performed on sections of growing preantral bovine follicles 
cultured for 8 days in the presence or absence of lOOng/mi rhAct A to localise the 
activated SMAD2/3 (pSMAD2/3) protein in cultured follicular cells. pSMAD2/3 was 
localised within all the cells contributing to the follicle in the presence of rhAct A, with 
the germinal vesicle staining strongly (Figure. 5.3a). In the absence of rhAct A almost all 
the granulosa cells present stained positive for pSMAD2/3 protein and several thecal 
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Figure. 5.3. Immunohistochemical detection of pSMAD2/3 proteins in cultured 
preantral bovine follicles. (a) Follicle cultured for 8 days in bOng/mI rhAct A 
supplemented medium; granulosa cells (GC), germinal vesicle (GV) and thecal cells 
(TC). Cells positive for pSMAD 2/3 stained brown. pSMAD2/3 positive TC indicated by 
arrowhead (A). (b) Follicle cultured for 8 days in control medium, positive staining for 
pSMAD 2/3 observed in the granulosa cells (GC) and some thecal cells (TC), indicated 
by the arrowheads (A ).The germinal vesicle (GV) is poorly defined with no pSMAD2/3 
protein localisation observed. Scale bar 50pm. 
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5.4. DISCUSSION 
In this study oocyte growth occurred over time in all treatment groups compared to the 
oocytes of freshly isolated follicles (Day 0), and significantly in the presence of rhAct A 
in the absence of rFSH in agreement with observations made by Thomas et al. (2003a) in 
ovine preantral follicles with the mean diameter increasing in this study from 40.tm to 
65im in rhAct A supplemented follicles. On evaluation, the proportion of follicles 
containing morphologically healthy oocytes was observed to be significantly lower in 
follicles cultured in lOOng/mI rFSH and control media compared to all other cultured and 
freshly fixed follicles. It has previously been demonstrated that lower concentrations of 
FSH promote oocyte growth in murine oocyte-granulosa cell complexes (Thomas et al. 
2005), an observation attributed to the regulation by FSH of the ratio of soluble to 
insoluble kit ligand, the balance of which must be tightly controlled for oocyte 
development. It is hypothesized that in this study the significantly healthy morphology of 
oocytes cultured in a lower concentration of rFSH and rhAct A may be attributable to a 
similar mechanism. Addition of rhAct A alone to the culture media also significantly 
improved oocyte health over control and bOng/mi rFSI-1 suggesting that activin may also 
be involved in the mechanism of kit-ligand expression. Additionally the possible control 
of the kit-ligand ratio exerted by rFSH and rhAct A may positively affect other oocyte 
factors e. g. zona pellucida gene expression, BMP- 15 and GDF-9 expression and hence 
contribute to the maintenance of normal oocyte morphology, effects that may be 
suppressed by a higher concentration of rFSH and control media. Interestingly the 
incidence of oocyte investment by granulosa cells corresponds directly with oocyte 
health. The oocytes of freshly isolated follicles and follicles cultured in rhAct A, rhAct A 
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combined with rFSH and 50ng/mI rFSH have a significantly greater number of granulosa 
cells abutting the oocyte compared to oocytes cultured in bOng/mI rFSH and control 
(Fig. 5.1c). This was confirmed and extended by confocal analysis cell junction 
formation and maintenance by the visualisation of actin networks. Specifically, all 
treatment groups analysed showed that extensive somatic intercellular actin networks 
were established and tight granulosa cell adhesion to the zona pellucida was visible, 
relative to untreated controls, moreover the confocal results demonstrate that in the 
presence of the combination treatment of rhAct A and 50ng/ml rFSH actin projections 
were visible extending from the zona pellucida interface. These results suggest a positive 
correlation between the oocyte-somatic intercellular junctions, the proximity of granulosa ZD 
cells adhering to the zona pellucida and maintenance of oocyte morphological health. 
This agrees with the growing body of evidence that oocyte and somatic cell growth and 
development is dependent on paracrine and endocrine regulation via oocyte granulosa 
cell communication (Albertini et al. 2001, Eppig 2001, Carahatsos et al. 2000, 
Carabatsos et al. 1998). In this study the presence of rhAct A or a low concentration of 
rFSH correlates positively with the oocyte-granulosa cell association and with oocyte 
morphological health suggesting that activin and low concentration rFSH promote the 
continuance of intercellular communication throughout the culture period. The presence 
of rhAct A and/or a low concentration of rFSH in the culture medium may directly 
influence oocyte derived expression of connexin proteins and thus oocyte granulosa cell 
gap junction formation, alternatively the maintenance of the optimum kit ligancl isoform 
ratio attributed to low FSH and activin may positively affect connexin expression. 
Immunolocalisation of connexin proteins and relevant adhesion molecules will be 
important to evaluate in future studies on this system. 
Activin receptor proteins have been isolated in the oocytes and granulosa cells of 
preantral (Hulshof et al. 1997) and antral (Izadyar et al. 1998) bovine follicles, preantral 
immature rodent follicles (Zhao et al. 2001, Drummond et al. 2002), fetal oogonia and 
somatic cells of human follicles (Martins da Silva et al. 2004) and in the thecal layers of 
bovine (Huishof et al. 1 997) and rat (Drummond et al. 2002) follicles. Activin binding 
results in regulation of expression of activin dependent genes via an intracellular cascade 
of reactions mediated by the SMAD protein family, in particular phosphorylation of 
SMAD2 and SMAD3. The localisation of SMAD proteins and mRNAs has been 
demonstrated in the oocytes and somatic cells of rodent (Drummond et al. 2002) and 
human (Coutts et al. 2008, Pangas et al. 2002) follicles. lmmunohistocheniistry 
undertaken in this experiment demonstrated the activation of the intracellular SMAD 
second messenger cascade within in vitro grown follicles by the localisation of the 
activated i.e. phosphorylated form of the SMAD2/3 (pSMAD2/3) protein (Fig 5.3). In the 
presence of rhAct A pronounced positive staining for pSMAD2/3 was visible in all 
follicular components whereas in the absence of rhAct A although pSMAD 2/3 protein 
was localised in the granulosa and theca cells, the oocyte nucleolus was negative. In 
addition to activin, the SMAD2/3 intracellular signalling cascade can be activated by 
other TGFJ3 family members (Moustakas 2002. Souchelnytskyi et al. 2001), therefore it 
is possible to hypothesise that the staining observed in the somatic cells of control-
cultured follicles is due to binding of other TGFI3S however within the oocyte rhAct A is 
required to activate the SMAD2/3 cascade, suggesting that activin dependent oocyte- 
specific genes may be involved in the maintenance of the oocyte-granulosa cell 
association. A positive correlation was also observed between follicles cultured in 
50ng/ml rFSH without activin, and oocyte-granulosa cell association. Previous work has 
shown the localisation of functional FSH receptors in human and porcine oocytes from 
the primary stage of development onwards (Méduri et al. 2002) therefore it further 
hypothesised that the lower concentration of rFSH may act on oocyte receptors and 
thereby induce and/or maintenance of the activation of oocyte-specific genes involved in 
the maintenance germ and somatic cell communication observed. 
In summary these results demonstrate enhanced oocyte growth, morphological health and 
granulosa cell investment of oocytes in the presence of rhAct A, rhAct A supplemented 
with rFSH and 50ng/ml rFSH over an 8-day culture period. Further investigation of 
ability of oocytes from in vitro grown preantral follicles to undergo further development 
within oocyte-granulosa cells complexes is required to improve our knowledge of the 
precise role of activin and FSH in mammalian preantral follicle growth and development. 
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CHAPTER SIX 
EFFECT OF TESTOSTERONE IN ISOLATED 
AND STRIP-ENCLOSED BOVINE 
PREANTRAL FOLLICLES 
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6.1. INTRODUCTION 
The experiments described in chapters 4 and 5 have demonstrated that activin alone and 
in combination with a low concentration of rFSH has a positive effect on oocyte 
morphology, maintenance of oocyte-somatic cell association and oocyte growth 
promoting an increase of over a third in the oocyte diameters of cultured preantral bovine 
follicles. Activin causes significant oocyte growth but after 8 days in vitro these oocytes 
still have some way to go before they reach maturity as the smallest reported diameter of 
bovine oocytes successfully cultured, matured and fertilised in vitro is 95i.m on 
aspiration from the follicle (Hirao et al. 2004). Possible strategies for improving oocyte 
growth in vitro include extension of the culture period or further sLipplementation of the 
culture media within the existing 8-day period. The experiments described in chapter 3 
showed that follicles could be cultured for up to 20 days however a significant 
deterioration in both oocyte growth and oocyte morphology occurred beyond 8-days. 
Therefore rather than increase the in vitro period to augment oocyte development, 
additional supplementation of the culture media was chosen and the culture period fixed 
at 8-days. Recently testosterone has been recognised as a dose-dependent promoter of 
bovine primary 10 secondary stage transition moreover this effect was demonstrated to be 
independent of arornatisation as the stimulatory effects were inhibited by the addition of a 
specific androgen receptor blocker. Androgens are associated with the approach of 
maturity late in follicle development when, in response to the luteinising hormone surge, 
theca cells synthesise androstenedione, dihyrotestosterone and testosterone from 
cholesterol and pregnenolonc. Testosterone exerts its influence by being arornatised to 
oestrogen or by binding to either androgen receptors in the granulosa and thecal cells or 
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steroid hormone binding globulin receptor complexes (SHBGR c0m) found on the 
granulosa cell membrane and in the follicular fluid. Androgen associated follicle growth 
has been demonstrated in isolated preantral murine follicles (Wang etal. 2001, Murray et 
al. 1998) and in primate follicle growth (Vendola et al. 1999, Vendola et (i!. 1998) in vivo 
moreover androgens are thought to be linked to the abnormally increased follicle 
development observed in women with polycystic ovarian syndrome (Abbott et al. 2002). 
Taken together the results above indicate that testosterone can exert a growth promoting 
influence therefore the aim of the initial experiments described in this chapter was to 
determine the effect of testosterone and testosterone in combination with rhAct A and 
rFSH on follicle and oocyte development in isolated preantral bovine follicles over an 8-
day culture period. 
A second set of experiments was set up to investigate the effect of testosterone in 
combination with rhAct A and rFSH on the primary to secondary follicle transition 
within cultured bovine cortical strips. As their size prohibits individual ovary culture, the 
earliest stages of follicular development in large mammals i.e. primordial activation and 
primary to secondary stage transition have been investigated using cortical strip culture 
systems and from these investigations various factors have been associated with these 
early developmental stages in domestic species and primates including insulin, selenium, 
transferrin, Vascular Endothelial Growth Factor (VEGF) and testosterone (Yang and 
Fortune 2007. Yang and Fortune 2006, Hovatta et al. 1999, Wright etal. 1999, Fortune et 
al. 1998, Wandji ci al. 1997, Wandji et al. 1996). The roles of other factors believed to 
contribute to rodent follicle initiation and primary follicle development i.e. AMH. GDF-
9, Foxo3A, KL, Wilms' Tumor Protein (WTI), bFGF, LIF, BMP-4 and KGF (Kezele et 
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al. 2005, Castrillon et al. 2003, Kezele and Skinner 2003, Logan et al. 2003, Nilsson and 
Skinner 2003; 2002, Nilsson et al. 2002, Nilsson et al. 2001, Durlinger ci al. 1998) have 
yet to be confirmed in large mammalian ovaries. Immunohistochernical localisation of 
Stem Cell Factor (SCF) and its ligand, LIE and its receptor, the BMPs 4 and 7, growth 
factor and activin receptors in the oocytes of human primordial follicles suggests the 
involvement of these factors in the initiation of follicle growth in humans (Abir ci al. 
2007a, Abir et al. 2007b Abir et al. 2004a, Abir et al. 2004b, Martins da Silva et al. 
2004). If primary to secondary follicle transition can be enhanced within bovine cortical 
strips this could create a potential population of early growing follicles which could then 
be isolated and cultured individually advancing the development of systems to support 
complete large mammalian follicle development in vitro. Bovine cortical strips were 
cultured for 6 days in the presence of testosterone and testosterone in combination with 
rhAct A and rFSH. On completion of the culture period follicle developmental stage, 
oocyte diameter and oocyte morphology were assessed and compared to freshly fixed 
pieces of bovine cortex. 
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6.2. MATERIALS AND METHODS 
6.2.1. Isolated Preantral Follicle and Cortical Strip Culture 
Cortical pieces were removed from selected bovine ovaries trimmed of excess stroma and 
cultured as individual strips for 6 days in basic culture medium (control) or medium 
supplemented with testosterone or testosterone in combination with rhAct A and rFSH as 
described in chapter 2 sections 2. 1.1 and 2.2.2.1. Preantral follicles ranging in size from 
132 - 191tm in diameter were isolated from fresh bovine cortical pieces and cultured 
individually for 8 days as previously detailed in chapter 2 sections 2.1.3. and 2.2.2.2. with 
media being removed and replaced every fourth day. Follicles were assessed at 4 day 
intervals during the culture period. 
2 sets of experiments were established, Experiment 1 considered the effect of testosterone 
and testosterone in combination with rhAct A and rFSH on isolated preantral follicle 
development and Experiment 2 investigated the effect of testosterone and testosterone in 
combination with rhAct A and rFSH on primary follicle development within cultured 
cortical strips. 
10 replicate cultures were set up, tissue pieces were taken on 6 occasions from these 
replicates prior to follicle dissection and cultured individually as cortical strips or 
immediately fixed. The tissue strips did not exceed 3 mm 2, 36 cortical pieces were 
removed in total; 30 were randomly assigned to treatment groups and individually 
cultured while 6 cortical strips were fixed immediately as uncultured controls. 
Isolated preantral follicles were randomly assigned to treatment groups. To allow the 
comparison of cultured follicles to in vivo development a number of follicles (n = 10) 
were fixed immediately as uncultured controls (0 Hrs). 
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6.2.2. Treatments 
6.2.2.1 Isolated Follicles: Treatment with testosterone, rhAct A and rFSH 
Basic culture medium (control) was prepared as previously described in 2.2.1. Basic 
culture medium was supplemented with testosterone 10 7M (Sigma Chemicals, Poole, 
Dorset UK), (BioSera Ltd, East Sussex, UK) alone or with rhAct A and/or rFSH. 
Testosterone was initially dissolved in absolute ethanol then diluted with culture medium 
to the desired concentration. Final concentration of ethanol in the culture medium did not 
exceed 0.042% v/v. The concentration of testosterone (10 7 M) was previously 
demonstrated by Yang and Fortune (2006) to promote significant follicle development in 
strip-enclosed bovine follicles. The specific treatment groups were as shown in Table 6.1. 
Table 6.1. Treatment groups, number of isolated follicles and number of cortical 
strips in each group per experiment 
Control 
FolliclesIsolated 	,I T 
n = 37 
Strips  
I 	= 6 
Testosterone n = 35 n = 6 
Testosterone +lOOng/ml rhAct A n = 35 n= 0 
Testosterone +50ng/ml rFSI-I ii = 35 n = 6 
Testosterone+lOOng/mlrhActA+SOng/ml rFSI-I n = 37 n = 6 
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6.2.3. Detection of Androgen Receptor by Immunohistochemistry 
To localise androgen receptors in cortical strips and isolated follicles which had 
undergone in vitro growth, a number of slides were selected from both experiments. 
Strips of freshly fixed ovarian tissue (n = 3) and follicles cultured in the presence of 
control medium (n = 5) or testosterone 10 -7M (n = 5) were fixed in 4% paraformaldehyde 
(preparation described in 2.3. I.) for 24 hours then processed and affixed to charged slides 
as described in 23.1.1. Details of the antibodies and serum used are shown in Table 6.2. 
Table 6.2 Immunolocalisation of Androgen Receptors: Antibodies and Serum 
Blocking Serum Primary Antibody Secondary Antibody 
Horse Serum Mouse Monoclonal ABC-Elite Mouse IgG 
Vectastain Elite Kit Androgen Receptor Vectastain Elite Kit 
PK-6102 NCL-AR-318 PK-6102 
Vector Laboratories, Novocastra Laboratories, Vector Laboratories, 
California, USA. Newcastle Upon Tyne, UK California, USA. 
150p1 horse serum+ Reconstituted with distilled H0, 50!il 
lOml TBS Diluted with TBS hiotinylated 
Working concentration 1:50 secondary antibody+ 
150[d horse serum+ 
lOmi TBS 
Slides were deparaffinised in xylene for 5 minutes, rehydrated in reducing concentrations 
of alcohol (1 00%, 90% and 70%) for 2 minutes in each concentration, then rinsed in 
distilled Il2O for 5 minutes followed by 2 x 5 minutes washes in TBS 0.05M (pH 7.6) on 
a rocking tray at 25 °C. To unmask antigen sites, the slides were placed in a glass vessel to 
which enough recently boiled Sodium Citrate 0.01M (pH 6.0) was added to cover the 
slides. Slides were covered with film to prevent drying out and heated in a microwave 
oven for a total of 8 minutes. 4 minutes at 800W followed by 4 minutes at 400W, 
thereafter the slides cooled in the citrate for 20 minutes before being washed for 2 x 5 
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minutes in TBS on a rocking tray at 25°C. To quench endogenous peroxidases, slides 
were then incubated in 3% hydrogen peroxide in methanol for 15 minutes at 25 °C then 
washed for 2 x 5 minutes in TBS on a rocking tray at 25 °C. Excess moisture was 
carefully removed from the slides then blocking serum applied (see Table 6.2). Slides 
were incubated in blocking serum for 30 minutes in a humidified chamber at 25 °C. 
Excess serum was shaken off the slides and primary antibody applied (see Table 6.2) 80 - 
lOOpi per slide depending on the number of sections. A negative control was established 
by omitting the primary antibody and leaving blocking serum on one slide. Slides were 
incubated in primary antibody (or blocking serum for negative control) overnight 
(minimum 12 hours) at 4°C then washed for 2 x 5 minutes in TBS/Tween (Tweeri-20, 
BDH Laboratory Supplies, Poole, UK; 50il Tween in 500m] PBS) on a rocking tray at 
25°C. Negative control washed separately. Secondary antibody was prepared and applied 
(see Table 6.2) 100 - 120p  per slide depending on the number of sections and incubated 
in a humidified chamber at 25 °C for 30 minutes. Avidin biotinylated complex (ABC) 
(Vectastain Elite ABC Kit, PK-6 100, Vector Laboratories, CA) prepared by combining 5 
ml TBS, 2 drops of Avidin DH solution and 2 drops of Biotinylated Peroxidase together 
and standing for 30 minutes. Following secondary antibody incubation, slides were 
washed in TBS/ Tween for 2 x 5 minutes and ABC was applied to sections (100— 120il 
per slide). Slides were incubated in a humidified chamber at 25 °C for 30 minutes then 
washed in TBS for 2 x 5 minutes. 3, 3 Diaminobenzdine (DAB) (DAB Substrate Kit, SK-
4100, Vector Laboratories, CA) solution was prepared by combining 5m1 distilled H20, 2 
drops of buffer, 4 drops of DAB solution and 2 drops of hydrogen peroxide. DAB 
solution was applied to the slides for a maximum of 10 minutes thereafter the slides were 
rinsed in tap water for 5 minutes, counterstained in haematoxylin for 15 seconds, rinsed 
again in tap water (2 x 5 minutes) and dehydrated, firstly using increasing concentrations 
of alcohol (70%, 90% and 100%), 2 minutes in each concentration and then xylene for 5 
minutes. Slides were then mounted using DPX and left to dry overnight. 
6.2.4. Statistical Analyses 
Distribution of data for parametric analysis was checked using GraphPad Software Instat 
Guide to choosing and interpreting statistical tests version 3.05, 1998, GraphPad 
Software Inc., San Diego, California, USA. Mean follicle (isolated follicles) and mean 
oocyte (isolated follicles and cortical strips) diameters were compared between treatment 
groups on completion of the culture periods using Minitab 14 Statistical Software one-
way unstacked ANOVA with subsequent t-tests to allow for inter- group comparison. The 
proportions of antral cavity formation and oocyte morphological health were assessed 
using Minitabl4 Statistical Software Contingency Tables: Chi Square Test. 
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6.3. RESULTS 
6.3.1. Experimental Outline 
2 experiments conducted, Experiment 1: 8-day culture of preantral follicles in 
testosterone in the presence, and absence, of activin and FSH. Experiment 2: 6-day 
culture of ovarian cortical strips follicles in testosterone in the presence, and absence, of 
activin and FSH. 
In Experiment I, in vitro follicle diameters measured on days 0, 4 and 8 of the culture 
period. Follicles processed for immunohistochernical localisation of androgen receptors 
and histological analysis of follicle and oocyte morphological status on Day 8; no 
follicles removed for analysis prior to Day 8 of the culture period. 
In Experiment 2, cortical strips processed for histological analysis of developmental stage 
and oocyte morphological status on Day 6 no strips removed for analysis prior to Day 6 
of the culture period. Freshly fixed tissue strips processed for iinmunohistochemical 
localisation of androgen receptors. 
6.3.2. Experiment 1: Follicle Growth and Differentiation: Control versus 
Testosterone and Activin and FSH 
6.3.2.1. Effect of testosterone, rhAct A and rFSH on the growth of cultured bovine 
preantralfollicles 
Follicles were cultured individually for 8 days in control medium or in medium 
containing testosterone 10 7M in the presence and absence of rhAct A and rFSI-I. 
Significant follicle growth was observed over time in all groups (p < 0.01). In the 
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presence of rhAct A, significant follicle growth was observed at Day 4 (p< 0.01) and Day 
8 (p< 0.01) of the culture period compared to all other treatments (Figure 6.1). 
In vitro Bovine Preantral Follicle Growth: 
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Figure. 6.1. Effect of testosterone, rhAct A and rFSH on the growth of preantral 
bovine follicles in vitro. Follicles were cultured for 8 days in the presence of testosterone 
10 7M (white), testosterone 10 7M and lOOng/mI rhAct A (red), testosterone 10 7 M and 
50ng/ml rFSE-1 (grey), testosterone 10 7M and lOOng/mi rhAct A and 50ngIml rFSH 
(blue) or control medium (black). Values are mean follicle diameters ±SEM. (a) and (b) 
denote a significant difference between treatment groups. On Day 4 and Day 8 of the in 
vitro period, follicles cultured in testosterone 10 7M and tOOng/mi rhAct A (p <0.0l)and 
testosterone 10 7M and lOOng/ml rhAct A and 50ng/mI rFSI-1 (p< 0.01) were significantly 
larger than follicles cultured in all other treatment groups. 
6.3.2.2. Effect of testosterone, rhAct A and rFSH on Antral Cavity Formation in 
Cultured Preantral Bovine Follicles 
The presence of an antral cavity was determined on histological evaluation of follicles 
fixed at Day 8 of the culture period. Antral cavity formation is expressed as a proportion 
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of the total number of follicles per treatment group per day of culture (see Table 6.1 for ii 
values per treatment group). Antral formation was observed to be significantly higher in 
follicles cultured in testosterone 10 7M and bOng/mI rhAct A (p  <0.01) and testosterone 
10 7M and bOng/mb rhAct A and SOng/mb rFSH (p  <0.05) compared to follicles cultured 
in either control medium or testosterone 10 7M on Day 8 of the culture period (Figure 
6.2). 
Antral Cavity Formation in Cultured Preantral 
Bovine Follicles: Control versus Testosterone, 
Activin and FSH 
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Figure 6.2. The effect of testosterone, rhAct A and FSH on antral cavity formation 
in preantral bovine follicles in vitro. Antral cavity formation occurred in all treatment 
groups by Day 8. (a), (b) and (c) denote significant differences between treatment groups. 
A significantly larger proportion of follicles formed antral cavities when cultured in 
testosterone 10-7  M  and I OOng/ml rhAct A (red) (p< 0.01) and testosterone 10-7  M  and 
lOOng/mI rhAct A and SOng/mi rFSH (blue) (p< 0.05) compared to follicles cultured in 
control (black ) and testosterone 10 7M (white). 
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6.3.3. Oocyte Growth and Morphological Health: Control versus Testosterone, 
Activin and FSH 
6.3.3.1. Effect of testosterone, rhAct A and rFSH oil the Growth and Morphological 
Health of Oocytes in Preantral Bovine Follicles in vitro 
Histological observations were made on freshly fixed follicles ( Day 0 ) (n = 10) and 
follicles cultured in control (n = 37) or medium containing testosterone 10 7M (n = 35 ), 
testosterone 10 7M and lOOngIml rhAct A (n = 35), testosterone 10 7M and SOng/mI rFSH 
(n = 35) or testosterone 10 7M and loong/ml rhAct A and SOng/mi rFSH (n = 37) for 8 
days. No significant oocyte growth was observed between freshly fixed follicles and any 
of the treatment groups. No significant oocyte growth was observed between cultured 
follicles (Figure. 6.3a). Oocyte health was assessed by determining the general 
morphology of the oocyte (Figure 6.3c). Oocyte health was significantly reduced in 
follicles cultured in control medium (p< 0.05), testosterone 10 7M (p< 0.01) and 
testosterone 10 7M and 50ng/rnl rFSI-I (p< 0.01) compared to the health of oocytes of 
freshly fixed follicles (Day 0) and those cultured testosterone 10-7  M  and I OOng/ml rhAct 
A (Figure. 6.3b). 
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Figure 6.3a. Effect of Testosterone, rhAct A and rFSFI on in vitro growth of oocytes 
in preantral bovine follicles. Oocyte growth in follicles cultured in control medium 
(black), testosterone 10 7M (white), testosterone 10 7 M and bOng/mi rhAct A (red), 
testosterone 10 7 M and 50ng!ml rFSH (grey) or testosterone 10 7M and bOng/mi rhAct A 
and 50ng/ml rFSI-1 (blue) compared to the diameters of oocytes in freshly fixed follicles 
(Day 0) (hatch). Values are mean oocyte diameters ± SEM. No significant oocyte growth 
occurred over time; no significant oocyte growth was observed between treatment 
groups. 
Figure 6.3b. Effect of testosterone in the presence and absence of activin and rFSH 
on oocyte morphological health in preantral bovine follicles cultured for 8 days. 
Oocyte health in follicles cultured in control medium (black) testosterone I 0 7M (white), 
testosterone 10 7M and bOng/mi rhAct A (red), testosterone 10 7M and 50ng/ml rFSH 
(grey) or testosterone 10 7M and lOOng/mI rhAct A and 50ng/ml rFSH (blue) compared 
to the health of oocytes in freshly fixed follicles (Day 0) (hatch). Values are healthy 
oocytes as expressed as proportion of the total number of oocytes analysed per treatment 
group. (a), (b), (c) and (d) denote a significant difference between treatment groups. A 
significantly higher proportion of morphologically healthy oocytes were observed in 
freshly fixed follicles (Day 0) and in follicles cultured testosterone 10 7M and rhAct A 
compared to those cultured in control medium (p< 0.05), testosterone 10 7M (p< 0.01) 
and testosterone 10 -7 M  and SOng/mI rFSH (p< 0.01). 
Fig 6.3a 
Oocyte Growth in Cultured Preantral Bovine Follicles: 














Oocyte Health in Cultured Preantral Bovine Follicles: 































Figure 6.3c. Oocyte morphology in isolated bovine preantrat follicles cultured in the 
presence and absence of Testosterone. (i) Oocyte cultured in control medium, signs of 
degeneration i.e. vacuoles, shrunken uneven cytoplasm and ruptured oolemrna visible. (ii) 
Oocyte cLiltured in testosterone I0I 7 M), shrunken missha?en  oocyte, somatic cell 
association lost. (iii) Oocyte cultured in testosterone 10 M and bOng/mI rhAct, 
morphologically healthy oocyte, germinal vesicle, nucleolus, and intact oolemma all 
clearly visible, also direct contact with surrounding somatic cells. 
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6.3.4. Experiment 2: Cortical Strip Enclosed Follicle Development 
6.3.4.1. Effect of testosterone rhAct A and rFSH on follicles development in cultured 
bovine ovarian cortical strips 
Strips of bovine ovarian cortex were cultured individually for 6 days as shown in Table 
6. I. To allow for comparison to be made to in vivo development, one piece of ovarian 
cortex was taken from 6 replicate cultures and fixed immediately on dissection (0 Hrs). 
The proportion of follicles present per stage of development was calculated in freshly 
fixed cortical strips (0 Hrs) and in cortical strips cultured for 6 days as described in 
Chapter 2 section 2.3.3. I. The number of follicles analysed per treatment groups is shown 
in Table 6.3. As discussed in Chapter 1 (section 1.2.2.1.) the morphology of early bovine 
follicles is thought to be unique amongst mammals (Van Wezel and Rodgers 1996) 
therefore primordial follicles and transitory follicles were combined into one category 
and considered a quiescent population. Primary and secondary stages of follicle 
development were categorised using the same criteria as Wanclji et a! (1996a) as 
described in Chapter 2 section 2.3.3.1. On completion of the in vitro period, significantly 
fewer quiescent follicles were found in the cultured cortical strips compared to freshly 
fixed tissue (Figure 6.4a). Significantly fewer primary and secondary follicles were 
observed in freshly fixed tissue compared to all cultured cortical strips (Figure. 6.4b and 
6.4c). Significantly more secondary follicles were observed in all cultured cortical strips 
compared to freshly fixed tissue, and, in cortical strips cultured in the presence of 
testosterone 10 7 M compared to all other cultured tissue (Figure. 6.4c). 
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Figure 6.4a. Effect of testosterone, rhAct A and rFSH on the quiescent follicle 
population in cultured bovine cortical strips. 
The proportion of quiescent follicles in the ovarian cortical strips cultured in control 
medium (black), testosterone 10 7M (white), testosterone 10 7M and bOng/mI rhAct A 
(red), testosterone 10 7M and 50ng/ml rFSH (grey) or testosterone 10 7M and lOOng/mi 
rhAct A and 50ng/ml rFSH (blue) compared to the proportion of quiescent follicles in 
freshly fixed follicles (Day 0) (hatch). Quiescent follicles are expressed as a proportion of 
the total number of follicles analysed per treatment group. (*) denotes a significant 
difference between freshly fixed tissue and all cultured tissue. A significantly greater 
proportion of quiescent follicles (p< 0.01) were observed in freshly fixed cortical strips 
compared to tissue cultured in any of the treatment groups. 
Table 6.3. Number of follicles per developmental stage analysed in each treatment 
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Control n = 369 n = 261 n = 36 n = 666 
Testosterone n = 501 n = 244 n = 185 n = 930 
Testosterone+rhActA n = 455 n = 314 n = 40 n = 809 
Testosterone+rFSH n = 382 n = 201 n =51 n = 634 
Testosterone+rhActA+rFSH n = 369 n = 403 n = 41 n = 813 
Fig 6.4a 
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Figure 6.4b. Effect of testosterone, rhAct A and rFSH on the primary follicle 
population in cultured bovine cortical strips. 
The proportion of primary follicles in the ovarian cortical strips cultured in control 
medium (black), testosterone 10 7M (white), testosterone 10 7M and lOOng/mi rhAct A 
(red), testosterone 10 7M and 50ngIinl rFSH (grey) or testosterone 10 7M and lOOng/mI 
rhAct A and 50ngfml rFSH (blue) compared to the proportion of primary follicles in 
freshly fixed follicles (Day 0) (hatch). Primary follicles are expressed as a proportion of 
the total number of follicles analysed per treatment group. (*) denotes a significant 
difference between freshly fixed tissue and all cultured tissue. A significantly smaller 
proportion of primary follicles (p< 0.01) were observed in freshly fixed cortical strips 
compared to tissue cultured in any of the treatment groups. 
Figure 6.4c. Effect of testosterone, rhAct A and rFSH on the secondary follicle 
population in cultured bovine cortical strips. 
The proportion of secondary follicles in the ovarian cortical strips cultured in control 
medium (black), testosterone 10 7M (white), testosterone 10 7M and bOng/mi rhAct A 
(red), testosterone 10 7M and SOng/mi rFSH (grey) or testosterone 10 7M and lOOng/mi 
rhAct A and 50ng/mi rFSH (blue) compared to the proportion of secondary follicles in 
freshly fixed follicles (Day 0) (hatch). Secondary follicles are expressed as a proportion 
of the total number of follicles analysed per treatment group. (*) and (**) denote 
significant differences in the proportion of secondary follicles between freshly fixed 
tissue and treatment group and (***) denote significant differences in the proportion of 
secondary follicles between freshly fixed tissue and treatment group and between 
testosterone 10 7M. A significantly greater proportion of quiescent follicles (p< 0.01) 
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6.3.5. Cortical Strip Enclosed Oocyte Development: Control versus Testosterone, 
rhAct A and rFSH 
6.3.5.1. Effect of testosterone, rhAct A and rFSH on Diameter and Health of Oocytes 
in Follicles within Cultured Bovine Cortical Strips 
Oocytes at each stage of development in freshly fixed cortical strips (0 Hrs) and strips 
cultured for 6 days were measured and mean diameters calculated. No significant 
difference was observed between the oocytc diameters of the quiescent and primary 
follicles stages between treatment groups or on comparison to freshly fixed tissue. 
Freshly fixed tissue contained oocytes within secondary follicles that were significantly 
larger than those cultured in the presence of testosterone alone (p  <0.05) and testosterone 
supplemented with rhAct A (p  <0.05). FSH (p  <0.05) or both (p  <0.05). The oocytes of 
secondary follicles within control cultured cortical strips were significantly larger than 
those cultured in the presence of testosterone in combination with rhAct A (p < 0.05) 1 
FSI-I (p < 0.05) or both (p < 0.05) (Figure 6.5a). Oocyte health was assessed by 
determining the general morphology of the oocyte as described in Chapter 2 section 
13.3.2. No significant difference was observed in morphological oocyte health between 
treatment groups in the quiescent follicle group. In primary follicles, morphological 
oocyte health was significantly higher in freshly fixed tissue (p  <0.01) (Figure 6.6a) and 
in tissue cultured in control medium (p  <0.01). A significant reduction in oocyte health 
was observed in the oocytes of secondary follicles in cortical strips cultured in 
testosterone 10 7M (Figure 6.6b) and those cultured for testosterone and SOng/mi FSH 
compared to freshly fixed follicles (p  <0.01) and those cultured in control medium (p < 
0.05) or in the presence of rhAct A (p  <0.05) (Figure 6.5b). 
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Figure 6.5a. Effect of testosterone, rhAct A and rFSH, on oocyte diameters in 
cultured bovine ovarian cortical strips. 
Diameter of oocytes in quiescent (black), primary (white) and secondary (red) follicles in 
freshly fixed (0 Hrs) and cultured cortical strips. Values are mean oocyte diameters ± 
SEM. (a), (b) and (c) denote significant differences in the diameter of oocytes in 
secondary (red) follicles only. No significant difference observed between the diameters 
of quiescent (black) or primary (white) oocytes. Oocytes in the secondary follicles in 
freshly fixed tissue (p <0.05) were significantly larger than those cultured in the presence 
of testosterone (p < 0.05) and control cultured oocytes are significantly larger than those 
cultured in the presence of rhAct A and rFSH (p <0.05). 
Figure 6.5b. Effect of testosterone, rhAct A and rFSH on morphological oocyte 
health in follicles within cultured bovine ovarian cortical strips. 
Morphological oocyte health of quiescent (black), primary (white) and secondary (red) 
follicles in freshly fixed (0 Hrs) and cultured cortical strips. Values are healthy oocytes as 
expressed as a proportion of the total number of oocytes per treatment group. (a) and (b) 
denote significant difference in oocyte health in primary and secondary follicles 
respectively. No significant difference in the morphological health of quiescent follicles. 
A significantly higher proportion of healthy oocytes were observed in the oocytes of 
primary follicles in freshly fixed tissue (p  <0.01) and control cultured tissue (p < 0.01) 
compared to all other experimental groups. Significantly reduced oocyte health was 
observed in secondary follicles in tissue cultured in testosterone 10 7Malone (p <0.05) 
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Figure 6.6. Oocyte Morphology of Secondary Follicles in Cortical Strips. (a) Freshly 
fixed bovine cortical strip with morphologically healthy oocyte a in secondary follicle. 
(b) Morphologically unhealthy oocyte of a secondary follicle grown within a cortical 
strip cultured in testosterone 107  M for 6 days; grossly misshapen oocyte. 
6.3.6. Localisation of Androgen Receptors in Freshly Fixed Bovine Cortical Tissue 
and Cultured Bovine Follicles 
6.3.6.1. Localisation of Androgen Receptor in Quiescent and Growing Follicles in 
Cortical Strips 
Androgen receptor antigen localisation was determined in freshly fixed tissue cortical 
strips (n = 3) The localisation of androgen receptors appeared to be stage dependent in 
- 141 - 
freshly fixed cortical tissue with pronounced positive staining (brown) visible in the 
ooplasm of quiescent follicles (Figure 6.7a). In primary (Figure 6.7b) and secondary 
(Figure 6.7c) positive staining was detected in the ooplasm and within the granulosa 








Figure 6.7. Androgen receptor localisation in freshly fixed bovine cortical tissue. 
Immunohistochemistry against androgen receptor antibody, identified as brown staining. 
(a) Staining for the androgen receptor antigen was localised in the ooplasm of quiescent 
follicles. In primary (b) and secondary (c) follicles the androgen receptor antigen was 
localised to granulosa cells and the ooplasrn. 
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6.3.6.2. Effect of Testosterone on Androgen Receptor Localisation Cultured Bovine 
Preantral Follicles 
Androgen receptor antigen localisation was determined in preantral follicles cultured in 
control medium (ii = 5) and in the presence of testosterone 10 7M (n = 5). In control 
cultured follicles, brown positive staining for receptor localisation was visible within 
many granulosa cells but not in the oocyte (Figure 6.8a) whereas follicles cultured in the 
presence of testosterone 10 7 M, brown positive staining for the androgen receptor was 
observed within almost all of the granulosa cells and within the ooplasm (Figure 6.8b). 
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Figure. 6.8. Androgen receptor localisation in isolated cultured bovine preantral 
follicles. Immunohistochemistry against androgen receptor antibody, identified as brown 
staining. (a) Follicle cultured in control medium, the androgen receptor antibody was 
localised to the granulosa cell interstitial areas and in some granulosa cells, no staining 
was observed in the oocyte. (b) Follicle cultured in testosterone 10 7 M, androgen receptor 
antigen localised surrounding and within almost all of the granulosa cells and in the 
ooplasm. (c) Negative control for androgen receptor antigen, follicle cultured in control 
medium. 
Fig 6.8 
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Experiment 1 investigated whether testosterone could promote growth beyond the 
secondary stage of development by culturing isolated preantral bovine follicles in the 
presence of testosterone in combination with rhAct A and rFSH for 8 days. The 
paradoxical effect of androgens on growing follicles has been recognised with rodent and 
primate follicle growth (Wang et al. 2001, Vendola et al. 1999, Murray et al. 1998, 
Vendola et al. 1998) and porcine and rodent follicular atresia (Billig etal. 1993, Bagnell 
et at. 1982, Maxson et al. 1985) being demonstrated. In this study significant follicle 
growth was demonstrated on Day 4 and Day 8 of the in vitro period in the presence of 
testosterone and activin concomitant with significant antral formation in the same groups, 
although in the presence of testosterone alone neither were significant therefore it is 
likely that the observed effects are attributable to activin rather than the inclusion of 
testosterone. As previously described androgens can exert their follicular effect via 3 
mechanisms, it is possible therefore that a combination of these mechanisms is required 
for normal follicle growth moreover the combination of mechanisms may alter in a stage 
and/or species dependent manner, the regulation of which may be perturbed by the in 
vitro environment resulting in aberrant development. No significant oocyte growth was 
observed in this study, and oocyte health was significantly reduced in the presence of 
testosterone compared to freshly isolated follicles, however the addition of activin to the 
culture medium improved oocyte health significantly. As seen in earlier chapters, 
morphologically unhealthy oocytes were associated with loss or reduced somatic cell 
oocyte contact, therefore it is proposed that in this experiment that the maintenance of 
normal oocyte morphology exerted by activin may be 1) a direct effect of activin 
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preserving oocyte-somatic contact or 2) an indirect effect by regulating the mechanism of 
testosterone action in favour of oocyte graniilosa cell communication or a combination of 
both. Addition of testosterone 10 7M to isolated bovine follicle cultures disrupted normal 
development however the same concentration promotes follicle development in bovine 
cortical strip culture (Yang and Fortune 2006). It could be hypothesised that the 
disruption of growth may not be due to testosterone per se rather that is a result of the 
differing tissue requirements of isolated follicles and cortical strips therefore to 
investigate whether the aberrant effects attributed to testosterone could be avoided and 
growth of isolated follicles enhanced, a dose response experiment could be performed. 
In isolated cultured bovine follicles the androgen receptor was localised to granulosa, 
and, in the presence of testosterone, intense staining for the receptor was observed in the 
granulosa cells and the oocyte, supporting the study by Hampton et a! (2004) who 
observed immuno local isation of androgen receptor mRNA in the bovine granulosa cells, 
which increased during bovine preantral follicle development. In both control and 
testosterone cultured follicles some brown staining appeared to be localised to the 
granulosa interstitium. This observation would seem anomalous as androgen receptors 
are classically defined as nuclear receptors confined to the cells interior and able to 
regulate gene transcription via ligand binding, dimerisation and translocation to the 
nucleus of the target cell. A possible explanation for this observation is that the 
apparently extracellular staining indicates androgen receptor localisation in granulosa 
cells or fragments of granulosa cells contained within the tissue section but below the 
uppermost layer of cells in the plane of focus giving the appearance of a diffuse positive 
stain. Interestingly in this study no stromal or thecal localisation was observed in the 
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presence or absence of testosterone, this contrasts with a recent study by Yang and 
Fortune (2006) who localised the androgen receptor to the bovine ovarian strorna and all 
cellular compartments of follicles however Yang and Fortune (2006) localised the 
receptor in follicles cultured within cortical strips whereas in this experiment the follicles 
were isolated from cortical strips and excessive stromal tissue removed prior to culture. 
These results suggest that androgen receptor expression in the bovine cortex may be 
regulated by extra-follicular mechanisms furthermore it is proposed that removal of the 
follicle from the stroma and subsequent culture in the presence of androgens alters the 
follicles' ability to regulate androgen binding resulting in the observed perturbation of 
development. Taken together these results indicate that in this system testosterone 
supplementation of isolated follicle culture medium disrupts oocyte and somatic cell 
development in vitro although the mechanism through which these effects are exerted has 
not been identified. 
Experiment 2 investigated the ability of testosterone to promote bovine follicle growth 
within cultured cortical strips in the presence of activin and FSH. In order to understand 
large mammalian follicle development from the earliest stages it is necessary to identify 
factors promoting primordial activation and investigate their effects on the oocyte and 
granulosa cells in vitro. As discussed earlier in this chapter, activation of bovine follicles 
can be acomplished in gonadotrophin and serum-free systems in the presence of insulin, 
selenium and transferrin (Fortune et al. 1998, Wandji et al. 1997) however, this medium 
appears to be insufficient to promote follicle growth beyond the primary stage (Fortune et 
al. 2000, Braw-Tal and Yossefi 1997, Wandji et al. 1997). The primary to secondary 
transition in cultured bovine cortical tissue has been the subject of several studies and as 
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a result FCS (Gigli et al. 2006) and recently VEGF and testosterone have been 
recognised as promoters of this critical stage (Yang and Fortune 2007, Yang and Fortune 
2006). Androgens have been associated with follicular development in isolated rodent 
follicles (Wang et al. 2001, Murray et al. 1998) and in viva follicle growth in rhesus 
monkeys (Vendola et al. 1999, Vendola et al. 1998) effects demonstrably separate from 
aroniatisation, moreover, excessive androgen secretion in the thecal cells is thought to be 
associated with polycystic ovarian syndrome in women resulting in abnormally increased 
numbers of follicles being recruited to develop (Abbott et at. 2002). In Experiment 2 the 
effect of testosterone in the presence of activin and FSH was investigated as both of these 
factors have been associated with the early stages of large animal follicle development 
(Telfer et at. 2008, Thomas et al. 2003a, Gutierrez et al. 2000, McNatty et al. 2000, Saha 
et al. 2000, Wandji et at. 1996b) moreover significant oocytc development has been 
observed in the combined presence of activin and FSH in rodents (Li et al. 1995). After a 
6-day in vitro period, the proportions of quiescent and primary follicles were observed to 
have decreased and increased respectively on comparsion with freshly fixed cortical 
tissue with no significant inter-treatment differences observed, a result that is congruent 
with previous studies using large mammalian ovarian cortical culture over similarly 
timed and longer culture periods (Fortune ci' al. 1998, Wandji et al. 1997, Wandji et (1!. 
I 996a). In agreement with Yang and Fortune (2006), the proportion of secondary follicles 
was observed to increase in this study with a lowering, but not significantly so, in the 
proportion of primary follicles suggesting that, the primary follicle loss was too small to 
be statistically significantly (Yang and Fortune 2006). The proportion of secondary 
follicles was significantly higher in all cultured tissue compared to freshly fixed tissue, 
and, significantly higher in the presence of testosterone alone compared to any of the 
other treatment groups suggesting that the presence of rhAct A and/or rFSH ameliorates 
but does not completely override the ability of testosterone to promote growth to 
secondary stage. In this study there was no observed increase in the diameters of oocytes 
in quiescent or primary follicles, irrespective of treatment, compared to the corresponding 
diameters in freshly fixed tissue in contrast to previous studies where small but 
significant oocyte diameter increases were observed (Fortune et at. 1998, Wandji ci al. 
1996), however these studies were conducted over longer in vitro periods. In secondary 
follicles, oocyte diameters were significantly lower in the presence of testosterone 
compared to freshly fixed tissue an effect which corresponds to the loss of oocyte 
morphology in these follicles. Interestingly, although not able to negate the negative 
effect in primary follicles, in the presence of rhAct A, oocytes morphology improved 
significantly in secondary oocytes. In this study deteriorating oocyte health was 
associated with a loss of contact between the oocyte and its surrounding somatic cells, 
apparent from the primary stage onwards, therefore it is suggested that whilst testosterone 
promotes the development of follicles to the secondary stage this acceleration of growth 
is asynchronous resulting in poor germ and somatic cell contact ultimately decreasing 
oocyte morphological health. This observation is congruent with current thinking that the 
maintenance of oocyte and granulosa cell contact is essential to bi-directional 
communication of paracrine and endocrine of factors vital for normal follicle 
development (Albertini etal. 2001. Eppig 2001, Carabatsos et al. 2000. Carabatsos et al. 
1998) and that rhAct A is involved in the maintenance of this communication (Telfer et 
al. 2008). Androgen receptor localisation was performed on freshly fixed cortical tissue 
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with androgen receptor staining being confined to the ooplasm of quiescent (primordial 
and transitory) follicles whereas in primary and secondary follicles the androgen receptor 
was localised to the granulosa cells and the ooplasm. Previous studies have localised the 
androgen receptor in bovine granulosa cells from the primary stage onwards (Hampton et 
al. 2004) although Yang and Fortune (2006) found its presence in only 40% of follicles. 
In this study localisation was observed within the granulosa cells of primary and 
secondary follicles with the intensity of the staining increasing from the primary to the 
secondary stage, suggesting that the effect of testosterone in promoting primary to 
secondary growth may be, in part at least, mediated by an androgen receptor-dependent 
mechanism, although aromatisation in the presence of FSH and the possibility of 
testosterone binding to SI-IBGR 0 cannot be excluded. In summary, the experiments in 
this chapter demonstrated that testosterone promoted the development of follicles to the 
secondary stage of growth within cultured cortical strips however oocyte health was 
compromised, an effect ameloirated, in secondary follicles, by the presence of rhAct A. 
The presence of rhAct A also significantly improved the follicle growth, antral cavity 
formation and oocyte morphology of preantral follicles cultured individually in the 
presence of testosterone. Moreover these results suggest the culture of cortical strips in 
testosterone 10-7M  would not provide a population of follicles suitable for isolation and 




ISOLATION AND CULTURE OF BOVINE 
PREANTRAL FOLLICLES FROM CULTURED 
CORTICAL STRIPS 
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7.1. INTRODUCTION 
The progress of ART in domestic species has been limited due to the lack of availability 
of high quality oocytes. A possible source of oocytes for use in these technologies is the 
immature follicular pool. In previous chapters the ability of bovine oocytes to grow and 
maintain morphological health in vitro has been investigated in response to activin, FSI-I 
and testosterone using isolated preantral follicles, with activin and lower concentrations 
of FSH being associated with increased oocyte diameter, preservation of normal oocyte 
morphology and maintenance of oocyte and somatic cell communication. It has already 
been established that the mammalian follicle reserve comprises mainly of primordial 
follicles (Gosden and Telfer 1987) which also represent the population of follicles least 
affected by apoptotic sequelae (Telfer et al. 1998b, review Telfer 1998a) therefore 
primordial follicles are clearly candidates for in vitro growth and subsequent oocyte 
harvesting. Multi-step systems have been designed to support in vitro murine follicle 
development with the birth of pups from in vitro matured oocytes derived from murine 
cumulus-oocyte complexes (Eppig and Schroeder 1989), primordial follicles (Eppig and 
O'Brien 1996) and from cultured primary follicles (Spears et (if. 1994) however it has not 
been possible to date to repeat this success using incompetent oocytes from domestic 
species or humans which both undergo a protracted follicular developmental period in 
vivo. A major obstacle to progress in the development of long-term culture systems is 
oocyte degeneration associated with the disruption of the connections between the oocyte 
and its surrounding somatic cells, therefore a better understanding of these connections 
and the factors influencing their maintenance is essential to achieving oocyte competency 
in cultured follicles. 
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Previous studies have demonstrated that bovine and primate primordial follicles 
contained within cortical strips can be activated to grow in gonadotrophin-free media and 
can reach the secondary stage of development (Telfer et al. 2008, Yang and Fortune 
2007, Yang and Fortune 2006, Gigli et at. 2006, Wandji et at. 1997). As discussed earlier 
although follicle growth can be maintained within cortical strips for extended periods 
(Fabbri et at. 2007, Segino et at. 2005. Zhang et al. 2004, Louhio et at. 2000, Hovatta et 
at. 1 997) antral formation is inhibited therefore to allow further development it is 
necessary to dissect follicles out of the strips and continue culture individually (Telfer et 
al. 2008). In the following experiments a two-step culture system was designed to 
support activation of follicle growth within fragments of cortex followed by dissection 
and support of individual secondary follicles for a further period of development in an 
activin supplemented medium. Activin was added to the follicle culture media as 
previous studies indicate that activin is associated with preantral follicle and oocyte 
development and maintenance of oocyte-somatic cell connections (Telfer et at. 2008, 
Silva et at. 2006, Thomas et al. 2003a, Zhao et at. 2001, Liu et at. 1998, Hulshof et at. 
1997). 
A number of studies have used cultured strips of ovarian cortical tissue to investigate the 
ability of growth factors and hormones to affect initiation of primordial follicle growth in 
rodents and large mammals. Although testosterone (Yang and Fortune 2006), VEOF 
(Yang and Fortune 2007), FCS 
 
(Gig et al. 2006), FSH (Wright et al. 1999), LIF 
(Nilsson et al. 2002), KL (Kezele and Skinner 2003, Parrott and Skinner 1999), BMP-4 
(Nilsson and Skinner 2003), bFGF (Nilsson et al. 2001) and KGF (Kezele etal. 2005) are 
all associated with early follicle growth within cultured cortical strips, it is not clear 
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whether follicles activated to grow within cultured cortical strips can be isolated and 
undergo further growth and development as individually cultured follicles. The aims of 
this chapter were I) to determine whether bovine follicles grown from the 
primordial/primary stage in vitro could be isolated and cultured individually and 2) to 
evaluate the effect of rhAct A on development of this isolated follicle population. 
- =-_=--= 
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7.2. MATERIALS AND METHODS 
7.2.1. Culture of Fragments of Ovarian Cortex 
Cortical pieces were removed from selected bovine ovaries. Fragments of cortex were 
formed by trimming off excess stroma and damaged tissue from the cortical pieces and 
removing any areas containing follicles with a mean diameter of > 40im. Cortical 
fragments were cultured individually in basic culture medium (control) for 6 days as 
described in Chapter 2, section 2.2.2. 1. After 6 days the cortical fragments were 
transferred to dissecting medium, preantral follicles were dissected out and cultured 
individually in the presence or absence of activin for a further 6 days, both procedures 
being detailed previously in Chapter 2, sections 2.1.3 and 2.2.2.2. 3 replicate cultures 
were set up, a total of 134 cortical fragments between 0.5mm 2 - I mm2 in size were 
cultured from which 47 secondary follicles were dissected. 10 of these follicles were 
fixed immediately (0 Hrs) and the remaining 37 were randomly assigned to treatment 
groups. 
7.2.2. Treatments 
7.2.2.1. Treatment with rhAct A 
Preantral follicles (diameter 99 - 148tm) were cultured in the presence (n = 19) or 
absence of rhAct A (n = 18). 
7.2.3. Measurement of Oestradiol by Enzyme Immunoassay 
Concentrations of oestradiol in reserved culture media from experiment 7.2.2.1 were 
determined against pre-measured standard dilutions using Estradiol ELISA enzyme 
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immunoassay (DRG Instruments, GmbH, Germany). Media removed from follicles 
cultured in the presence (n = 5) and absence (n = 5) of activin on days 9 and 12 of the 
culture period was diluted with freshly prepared culture medium (I inlO), placed in 
microtiter wells coated with polyclonal (rabbit) antibody raised against the oestradiol 
antigenic site, mixed with oestradiol -horseradish peroxidase conjugate and incubated for 
120 minutes. After incubation the unbound conjugate was washed off and a substrate 
solution of tetramethylbenzidine was added to allow development of colour. After 15 
minutes the reaction was stopped using dilute sulphuric acid, the wells washed and the 
absorbance of each well at 450 ±10 urn measured using a mici -otiter plate reader. The 
absorbencies were converted to oestradiol concentrations using Sigma Plot Version 9, 
with 4 parametric logistic function (Systat Software Inc) and oestradiol sensitivity 
25pglml. 
7.2.4. Statistical Analyses 
Distribution of data for parametric analysis was checked using GraphPad Software Instat 
Guide to choosing and interpreting statistical tests version 3.05. 1998, GraphPad 
Software Inc., San Diego, California, USA. Inter and intra - treatment differences were 
compared by measuring mean follicle diameters, mean oocyte diameters and oestradiol 
production on every third day of individual follicle culture using Minitabl4 Statistical 
Software Students t-test: unpaired. The proportions of antral cavity formation and oocyte 
morphological health were assessed using Minitab14 Statistical Software Contingency 
Tables: Chi Square Test. 
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7.3. RESULTS 
7.3.1. Experimental Outline 
12 day, two-step culture system established. 1 step: fragments of bovine ovarian cortex 
cultured in basic culture medium for 6 days. 2 nd step: secondary follicles dissected from 
cortical fragments and cultured individually with or without lOOng/mI rhAct A for a 
further 6 days. In vitro follicle diameters measured on days 6, 9 and 12. Follicles 
processed for histological analysis of antral cavity formation, oocyte size and 
morphological status on Day 12; no follicles removed for analysis prior to Day 12 of the 
culture period. Steroidogenic capacity of growing follicles assessed by enzymatic 
immunoassay of spent media reserved on Day 9 and Day 12. 
7.3.2. Follicle Growth and Differentiation 
7.3.2.1. Effect of rhAct A on the growth offollicles isolated from cultured cortical 
fragments 
Bovine cortical fragments were cultured in control medium for 6 days, thereafter 
secondary follicles (mean diameter 116 ± 2.771Jm) were dissected from the fragments 
(Figure 7.1 a) and cultured individually for a further 6 days in either control medium (n = 
18) or medium supplemented with lOOngIml rhAct A (n = 19). Significant follicle growth 
occurred in the both groups over time. Follicles treated with lOOng/mi rhAct A were 
significantly larger compared to control follicles (p < 0.01) from Day 9 of the culture 
period onwards (Figure 7.1 b). 
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Figure 7.1-a. Bovine preantral follicles dissected from cultured cortical fragments. 
Secondary follicles were dissected out from fragments of bovine cortex following 6 days 
in vitro and cultured individually for a further 6 days. 
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Figure 7.11b. Effect of rhAct A on the growth of follicles isolated from cultured 
ovarian cortical fragments. Bovine preantral follicles isolated from cultured fragments 
of ovarian cortex and grown in either control medium (black) or media supplemented 
with lOOng/mi rhAct A (red). Values are mean follicle diameters ±SEM. (a), (b). (c) and 
(d) denote significant differences between treatments at Day 9 and Day 12. Significant 
growth occurred in both groups over time (p< 0.05). Significant growth occurred in 
follicles cultured in lOOng/mI rhAct A on Day 9 (p<  0.01) and Day 12 (p< 0.01) 
compared to control. 
7.3.2.2. Effect of rhAct A on Antral Cavity Formation in Follicles Isolated from 
Cultured Cortical Fragments 
Antral follicles were distinguished from non-antral follicles by histological analysis 
(Figure 7.1c). An antral follicle was identified by the presence of a fluid filled cavity 
within the basal lamina dividing the surrounding granulosa cells into the mural granulosa 
adjacent to the basal lamina and the cumulus close to the oocyte. Antral formation is 
expressed as a proportion of the total number of follicles per treatment group. A 
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Figure 7.1c. Antral and non-antral cultured bovine follicles. 
(I) Formation of an antral cavity in a bovine follicle cultured for a total of 12 days in 
vitro, 6 days within a cortical fragment and a further 6 days as an individually isolated 
follicle in the presence of lOOng/mi rhAct A. (ii) Non-antral bovine follicle cultured 
under identical conditions for the same length of time. 
Figure 7.1d. Antral cavity formation in bovine follicles cultured for a total of 12 
days. 
Antral cavity formation is expressed as a proportion of the total number of follicles per 
treatment group. (*) denotes a significant difference between treatment groups. A 
significantly larger proportion of follicles formed antra when cultured in lOOng/mI rhAct 
A (p <0.05) (red) compared to follicles cultured in control medium (black). 
significantly higher proportion of antra was observed in follicles cultured in lOOng/ml 
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7.3.3. Oocyte Growth and Morphological Health 
7.3.3.1. Effect of rhAct A on the growth and health of oocytes in follicles isolated from 
cultured cortical fragments 
Follicles cultured within cortical fragments for 6 days were isolated and cultured for a 
further 6 days in the presence (n = 19) or absence (n = 18) of bOng/mI rhAct A. The 
mean diameter of oocytes cultured in the presence of lOOng/ini rhAct A was significantly 
greater compared to the mean diameter of oocytes cultured in control medium and the 
mean diameter of oocytes of follicles cultured in cortical fragments for 6 days only (n = 
10) (Figure 7.2a). Oocyte health was assessed by determining the general morphology of 
the oocyte as described in Chapter 2 section 2.3.3.2. On completion of the culture period, 
the morphological health of oocytes in follicles cultured in control medium was 
significantly lower compared to oocytes in follicles cultured in lOOng/mI rhAct A 
(p<0.05) and those isolated from cultured fragments of cortex after 6 days of culture 
(p<0.05) (Figure 7.2b). 
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Figure 7.2a. Effect of rhAct A on the growth of oocytes in follicles isolated from 
cortical fragments. 
Growth of oocytes cultured in control medium (black) and oocytes cultured in medium 
supplemented with bOng/mi rhAct A (red) compared to the growth of oocytes of 
follicles cultured in cortical fragments for 6 days only (Fragment Cultured Only) (hatch). 
Values are mean oocyte diameters ± SEM. (*) denotes a significant difference between 
treatment groups. Significant oocyte growth occurred in oocytes cultured in the presence 
of I OOng/ml rhAct A compared to those cultured in control medium (p  <0.01) and those 
cultured in ovarian cortical fragments for 6 days only (p <0.01). 
Figure 7.2b. Effect of rhAct A on the morphological health of oocytes in follicles 
isolated from cortical fragments. 
Morphological health of oocytes cultured in control medium (black) and oocytes cultured 
medium supplemented with lOOng/ml rhAct A (red) compared to the oocytes of follicles 
cultured cortical fragments for 6 days only (Fragment Cultured Only) (hatched). Values 
are healthy oocytes as expressed as proportion of the total number of oocytes analysed 
per treatment group. (*) denotes a significant difference between treatment groups. A 
significantly higher proportion of healthy oocytes was observed in follicles cultured in 
lOOng/mI rhAct A (p<0.05) and cultured fragments (p<0.0 1) compared to those oocytes 
cultured in control medium. 
Fig 7.2a 	Oocyte Growth of In Vitro Activated Isolated 







 Cua 10 
0 
Fragment Cultured 	Control 	 Activin 
Only 
Treatment Group 
Fig 7.2b 	Oocyte Health of In Vitro Activated Isolated 
Bovine Follicles: Control versus Activin 
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7.3.4. Oestradiol Secretion 
7.3.4.!. Effect of rhAct A on oestradiol secretion in follicles isolated from cultured 
cortical fragments 
Media from growing follicles cultured individually in control medium (Day 9, n = 5; Day 
12, n = 5) and lOOng/ml rhAct A supplemented medium (Day 9, n = 5; Day 12, n = 5) 
was analysed for oestradiol content by irnmuno-enzyme assay. Significant oestradiol 
secretion was observed in follicles cultured in lOOng/ml rhAct A supplemented medium 
(p < 0.01) compared to follicles cultured in control medium by Day 9 of the culture 
period, however this effect was not sustained to Day 12 (Figure 7.3). 
Oestradiol Secretion of in vitro Activated Isolated 
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Figure 7.3. Effect of rhAct A on oestradiol secretion in cultured bovine follicles 
isolated from cortical fragments. Values are mean oestradiol secretion ± SEM. (*) 
denotes a significant difference between treatments at Day 9. Oestradiol secretion was 
significantly higher in follicles cultured in bOng/mi rhAct A (red) on Day 9 compared to 
follicles cultured in control medium (black) on Day 9 (p < 0.001). No significant 
difference in oestradiol secretion between treatment groups on Day 12. 
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7.4. DISCUSSION 
If the potential of immature follicles from non- rodent mammals as a source of fertilisable 
oocytes is to be achieved, systems supporting the growth of large mammalian follicles 
from the earliest stages are necessary. Although various milestones in bovine follicle 
growth have been realised in vitro i.e. primordial follicle activation (Gigli et al. 2006, 
Fortune et al. 1998, Wandji et al. 1996b), preantral follicle growth (Thomas et al. 2007, 
Thomas et al. 2001, Gutierrez et al. 2000, Saha et al. 2000, Katska and Ryñska 1998, 
Hulshof et al. 1997, Wandji et al. 1996b, review Telfer et al. 1999), oocyte-cumulus cell 
complex culture (Hirao et al. 2004. Ralph et al. 1995), oocyte maturation (Hirao et al. 
2004; review Sirard and Coenen 2006) and fertilisation with resulting live offspring 
(Hirao et al. 2004), gaps still exist and a complete system capable of supporting 
primordial follicles through to fertilised oocytes has yet to be defined for domestic 
species and humans. An important step in accomplishing this is the support of large 
animal primordial/primary follicles in vitro through to the antral stage of development. 
The experiments described in this chapter demonstrate that secondary follicles grown 
from the primordial/primary stage within cultured bovine ovarian cortical fragments can 
be isolated and continue to grow in individual culture forming antral cavities and undergo 
significant steroidogenesis in the presence of activin. 
Prior to culture the dissected fragments were examined microscopically and any pieces 
containing follicles with a mean diameter of greater than 4011m were excluded from the 
experiment to ensure that the presumptive population of follicles contained within the 
follicles strips were either primordial or primary. This parameter was chosen as previous 
studies observed that in vivo the diameter of bovine primordial to primary follicles is 
between 40-100tm (Telfer etal. 1999, Webb et al. 1999). It is not known exactly how 
long it takes from the point of activation for bovine follicles to reach the secondary stage 
in viva however previous studies have observed a significant reduction in the primordial 
follicle population with a concomitant increase in the later stages of development in 
bovine cortical strips grown over 7 (Gigli etal. 2006, Wandji etal. 1996), 10 (Yang and 
Fortune 2007, Yang and Fortune 2006) and 20-day (Fortune et al. 1998) in vitro periods 
with primordial activation being observed as early as the second day of culture (Fortune 
ci' al. 1998). Activation of bovine primordial growth occurs spontaneously in vitro in 
gonadotrophin and serum-free media (Yang and Fortune 2007, Yang and Fortune 2006, 
Gigli et al. 2006, Braw-Tal and Yossefi 1997). In this study, follicles of mean diameter 
115 ± 2.77lJn1 were isolated from ovarian cortical fragments, cultured for 6 days in a 
supplemented medium and inspected for the presence of an antral cavity under light 
microscopy, where all were noted to be preantral. Moreover isolated follicles were 
considerably smaller than the minimum diameter associated with antral cavity formation 
in cattle and larger than 401im, the diameter which would have excluded follicles from 
the experiment had they been present in the cortical fragments prior to culture. This 
indicates that these follicles were from the primordial/primary population therefore 
follicle activation and/or primary follicle growth had occurred over the initial 6-day 
culture period. 
Systems supporting in vitro development of small bovine preantral follicles have led to a 
number of factors being associated with follicle and oocyte health and development. 
Wandji and colleagues (1996b) demonstrated granulosa cell proliferation can be 
stimulated in isolated follicles (60-179tm) cultured for 6 days in the presence of bFGF, 
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FSH and EGF, whilst Saha et al. (2000) observed similar results in slightly smaller 
follicles (40 - 100tm) over a 10-day in culture period. Granulosa cell proliferation was 
also seen in bovine preantral follicles (30-70p.m diameter) cultured for 5 days in a serum-
free medium in the presence of activin (Hulshof et al. 1997), indeed activin is also 
associated with in-vitro preantral human (Telfer et al. 2008), ovine (Thomas et al. 
2003a). caprine (Silva et cii. 2006) and immature rodent (Yokata et al. 1997, Zhao et al. 
2001) follicle growth, as well as antral formation in cultured rodent cumulus oocyte 
complexes (Li et al. 1995) and steroidogenesis in cultured human (Telfer ci' al. 2008) and 
ovine follicles (Thomas et cii. 2003). 
Follicle growth was promoted by the presence of rhAct A in this study however the rate 
of growth was not uniform throughout the in vitro period. The rate of follicle growth in 
vitro was estimated by calculating the gradient of the growth (in = AY/ AX) as graphed in 
Figure 7.1b. It is estimated that rhAct A supplemented follicles grew almost 4 times as 
quickly (in = 18,7) compared to follicles cultured in control medium (in = 4.9) between 
Day 6 and Day 9. Between Day 9 and Day 12 the estimated rate of growth more than 
doubled in the control follicle group (in = 10.2) whereas in rhAct A supplemented 
follicles the rate was decreased (in = 13.8). Although rhAct A promoted significant 
follicle growth the initial rate of growth was not maintained suggesting that further 
supplementation of the culture medium should be considered from Day 9 onwards. The 
mean follicle diameter reached by rhAct A supplemented follicles by Day 9 of the culture 
period was in excess of I 50,tm which is beyond the expected diameter for antral cavity 
formation to occur in viva therefore FSH would be an appropriate addition to the culture 
medium at this stage. In addition to follicle growth this study demonstrated significant 
owes 
oocyte growth and significant antral cavity formation in the presence of activin 
suggesting its importance in the promotion bovine follicle differentiation in vitro. These 
results demonstrate a markedly accelerated rate of development compared to in vivo 
growth as it is estimated that in the bovine ovary primordial follicles take several months 
to reach the antral stage (Gosden etal. 1994a, Lussier ci al. 1987). Previous studies have 
achieved antral cavity formation in isolated cultured larger diameter preantral follicles 
(166 ± 2.15jim) as early as Day 10 of a 28-day culture period (Gutierrez etal. 2000) and 
by Day 7 of a 13-day culture period when similar sized bovine follicles were cultured in 
collagen gels (Itoh ci al. 2002) however these studies did not evaluate the health of the 
oocytes on completion of these culture periods. In this study follicle diameters increased 
from I 15tm to 215Lm when cultured in activin an increase which was reflected in oocyte 
diameters which grew in the presence of activin from 34psn to 55gm diameter. Moreover 
activin supplemented follicles secreted significant oestradiol which, taken together with 
significant antral formation is indicative of the beginning of follicle differentiation. 
Significant oestradiol secretion was not maintained throughout the culture period, 
peaking on Day 9, suggesting that although the addition of activin appears to support 
initial growth and development further supplementation of the medium would be required 
to ensure continued development beyond the small antral stage. Although significant 
steroidogenesis was not maintained these results are encouraging as antral formation with 
concurrent follicle and oocyte growth demonstrate co-ordinated somatic and germ cell 
development in vitro at least for the early part of the culture period using this system. In 
this study oocyte health was evaluated by histological examination of oocyte morphology 
on completion of the culture period. Oocyte morphology was maintained in the presence 
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of activin and significantly reduced in follicles cultured in control medium, this again is 
an encouraging observation suggesting that activin not only enhances oocyte growth but 
in doing so does not cause perturbation of the morphological norms. The developmental 
competence of these oocytes however is unknown as on completion of the culture period 
the mean diameter was 55p.m; just over half of the size of bovine oocytes successfully 
cultured, matured and fertilised in vitro (Hirao et al. 2004) therefore in order to achieve 
larger oocyte diameters a further in vitro growth period is indicated. Further optimising of 
the current system will be required to determine whether oocyte diameters conducive to 
in vitro maturation can be achieved by a prolonged period of intact follicle culture or 
whether this should be an modified to include culture of oocyte-cumulus complexes. In 
summary this study demonstrates the development of primordial/primary bovine follicles 
within cultured cortical strips and follicle and oocyte growth, steroidogenesis and 
maintenance of oocyte morphological health in cultured secondary bovine follicles 
dissected from cultured cortical strips in the of presence activin. 
CHAPTER EIGHT 
ISOLATION AND CULTURE OF HUMAN 




The availability of mature fertilisable oocytes remains the primary restricting factor 
limiting the rate of success of ART in humans. It is widely accepted that the human 
oocyte population is not replenished during adult life (Zuckerman 1951) and that growth 
and atresia over time results in the loss of all but a few hundred of the million strong 
oocyte pool present in the neonatal ovary (Hardy et al. 2000). Primordial and preantral 
follicle pools represent the least apoptotic follicles within the ovarian cortex (Telfer et al. 
1998a, Telfer et at. 1998b) moreover it has been demonstrated that the human ovary 
contains predominantly primordial and primary follicles (Lass et al. 1997, Hovatta et al. 
1997). Techniques to development these follicles in vitro have been examined with 
various approaches taken including the culture of follicles within cortical tissue slices 
(Otala et al. 2004, Wright et al. 1999, Hovatta et al. 1997) and the culture of immature 
follicles isolated mechanically (Abir et al. 1997) and enzymatically (Abir et at. 2001. 
1-lovatta et al. 1999, Oktay et al. 1997a. Roy and Treacy 1993) with primordial follicle 
activation (Abir et at. 2001, Hovatta et al. 1999), primary to secondary transition 
(Hovatta et at. 1999) and secondary follicle growth achieved (Hovatta et al. 1999, Abir et 
al. 1997, Roy and Treacy 1993). Mechanically isolated preantral and early antral human 
follicles (> 120.tm diameter) cultured in the presence of serum and gonadotrophins have 
been maintained in vitro for 4 weeks however, although the presence of gonadotrophins 
enhanced follicle survival, a high rate of atresia was observed particularly between the 
preantral and early antral stages with up to 80% of the early antral follicles cultured 
having no oocyte, despite maintaining steroidogenesis (Abir et al. 1997). Hovatta and 
colleagues (1999) demonstrated the presence of healthy secondary follicles in cultured 
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human strips cultured for up to 21 days, however around 14 days in culture, oocytes 
began to be extruded from follicles moreover when collagenase was applied to the 
cortical strips and the resulting tissue fragments cultured they were found to contain a 
significantly greater proportion of atretic follicles than cultured cortical strips or follicles 
mechanically isolated from cortical strips. Interestingly in the same study, when the rate 
of follicle activation was analysed it was observed that the majority of primordial follicle 
activation occurred during days 7-9 of the culture period (Hovatta et al. 1999) an 
observation congruent with Wright et al. (1999) who demonstrated significant primordial 
activation in the first 10 days of a 15 day culture of human cortical pieces. Taken together 
these results suggest that while cortical strip culture supports human follicle activation 
and growth to the secondary stage, these growing follicles and the oocytes therein remain 
healthy for a relative short period of time only and prolonging the culture period within 
cortical strips can result in oocyte extrusion, moreover in human cortical tissue 
mechanically isolated follicles are less likely to develop atresia than enzymatically 
isolated follicles in culture. It seems appropriate therefore to apply the two-step system 
designed in Chapter 7 for the culture of bovine cortical strips to human cortical tissue. In 
this chapter preliminary experiments were conducted using ovarian cortical biopsies to 
determine whether secondary follicles grown within cultured human ovarian cortical 
strips could be isolated and undergo further development during a 4-day in vitro period in 
the presence of I) activin and 2) activin with FSH. The parameters used to determine 
follicle development were follicle diameter, dynamics of follicle growth, morphological 
follicle health, antral cavity formation and oestradiol secretion during the 4-day 
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individual follicle culture period. Approval of this study was granted by the local ethical 
committee of the New Royal Infirmary Edinburgh. 
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8.2. MATERIALS AND METHODS 
8.2.1. Cortical Fragment and Individual Follicle Culture 
Human cortical tissue was removed by biopsy from consenting patients undergoing 
elective caesarean section (n = 10). On collection biopsied tissue pieces were held in 
lOmi of pre-warmed Leibovitz dissecting medium with supplements, as described in 
Chapter 2, until arrival in the laboratory where the holding medium was replaced with the 
same. The ovarian biopsies were examined under the light microscope to distinguish 
between stromal tissue and cortex, with excess underlying stroma and torn, damaged or 
haemorrhaged tissue being removed. Thereafter biopsies were cut into small fragments 
approximately 0.5mm 3 and re-examined to ensure underlying stroma was released or 
removed allowing the fragments of cortex to flatten. At this point any tissue slices 
containing visible follicles with a mean diameter of greater than 40tni were excluded 
from the experiment to ensure that the presumptive population of follicles contained 
within the cortical fragments were either primordial or primary. The cortical fragments 
were cultured individually in basic culture medium (control) for 6 days as described in 
chapter 2 section 2.2.2. I. At the end of the 6 day culture period the cortical fragments 
were transferred to dissecting medium and preantral follicles were dissected and cultured 
individually for a further 4 days, both procedures being detailed previously in chapter 2 
sections 2.1.3 and 2.2.2.2. Experiments were divided into 2 sets with a total of 10 cultures 
established. For the first set of experiments biopsies (n = 6) were obtained and dissected 
as described from women undergoing elective caesarean mean age 36.4 ± 5.3 years; 
range 26 - 40 years; 96 cortical pieces were cultured in total; 74 follicles were dissected 
out from the cortical strips and randomly assigned to culture in the presence or absence of 
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rhAct A. For the second set of experiments biopsies (n = 4) were obtained and dissected 
as described from women undergoing elective caesarean (n 3) or bilateral 
oophorectomy (n = 1) mean age 36.25 ± 4.1 years; range 24 - 41 years; 230 cortical 
pieces were cultured in total; 41 follicles were dissected out from the cortical strips and 
randomly assigned to culture in the presence of rhAct A with and without FSH. 
8.2.2. Treatments 
8.2.2.1. Treatment with rhAct A and rFSH 
Basic culture medium was prepared as described in 2.2.1. Basic culture medium was 
supplemented with rhAct A or rhAct A and rFSH. The specific treatment groups were as 
shown in table 8.1. 
Table 8.1 Treatment groups and number of follicles in each group per experiment 
8.2.3. Measurement of Oestradiol by Enzyme Immunoassay 
Concentrations of oestradiol in reserved culture media from the first experiment (control 
versus rhAct A) were determined against pre-measured standard dilutions using Est radio! 
ELISA enzyme immunoassay (DRG Instruments, GmbH, Germany). Media removed 
from follicles cultured in the presence (n = 6) and absence (n = 6) rhAct A on days 8 and 
10 of the culture period was diluted with freshly prepared culture medium (1 in 10), 
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placed in microtiter wells coated with polyclonal (rabbit) antibody raised against the 
oestracliol antigenic site, mixed with oestradi ol -horseradish peroxidase conjugate and 
incubated for 120 minutes. After incubation the unbound conjugate was washed off and a 
substrate solution of tetramethylbenzidine was added to allow development of colour. 
After 15 minutes the reaction was stopped using dilute sulphuric acid, the wells washed 
and the absorbance of each well at 450 ±10 nm measured using a microtiter plate reader. 
The absorbencies were converted to oestradiol concentrations using Sigma Plot Version 
9, with 4 parametric logistic function (Systat Software Inc) and oestradiol sensitivity 
25pg/ml. 
8.2.4. Statistical Analyses 
Mean values of growth measurements were compared using a Mann-Whitney U test, a 
non-parametric comparison of means (Sokal and Rohlf 1994). Distribution of data for 
parametric analysis was checked using GraphPad Software Instat Guide to choosing and 
interpreting statistical tests version 3.05, 1998, GraphPad Software Inc., San Diego, 
California, USA. Inter and intra-treatment oestradiol production on Day 8 and Day 10 of 
culture period were compared using Minitabl4 Statistical Software Students 1-test: 
unpaired. The proportions of antral cavity formation and oocyte health were assessed 
using Minitabl4 Statistical Software Contingency Tables: Chi Square Test. 
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8.3. RESULTS 
8.3.1. Experimental Outline 
10 day, two-step culture system. l step: fragments of human ovarian cortex cultured in 
basic culture medium for 6 days. 2 nd  step: secondary follicles dissected from cortical 
fragments and cultured individually in lOOng/mi rhAct A in the presence (Experiment 2) 
or absence (Experiment 1) of 50ng/mI rFSH for a further 6 days. In vitro follicle 
diameters measured on days 6, 8 and 10 in both experiments. Follicles processed for 
histological analysis of follicle morphological status on Day 10 (Experiment I); no 
follicles removed for analysis prior to Day 10 of the culture period. Steroidogenic 
capacity of growing follicles assessed by enzymatic immunoassay of spent media 
reserved on Day 8 and Day 10 (Experiment 1). 
8.3.2. Cultured Cortical Fragments 
In both experiments, after 6 days in culture, the appearance of growing follicles could be 
observed microscopically in the tissue fragments (Fig. 8.la) although follicle density 
varied greatly between tissue pieces taken from the same biopsy, between biopsies in the 
same experiment and between experiments; no antral follicles were observed in the 
cultured strips. 
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Figure 8.1a. Human follicles growing within cultured cortical fragments and 
dissected follicle. Secondary follicles (a) were observed in human cortical fragments 
after 6 days in vitro as indicated by arrows (). Follicles were dissected out from 
fragments of human cortex (b) and cultured individually for a further 4 days. Secondary 
follicle fixed on dissection after 6 days in vitro within cortical slice (c). 
8.3.3. Follicle Growth and Differentiation 
8.3.3.1. Effect of rhAct A and rFSH on the growth of human follicles isolated from 
cortical strips 
In the first experiment secondary follicles were dissected from cortical fragments 
cultured for 6 days in control medium. Follicles (mean diameter 100 ± 3.4p.m) were 
randomly assigned to treatment groups and individually cultured in control medium (n = 
36) or in medium containing bOng/mi rhAct A (n = 38) for a further 4 days. Significant 
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follicle growth occurred in the lOOng/mi rhAct A treated group (p <0.005) compared to 
control from Day 8 onwards. 
In the second experiment follicles were dissected as described above (mean diameter 72 
± 4.4tni) and cultured in lOOng/mi rhAct A (n = 41) for 2 days. Follicles were then 
randomly assigned to treatment groups and cultured in lOOng/mi rhAct A (n = 19) or 
lOOng/mi rhAct A and 50ng/ml rFSH (n = 22) for a further 2 days. Significant growth 
occurred in both groups over time (p < 0.01). On completion of the culture period, the 
mean diameter of follicles cultured in the presence rFSH was greater than the mean 
diameter of those cultured in rhAct A alone however this difference was not significant. 
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Figure 8.1b. Effect of rhAct A on the growth of follicles isolated from cultured 
human ovarian cortical fragments. 
Growth of isolated human preantral follicles in control media (black) and media 
supplemented with lOOng/mi rhAct A (red). Values are mean follicle diameters ±SEM. 
(*) denotes a significant difference between treatments. Significant growth occurred in 
follicles cultured in bOng/mi rhAct A compared to control at Day 8 (p  <0.01) and Day 
10 (p  <0.01) of the culture period. 
Figure 8.1c. Effect of rhAct A in the presence and absence of rFSH on the growth of 
follicles isolated from cultured human ovarian cortical fragments. 
Growth of isolated human preantral follicles in bOng/mI rhAct A (red) and media 
supplemented with lOOng/mi rhAct A and 50ng/ml rFSH (blue). Values are mean follicle 
diameters ±SEM. Significant follicle growth occurred in both groups over time (p< 0.01). 
No significant difference was observed in mean follicle diameter between treatment 
groups during the culture period. 
Fig 8.lb 
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8.3.3.2. Effect of rhAct A and rFSH on follicle growth dynamics in human follicles 
isolated from corticaifragments 
Isolated follicle growth did not occur uniformly in culture. The proportion of follicles 
whose diameter increased, remained static or decreased during the 4-day individual 
culture period was calculated and expressed as a proportion of the total number of 
follicles per treatment group (Figure 8.2). In Experiment I growth occurred mainly 
within the initial 2 days of individual culture in follicles supplemented with rhAct A with 
over 80% of these follicles increasing in diameter compared to 36% of the follicles 
exposed to control medium (Figure 8.2a). Over the following 2 days the percentage of 
rhAct A supplemented follicles growing decreased to 58% whilst the control cultured 
follicles showed no significant difference (Figure 8.2b). 
In Experiment 2 all isolated follicles were exposed to rhAct A for the first 2 days of 
individual culture and whilst no follicles decreased in diameter, no significant difference 
was observed between the proportion of growing and static follicles (Figure 8.2c). Over 
the following 2 days no significant difference was observed between the treatment groups 
in decreasing, static or increasing follicle diameters with the percentages of growing 
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(c) Dynamics of Follicle Growth Activity in 
Strip Activated Isolated Human Follicles 
cultured in Activin: Day 0- Day 2 
(d) 	Dynamics of Follicle Growth Activity in Strip Activated 
Isolated Human Follicles: Aclivin versus FSH 
Day 2 - Day 4 
Figure 8.2. Comparison of the proportion of growing follicles during the 4 days of 
individual follicle culture in the presence and absence of rhAct A and rhAct with 
rFSH. Histogram shows a decrease (black bar), stasis (white bar) or an increase (red bar) 
in follicle diameter during culture on days 0-2 (a,c) and days 2-4 (b,d). Between days 0 
and 2 a significantly higher proportion of follicles increased in size in the presence of 
rhAct A (p  <0.01) compared to follicles cultured in control medium (a). No significant 
difference observed between the proportions of follicles growing in rhAct A compared to 
control on days 2 — 4 (b). No significant difference observed between the proportions of 
rhAct A exposed growing and static follicles on day 0 — 2 (c). No significant difference 
observed between the proportions of follicles growing in rhAct A compared to rhAct A 
and rFSE-1 on days 2 — 4 (d). 
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8.3.3.3. Effect of rhAct A and rFSH on Morphology of Human Follicles isolated from 
Cultured Ovarian Cortical Fragments 
During the course of the in vitro period some follicles became fragile and appeared to 
fragment therefore these follicles were excluded from analysis as the culture period 
progressed; the presence of rhAct A did not significantly affect the likelihood of follicles 
becoming non-viable in culture. Based on the morphology of follicles observed on 
completion of the 10 day culture period (6 days in cortical slices. 4 days in individual 
culture) follicles from Experiment 1 were classified as follows: type I - healthy; intact 
oocyte with regular shape and even cytoplasm, a complete layer of granulosa cells and 
less than 10% pyknotic granulosa cells; type 2 - misshapen oocyte, some Surrounding 
granulosa and greater than 10% pyknotic granulosa cells; type 3 - oocyte granulosa cell 
dissociation with greater than 10% pyknotic granulosa cells and type 4 - fragmented 
oocyte with greater than 10% granulosa cell pyknosis (Fig. 8.3). On completion of the 
culture period, follicles grown in control medium were smaller than rhAct A 
supplemented follicles, had more granulosa cell pyknosis and oocyte degeneration; 
consequently 80% of these follicles were classified as type 3 or type 4. Conversely a 
significant number of follicles cultured in the presence of rhAct A were classified as 
healthy moreover some of these follicles formed antral cavities and appeared to have 
undergone oocyte growth (Figure. 8.4a) with granulosa cell division observed in the 
presence of rFSH (Figure 8.4b). In Experiment 2 no significant difference was observed 
between the morphology of rhAct A culwred follicles and those cultured in rhAct A and 
50ngIml rFSH. 
Morphological Health of In Vitro Activated Isolated 
Human Follicles: Control versus Activin 
• Control 
• Activin 
Type 1 	Type 2 	 Type 3 	Type 4 
Morphological Category 
Figure 8.3. Effect of activin on the morphological health of in vitro activated isolated 
human follicles. Comparison of the health status of strip activated isolated cultured 
human follicles in the presence (red) or absence (black) of activin. (*) and (**) denote a 
significant difference between treatments within a specific morphological category. Of 
the healthy follicles observed on completion of the culture period (type I), a significantly 
greater proportion were cultured in activin supplemented medium (p< 0.005) compared to 
control medium. Type 2, 3 and 4 represent increasingly degenerate oocytes with type 4 
denoting complete degeneration. A significantly greater number of follicles cultured in 
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Figure 8.4a. Histological sections of isolated human follicles activated within 
fragments of cultured ovarian cortex. Fragments of human cortex were cultured for 6 
days in control media then follicles were dissected out and randomly assigned to either 
control or activin supplemented medium for a further 4 days. (I) Follicles cultured in 
control medium were significantly smaller than follicles grown in activin and showed 
signs of oocyte degeneration. (ii) Follicles grown in activin were observed to have a 
healthy morphology with an intact oocyte and surrounding granulosa cells. Incipient 
antral cavities can be seen in (ii). (iii) Activin supplemented follicle with an established 
antral cavity. 
EWE 
l ..- g— l•'p S /' 	 .4 










A— Uq ~ A&. 
Figure 8.4b. Histological section of an in vitro activated isolated human follicle 
cultured in rhAct A and rFSH. Granulosa cell division observed (circled in red) in 
human follicle cultured for a total of 10 days. 6 days within a fragment of cortex and 4 as 
an isolated follicle. During the last 2 days of isolated follicle culture, 50ng/ml rFSH was 
added to the rhAct A supplemented culture media. 
8.3.4. Oestradiol Secretion 
8.3.3.1. Effect of rhAct A on oestradjo/ secretion of in vitro activated isolated human 
follicles 
Media from follicles from the Experiment I noted to have increased in diameter and 
cultured individually in control medium (Day 8, n = 5; Day 10, n = 5) and lOOng/mI 
rhAct A supplemented medium (Day 8, n = 5; Day 10, n = 5) was analysed for oestradiol 
content by inlmuno-enzyme assay. Significant oestradiol secretion was observed in 
follicles cultured in IOOng/ml rhAct A supplemented medium compared to follicles 
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cultured in control medium on Day 8 (p  <0.01) and Day 10 (p  <0.01) of the 
culture period respectively; oestradiol secretion significantly decreased between Day 8 
and Day 10 in the rhAct A supplemented group (Figure 8.5). 
Oestradiol Secretion of In Vitro Activated Isolated 
Human Follicles: Control versus Activin 
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Figure. 8.5. Effect of rhAct A on oestradiol secretion in vitro activated isolated 
human follicles. Oestradiol secretion from growing follicles cultured within cortical 
fragments for 6 days then cultured individually in control medium (black) or in the 
presence of I OOng/rnl rhAct A (red) for a further 6 days. Values are mean oestradiol 
secretion ± SEM. (*) denotes a significant difference in oestradiol secretion between 
treatment groups. (a) and (b) denote a significant difference in oestradiol secretion over 
time within a specific treatment group. Significantly less oestradiol secretion occurred in 
follicles cultured in control on Day 8 (p < 0.01) and Day 10 (p  <0.01) of the culture 
period compared to follicles cultured in lOOng/mi rhAct A on corresponding days. Of the 
follicles cultured in rhAct A, significantly more oestradiol secretion occurred in follicles 
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8.4. DISCUSSION 
The results of these preliminary experiments demonstrate that the culture of human 
cortical strips can be utilised as a means of activating viable primordial and primary 
follicles capable of reaching the secondary stage of development and, when isolated and 
cultured individually in the presence of rhAct A, these follicles are capable of antral 
formation whilst maintaining morphological health. As discussed in Chapter 7, although 
multi-step systems have been designed to support in vitro murine follicle development 
with the birth of pups from in vitro matured oocytes derived from murine cumulus-oocyte 
complexes (Eppig and Schroeder 1989), primordial follicles (Eppig and O'Brien 1996) 
and from cultured primary follicles (Spears et al. 1994) applying these techiques to large 
mammals has proved problematic. Nevertheless much is now known about the activation 
of bovine primordial follicles (Yang and Fortune 2007, Gigli et al. 2006, Yang and 
Fortune 2006, Fortune et al. 1998, Wandji et al. 1996a), and preantral follicle and oocyte 
culture (Thomas es al. 2007, Walters et al. 2006, Thomas et al. 2001. Gutierrez et al. 
2000, Saha et al. 2000, Katska and Ryñska 1998, Hulshof et al. 1997, Wandji et al. 
1996b, 1-limo et (i!. 2004. Ralph es al. 1995, reviews Sirard and Coeiien 2006, Telfer et al. 
1999) and as demonstrated in Chapter 7, the culture of cortical fragment activated bovine 
primordial follicles to the antral stage of development is possible. In this experiment the 
cortical fragment culture medium was gonadotrophin and serum-free with no tissue 
support mechanism differing from previous studies utilising serum and FSH (Hovatta et 
al. 1999, Wright el al. 1999, Hovatta et al. 1997), moreover in this study the cortical 
tissue was examined carefully to distinguish between stromal and cortical areas both 
before dissection into fragments and afterwards to ensure that excess underlying stroma 
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and damaged tissue was removed prior to culture allowing the fragments to flatten out 
thereby maximising exposure of the cortical areas to the medium. It is suggested that the 
combination of these strategies promoted activation and growth allowing secondary 
follicles to be isolated after 6 days in vitro, indeed this relatively brief culture may 
prevent the degenerative processes seen arising as a result of a more prolonged in vitro 
period (Hovatta et al. 1999). In contrast to previous observations (Abir et al. 1997) the 
mechanically isolated follicles obtained did not show a high incidence of oocyte 
degeneration indeed during individual follicle culture significant oocyte growth occurred. 
It is hypothesised that exposure of the cortical slices to serum during culture may increase 
the likelihood of asynchronous growth in the resulting secondary follicles as 
demonstrated in isolated bovine preantral follicle culture in Chapter 3. In this experiment 
by omitting serum from the medium, the growing follicle population within the cortical 
slices appears to undergo coordinated acceleration of growth. 
A striking difference was observed in this study between the numbers of follicles isolated 
from cortical biopsies. In Experiment I a total of 6 biopsies were obtained and 96 
fragments of cortex cultured from which a total of 74 follicles were isolated; in 
Experiment 2, 41 follicles were isolated from 230 cultured cortical fragments obtained 
from 4 biopsies. As the source of the biopsies and mean age the donating women did not 
vary between the experiments it is suggested that the density of follicles within the biopsy 
pieces varied greatly indeed it has been observed that the distribution of follicles varied 
widely between and within cortical biopsy with site-dependent follicle distribution also 
reported (Poirot et cii. 2003, Schmidt et al. 2003, Kohl et al. 2000, Qu et al. 2000). On 
isolation the secondary follicles were cultured in the presence or absence of lOOng/mI 
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rhAct A or lOOng/mi rhAct A and 50ng/ml rFSH. In Experiment I significant follicle 
growth was observed in the rhAct A supplemented group with most growth occurring 
during the initial 2 days; whilst the mean diameter of follicles cultured in control medium 
was not significant over time. During the period from Day 8 to Day 10 both rhAct A 
supplemented and control follicles grew however the proportion of follicles growing in 
the presence of rhAct A had decreased from over 80% in the previous 2 days to 58% 
indicating that supplementation of the culture media with gonadotrophins and other 
growth stimulating factors may be required as the culture period is extended. In 
Experiment 2, all isolated follicles were cultured in the presence of rhAct A initially with 
half the follicles being supplemented with rFSH after two clays. Both rhAct A and rhAct 
A with FSH supplemented follicles grew significantly over time however no significant 
inter-treatment difference was observed. Interestingly the follicle population dissected for 
Experiment 2 were smaller compared to Experiment I with a mean diameter of 72pm 
compared 100im on isolation. In Experiment I the mean diameter of follicles cultured in 
rhAct A was 154m after two days, the point at which gonadotrophin supplementation 
was suggested, however in Experiment 2 the mean diameter of identically cultured 
follicles 88jim at this juncture. Although FSH did not appear to promote growth in these 
follicles, it had no deleterious effect and it is suggested that due to the much smaller size 
of the follicles and therefore less advanced stage of development a longer in vitro period 
is required to fully analysis the effect of FSH in this system. In contrast to a previous 
study (Abir et al. 1997) the secretion of oestradiol occurred from the second day of 
individual follicle culture onwards in both control and rhAct A treated groups in the 
absence of gonadotrophins, significantly so in the presence of rhAct A, reaching a 
maximum on Day 8 the same time point at which most follicle growth occurred. Abir et 
al. (1997) and Roy and Treacy (1993) observed oestradiol secretion in isolated human 
follicles in the presence of FSH, however in the Experiment I no gonadotrophins were 
added to the culture medium, therefore it is suggested that the culture medium provided 
was sufficient to stimulate aromatase action in the growing follicles giving rise to 
oestradiol secretion however as the proportion of follicles growing decreased with time 
so did oestradiol secretion indicating that without exogenous support steroidogenesis 
could not be maintained. In this study antral formation occurred in Experiment 1, 
promoted by rhAct A with cavities observed after 10 days in vitro, 6 days of cortical 
fragment culture and a further 4 days of isolated follicle culture. In large mammals 
although it is not known exactly how long primordial follicles take to form antral cavities 
in vivo, the time taken in human (Gougeon 1986) and bovine ovaries (Gosden etal. 1994. 
Lussier et al. 1987) is believed to be months rather than days, therefore rhAct A 
supplementation appears to support a marked acceleration of follicle differentiation 
whilst maintaining morphological oocyte health. After 4 days of isolated follicle culture 
in the presence of rhAct A 59% were classified as type I or 2 healthy i.e. grossly normal 
oocyte morphology with granulosa cell contact whereas 80% of follicles cultured ill 
control medium were type 3 and 4 degenerate. This is an encouraging observation 
suggesting that activin promotes follicle growth and differentiation and in doing so does 
not cause perturbation of oocyte morphology however as discussed in Chapter 7 in 
relation to the oocytes of cultured primordial bovine follicles, the ability of oocytes from 
cultured human primordial follicles to undergo further development is unknown. In 
Experiment I the mean oocyte diameters achieved after 4 days of isolated follicle culture 
were 51 .33 ± 4.2j.im and 31.9 ± I .57tm in the presence and absence of rhAct A 
respectively therefore extension of the culture period with gonadotrophin support is 
indicated with the possible inclusion of an additional step to include culture of oocyte-
cumulus complexes to ascertain whether further oocyte growth and ultimately meiotic 





9.1. GENERAL DISCUSSION 
The overall aim of this thesis was to investigate the developmental potential of bovine 
and human ovarian follicles grown in vitro. The experiments described in this thesis dealt 
with two key transition stages of follicular development a) activation of primordial 
follicles into the growing pool (primordial to primary transition) and b) development of 
preantral follicles to the antral stage (preantral to antral transition). The work reported in 
this thesis has demonstrated that isolated immature bovine follicles can develop to the 
antral stage in vitro and that activin A enhances this transition by supporting the 
maintenance of oocyte-somatic cell interactions. In addition, this work has shown that 
culture conditions can support initiation of primordial follicle development to the 
preantral stage within cortical strips in both bovine and human and after isolation from 
the ovarian cortex these in vitro grown preantral follicles are capable of developing to 
antral stages. Activin A has emerged as a key regulator of follicle development from 
preantral to antral stages in vitro in both bovine and human systems and initial steps have 
been made to define the timing of exposure to FSH to support further development. 
Complete in vitro follicle development has been successfully achieved in rodents (Eppig 
and O'Brien 1996, O'Brien et al. 2003) with the activation of primordial follicles 
resulting in birth of several mice. The work reported in this thesis has advanced similar 
systems in bovine and humans and provides a strong foundation for future work to 
complete follicle development in vitro in these species. As well as having a clear 
practical application, the in vitro systems described in this thesis provide model systems 
to address basic biological questions relating to follicular development in cattle and 
humans. As discussed in chapter 1 the development of in vitro systems supporting the 
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growth of isolated large animal follicles has led to the definition of conditions and the 
identification of factors supportive of the preantral stages of follicle development (Telfer 
et at. 2008, Thomas et at. 2007, Yang and Fortune 2007, Yang and Fortune 2006, 
Thomas et al. 2003a, Thomas et al. 2001, Telfer et at. 2000, Hovatta et al. 1999, Cecconi 
et at. 1999, Abir etal. 1997, Wandji et al. 1996, Figueiredo et al. 1994, Hulshof et al. 
1 995) resulting in the achievement of significant developmental milestones in vitro 
(Telfer et al. 2008, Hirao et al. 2004, Guttierrez et al. 2000). However gaps remain and 
development of a mLIlti-step system capable of supporting complete large animal follicle 
development in vitro has yet to be realised. 
The experiments in chapter 7 and chapter 8 were designed to address these gaps by 
investigating the developmental potential of cortical strip-enclosed bovine and human 
follicles activated in vitro then isolated and cultured individually for a further period. By 
culturing cortical strips, containing only very small, immature follicles, homogeneity of 
the starting population was ensured and after 4-6 days, and in the presence of rhAct A, a 
significant proportion of the isolated follicles had increased in size, developed antral 
cavities, undergone steroidogenesis and retained morphologically healthy oocytes 
indicating that human and bovine follicles activated in vitro have developmental potential 
and that it is significantly enhanced by the presence of rhAct A. The mechanism of the 
observed effect of rhAct A in this system requires exploration with the identification 
(western blotting) and localisation (immunohistochemistry) of rhAct A receptors and 
their intracellular signalling pathways suggested as starting points for this investigation. 
The ability of these follicles to develop beyond 4 or 6 days in culture merits further study 
and an extension of the culture period and/or aspiration of the oocyte-cumulus complexes 
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and further membrane/matrix-supported culture may be an appropriate method of 
examining their maximum developmental potential. 
The effect of androgens on early bovine follicle development has been investigated 
recently by Yang and Fortune (2006) who demonstrated the significant transition of 
primary bovine follicles within cortical strips to the secondary stage in the presence of 
testosterone. The experiments described in chapter 6 were designed to determine the 
effect of testosterone in combination with rhAct A and rFSE-1 on primordial follicle 
activation and the primary to secondary follicle transition. Both activin and FSH in 
combination are known to have an additive effect on the growth of isolated early bovine 
preantral follicles (Huishof et al. 1997)   therefore by supplementing the culture media 
with these factors in addition to testosterone it was hypothesised that a further additive 
effect on follicle development might be observed. The results of these experiments 
demonstrated that testosterone promoted the transition of bovine follicles from the 
primary to the secondary stage of growth within cultured cortical strips however oocyte 
health was compromised, an effect arneloirated, in secondary follicles, by the presence of 
rhAct A. The effect of testosterone on isolated bovine follicle growth was also 
investigated with reduced oocyte health and loss of oocyte-somatic cell contact in the 
presence of testosterone observed, features significantly improved by the addition of 
rhAct A to the culture medium. Further studies are required to investigate whether the 
action of testosterone in these experiments is exerted by it conversion to oestradiol or by 
binding to either an androgen receptor or SHBGR COIl moreover the mechanism by which 
activin acts in the presence of testosterone also merits further examination as it may exert 
its effect directly by maintaining oocyte-somatic contact or indirectly by regulating the 
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mechanism of testosterone binding. In chapter 3 two aspects of follicle culture were 
evaluated; the effect of FCS on the isolated preantral bovine follicle development and the 
optimum length of time these follicles could be maintained in culture. FCS is a non-
specific growth promoter and has been used extensively in follicle culture systems in a 
wide variety of species however its specific effects can been difficult to identify due to 
the complexity of its composition. These experiments established that prolonging the 
culture period of preantral bovine follicles beyond 8 days was deleterious to oocyte 
survival furthermore, it was concluded that as the culture period progressed the addition 
of serum induced asynchronous growth with an observed loss of oocyte and somatic cell 
contact. These conclusions posed the problem of how to maximise follicle development 
within 8 days without jeopardising oocyte health and in chapters 4 and 5 the effect of the 
activin in this culture system was evaluated. The experiments in these chapters 
established an optimum concentration of rhAct A supplementation of the culture media 
and demonstrated that rhAct A promoted follicle growth, proliferation of granulosa cells, 
antral formation and oocyte health in isolated bovine preantral follicles thereby 
identifying activin as a important promoter of preantral follicle development. 
9.2. CONCLUDING REMARKS 
The work in this thesis has demonstrated growth and differentiation to the antral stage of 
development of in vitro activated human and bovine follicles. The experimental two-step 
system described bridges the gap between systems supporting in vitro activation of 
primordial follicles and growth to the secondary stage within cortical strips, and, systems 
designed for the culture of isolated preantral follicles. Moreover this thesis has identified 
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activin A as a promoter of growth, antral formation and oocyte health in human and 
bovine preantral follicles. Using the two-step system described the oocytes of either 
human or bovine in vitro activated follicles are too small to undergo in vitro maturation 
(IVM) on completion of culture, therefore modification of the system is indicated to 
allow further oocyte growth. Suggested alterations include extending the culture of 
isolated activated primordial follicles for up to 8 days, as indicated in chapter 5 of this 
thesis, thereafter release of the oocyte-cumulus complexes from the follicles and further 
culture of oocyte-cumulus complexes within a matrix or on a supportive membrane in the 
presence of rhAct A with the aim of supporting oocyte growth until diameters conducive 
to IVM can be achieved and the meiotic competence of these oocytes assessed. 
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